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December 2018
Health supply chains in low and medium-income countries are constantly
strained due to a lack of resources and infrastructure, poor management and
supply-side shortages. This often results in health care facilities experiencing
stockouts, leaving patients without access to certain medicines. It is therefore
important to recognise that the eﬃcient functioning of pharmaceutical supply
chains is a fundamental priority, as the failure to deliver certain important
medicines can result in numerous lives being lost.
These problems have led to the implementation of various approaches by a
number of healthcare organisations to address and alleviate the strain experi-
enced by pharmaceutical supply chains. Although these approaches have had
a mostly positive impact, the overall results have been disappointing. There-
fore, new and innovative approaches are required to improve the supply of
medicines.
In order to address the need for better functioning pharmaceutical supply
chains and improved medicine supply, this study investigates the potential for
the integration of public and private pharmaceutical supply chains. Speciﬁ-
cally, the study proposes a framework to assist developing countries to identify
opportunities for public-private integration in pharmaceutical supply chains.
The purpose of the framework is to: (i) determine a pharmaceutical supply
chain's current integration level; (ii) identify opportunities for integration; (iii)
determine the risks and beneﬁts of the opportunities; and (iv) prioritise the
identiﬁed opportunities.
ii
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Extensive literature reviews are carried out on three intersecting research
ﬁelds, namely: public health supply chains, pharmaceuticals and public-private
integration. The insights gained during the literature reviews are integrated to
develop the framework. The resulting framework consists of a guide contain-
ing descriptions of the purpose, how the framework should be used as well as
templates that are required during the assessment. In addition, the framework
consists of an Excel® ﬁle that is used for data collection and analysis.
The framework was validated through the use of questionnaires that were
completed by four subject matter experts (SMEs) who have experience in the
pharmaceutical and health supply chain ﬁelds. Feedback from the SMEs in-
dicated that there is a need for such a framework and that the framework is
able to identify opportunities for integration in pharmaceutical supply chains.
The feedback was also used to improve and reﬁne the framework.
An illustrative case study was carried out by applying the framework to a
real world scenario. The case study provides an illustration of how the frame-
work can be applied and the typical outcomes of using the framework to assess
supply chains. The case study also enabled the identiﬁcation of opportunities
where the framework can be further improved.
The study makes a contribution by introducing a novel framework that
enables decision makers and supply chain managers to assess pharmaceutical
supply chains and identify opportunities for beneﬁcial public-private integra-
tion.
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Uittreksel
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Privaatsak X1, Matieland 7602, Suid Afrika.
Tesis: MScIng (Ind)
Desember 2018
Gesondheidsvoorsieningskettings in lae en medium inkomste lande is voort-
durend onder druk as gevolg van 'n gebrek aan hulpbronne en infrastruktuur,
toenemende produkvolumes en vraag, asook swak bestuur. Farmaseutiese
voorsieningskettings is moontlik van die mees belangrike voorsieningskettings
omdat die ontoeganklikheid van medisyne tot lewensverlies kan lei. As gevolg
van die druk waaronder voorsieningskettings gebuk gaan, ervaar gesondheids-
fasiliteite dikwels 'n tekort aan produkte en baie mense het nie toegang tot
medisyne nie.
Weens hierdie probleme, het 'n aantal gesondheidsorganisasies verkeie be-
naderings geïmplimenteer om die druk wat farmaseutiese voorsieningskettings
ervaar aan te spreek en te verlig. Alhoewel hierdie benaderings meestal 'n
positiewe impak maak, is die algehele resultate teleurstellend. Derhalwe is
nuwe en innoveerende benaderings nodig om die voorsiening van medisyne te
verbeter.
Om die behoefte van beter funksionerende faramseutiese voorsieningsket-
tings aan te spreek, ondersoek hierdie studie die potensiaal vir die integra-
sie van openbare en private farmaseutiese voorsieningskettings. Die studie
stel spesiﬁek 'n raamwerk voor wat onwikkelende lande help om geleenthede
vir openbare-private integrasie in farmaseutiese voorsieningkettings te identi-
ﬁseer. Die doel van die raamwerk is om: (i) die huidige integrasievlak van 'n
farmaseutiese voorsieningsketting te bepaal; (ii) geleenthede vir integrasie te
iv
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identiﬁseer; (iii) die risiko's en voordele van die geleenthede te bepaal; en (iv)
die geïdentiﬁseerde geleenthede te prioritiseer.
Ekstensiewe literatuuroorsigte word op drie deurkruisende navorsingsvelde
uitgevoer, naamlik: openbare gesondheidskettings, farmaseutiese medisyne en
openbare-private integrasie. Die insigte wat tydens die literatuuroorsigte ver-
kry is, word geïntegreer om die raamwerk te ontwikkel. Die gevolglike raam-
werk bestaan uit 'n gids met beskrywings van hoe die raamwerk gebruik moet
word, sowel as template wat tydens die assessering benodig word. Daarbene-
wens bestaan die raamwerk uit 'n Excel® spreiblad wat vir data-insameling
en analise gebruik word.
Die raamwerk is ge-evalueer deur die gebruik van vraelyste wat deur vier
vakkundiges, met ervaring in faramaseutise en gesonheidsvoorsieningsketting-
velde, voltooi is. Terugvoer van die vakkundiges het aangedui dat so 'n raam-
werk benodig word en dat die raamwerk in staat is om geleenthede vir integra-
sie in farmaseutiese voorsieningskettings te identiﬁseer. Die terugvoer is ook
geruik om die raamwerk te verbeter en te verfyn.
'n Illustratiewe gevallestudie is uitgevoer deur die raamwerk op 'n werklike
wêreldsituasie toe te pas. Die gevallestudie gee 'n illustrasie van die moontlike
toepassing van die raamwerk en die tipiese uitkomste van die gebruik van die
raamwerk wanneer voorsieningskettings ge-assesseer word. Die gevallestudie
het ook die identiﬁseering van geleenthede waar die raamwerk verder kan ver-
beter, moontlik gemaak.
Hierdie studie lewer 'n bydrae deur 'n nuwe raamwerk voor te stel wat
dit vir besluitnemers en verskaﬃngkettingbestuurders moontlik maak om far-
maseutiese voorsieningskettings te evalueer en geleenthede te identiﬁseer vir
openbare-private integrasie om sodoende die voorsieningsketting te verbeter.
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Chapter 1
Introduction
This chapter introduces the study context by providing the background and
problem statement. The research aim and objectives are then established,
after which the scope of the study is discussed. Lastly, an overview of the
document layout is provided.
1.1 Background
Well-functioning supply chains are the foundation of a health system (MIT-
Z ILP, 2008). According to the World Health Organization (WHO), and as
manifested in the health system building blocks framework (WHO, 2010), a
well-functioning health system ensures equitable access to essential medical
products, vaccines and technologies of assured quality, safety, eﬃcacy and cost-
eﬀectiveness, and their scientiﬁcally sound cost-eﬀective use (WHO, 2010).
The goal of public health supply chains is not only to deliver the right prod-
uct at the right place and time, but also to contribute towards improving a
country's health outcomes and achieve broad development goals (such as re-
ducing poverty and increasing productivity) (John Snow Inc., 2017; Bornbusch
et al., 2014). Supply chains are crucial to deliver eﬀective health care across
all sectors by enabling the availability and provision of aﬀordable and qual-
ity products in areas that are accessible to the population (MIT-Z ILP, 2008).
Furthermore, supply chains can be used to track the supply and demand which
managers and policymakers can use to ensure the health system has adequate
resources (MIT-Z ILP, 2008).
A comparison of product availability between Organisation for Economic
Cooperation and Development (OECD) countries and low and medium-income
countries (LMICs) emphasise the underperformance of health supply chains in
many LMICs. In OECD countries, product availability in pharmacies is over
95 percent, whereas in LMICs, product availability at public health facilities is
approximately 38 percent (MIT-Z ILP, 2008). According to the WHO (2007),
1
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health systems across the globe are struggling to deliver satisfactory health
care. Moreover, health outcomes across developing countries are unacceptably
low (WHO, 2007). The vast number of people who do not have access to qual-
ity, eﬀective medicine suﬀer from illnesses that can be treated or prevented
(MSH, 2012). This indicates that there are fundamental problems in such
health care systems (MSH, 2012).
One of the key health sector challenges is the inequitable and discrimina-
tory access to essential medicines (WHO, 2011; Matowe, 2015). Often, those
who have access to medicines receive the wrong dosage, the wrong medicine or
there is insuﬃcient stock for the amount of medicine that is required (MSH,
2012). Health supply chains in LMICs face a number of additional challenges.
A large proportion of populations living in LMIC countries are impoverished
and at increased risk of contracting diseases (MIT-Z ILP, 2008). According to
the WHO (2011), the burden of chronic diseases is rapidly increasing which
will pressurise medicine suppliers to ﬁnd supply strategies that are more eﬃ-
cient and cost-eﬀective. However, developing countries not only have to deal
with an increase in chronic diseases, but also an increase of other diseases such
as malaria, HIV/AIDS and TB (WHO, 2011). Additionally, changes in the
demography (e.g. the distribution and size) and epidemiology of human pop-
ulations will have an impact on the burden of disease, as well as an impact on
how medicines are delivered and consumed (WHO, 2011).
Some of the major health system challenges are the shortage of human
resources, resource constraints that hinder recruitment and training of staﬀ,
geographically reaching all consumers, limited or no information for forecasting
and supply planning, insuﬃcient warehouse space and distribution capacity,
poor funding and management, increased complexity and increased number of
products (MIT-Z ILP, 2008; Allain et al., 2010; John Snow Inc., 2016; UN Com-
mission, 2015; Caulﬁeld and Hort, 2012; Barillas, 2005). In these situations,
improving access to medicines is crucial to protecting the public's health and
saving lives (UN Commission, 2015). Tetteh (2009) argues that the improve-
ment of pharmaceutical supply chains should be regarded as a top priority
as a result of its aﬀect on the aﬀordability, availability and acceptability of
medicines. In addition, Tetteh (2009) states:
The creation of reliable drug supply chains is critical to ensure
continuous provision of aﬀordable quality medicines....
Lives can be saved, and quality of life improved by improving the performance
of health supply chains (UN Commission, 2015). However, in order to provide
equitable access to medicines and ensure health supply chains function eﬀec-
tively, eﬃciently and reliably, actors need to work together (John Snow Inc.,
2016).
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Various solutions, such as capacity building, supply chain strengthening,
public-private engagements and vertical integration have been implemented
to improve developing countries' health supply chains (Matowe, 2015; Born-
busch et al., 2014; Bornbusch and Bates, 2013). However, numerous authors
argue that these methods may not be suﬃcient, sustainable and proactive
(Matowe, 2015; Allain et al., 2010; Bornbusch et al., 2014; USAID, 2009), and
some are only applied to disease-speciﬁc programme supply chains (Kaboru,
2012) or aimed at solving a speciﬁc problem in the supply chain (USAID, 2010;
UNICEF, 2016). Innovative solutions are required, for both current and future
health supply chain problems (Bornbusch et al., 2014; International Finance
Corporation, 2011; WHO, 2011).
MIT-Z ILP (2008) made the observation that in many OECD countries,
even though the public sector is the major provider of health products and ser-
vices, public health supply chains rely heavily on auxiliary services provided by
the private sector. Unlike developed countries, numerous LMICs health supply
chains are underperforming and have less assistance from the private sector.
This begs the question; could greater private engagement and/or the adop-
tion of private supply chain best practices improve the public health supply
chain (MIT-Z ILP, 2008)? According to the International Finance Corporation
(2011), the scale of health care challenges has necessitated the reassessment
of traditional methods of addressing health care needs. Stakeholders in sub-
Saharan Africa have begun to recognise that private sector engagement should
be a key aspect of any strategy aiming to improve health care (International
Finance Corporation, 2011). Public-private engagement can be mutually syn-
ergistic; the public sector can leverage the auxiliary resources to improve health
outcomes while the private sector fulﬁls social responsibility, for which it is un-
der increased pressure (Nishtar, 2004). A number of authors (International Fi-
nance Corporation, 2011; UN Commission, 2015; MIT-Z ILP, 2008; Bornbusch
et al., 2014; Kaboru, 2012) argue that private sector engagement is essential
to improve: (i) access to health care; (ii) eﬃciency, reliability and eﬀectiveness
of supply chains; and (iii) health outcomes of the country. However, supply
chain integration should not be considered a panacea as public-private engage-
ment cannot be used to solve all supply chain problems (PATH and WHO,
2013; UN Commission, 2015). Public-private engagements are not easily im-
plemented (USAID, 2010) and the management thereof is diﬃcult (Axelsson
and Axelsson, 2006). Barriers to successful implementation include diﬀerent
ﬁnancial streams, diﬀerent information systems and databases (Axelsson and
Axelsson, 2006), conﬂict of interests (UN Commission, 2015; Nishtar, 2004)
and diﬀerent governance structures (Nishtar, 2004). However, authors such
as Nishtar (2004) argue that public-private engagement may be both impera-
tive and unavoidable and that it is the governments' responsibility to improve
health systems. However, according to the IFC World Bank Group (2011),
the absence of public resources and the presence of a growing private sector
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suggests that governments cannot improve health systems unless there is at
least minimal engagement with the private sector. In order to overcome the
challenges of public-private engagements, parties need to build mutual trust,
foster transparency and commitment, ensure that there are mutual beneﬁts
and understand the risks associated with engagement (UN Commission, 2015;
Tennyson, 2011). According to the UN Commission (2015), many private sec-
tor initiatives have already contributed to solving public health supply chain
problems by increasing supply chain eﬃciency and providing expertise on sup-
ply chain best practices. Public health supply chains often operate alongside
many other health supply chains (such as the private sector supply chain)
which Bornbusch and Bates (2013) call a supply network or system. Born-
busch et al. (2014) argue that the multitude of supply chains and actors within
the health system could be woven together into an integrated system.
Integration is deﬁned by the Merriam-Webster Dictionary as follows: ...to
form, coordinate, or blend into a functioning or uniﬁed whole... (Merriam-
Webster Inc., 1966). Supply chain integration involves cross-functional or
cross-departmental interactions which are often associated with coordination,
cooperation or collaboration (Chen et al., 2009). There is a proliferation of
deﬁnitions for `integration' in both the supply chain and public health liter-
ature. In the public health domain, the term integration can be used for a
number of diﬀerent concepts that sometimes overlap (Contandriopoulos et al.,
2003). Examples of these concepts include integrated service delivery (PwC,
2007), integration of care (Contandriopoulos et al., 2003), clinical integration
(Miller, 1996; Contandriopoulos et al., 2003), physician integration (Miller,
1996), functional integration (Miller, 1996; Contandriopoulos et al., 2003) and
integrated national health system (Reddy et al., 2011; Arbulo et al., 2015).
In the supply chain literature, an integrated supply chain can be deﬁned
as: An association of customers and suppliers who work together to opti-
mize their collective performance in the creation, distribution, and support of
an end product (National Research Council et al., 2000). According to the
National Research Council et al. (2000), the objective of supply chain integra-
tion is to focus and coordinate the relevant resources of each participant on
the needs of the supply chain and to optimize the overall performance of the
chain. This integration can also be achieved by a focal company expanding
its existing operations into related activities. In this context, it is possible
to distinguish between horizontal and vertical integration (Axelsson and Ax-
elsson, 2006). Vertical integration takes place when an organisation assumes
control of sequential steps in a supply chain (Axelsson and Axelsson, 2006;
Roberts et al., 2010). For example, an organisation could take control of its
suppliers (backward vertical integration) or its distributors (forward vertical
integration) (Roberts et al., 2010). In these supply chains, information and
activities are visible up and down the chain, the number of steps in the process
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are fewer and there is greater coordination between the levels of the supply
chain (USAID, 2009). On the other hand, horizontal integration occurs when
two or more organisations, that are at the same point in the supply chain,
merge (Roberts et al., 2010). An example of horizontal integration is when
two companies that produce similar products, for example, when two retailers
selling similar clothing items, merge.
The term supply chain integration has also been used in various ways in
public health supply chain literature and practice. The focus has predomi-
nantly been on (i) integrating disease or program speciﬁc supply chains such
as immunisation or TB supply chains (Bornbusch and Bates, 2013; PATH
and WHO, 2013; Kaboru, 2012; USAID, 2009); (ii) vertical integration (John
Snow Inc., 2012); and (iii) product integration (horizontal integration) where
some logistics functions of diﬀerent commodities are combined (UNICEF, 2016;
USAID, 2009). The various forms of public health integration are frequently
pictured along a continuum of inter-organisational relationships (Axelsson and
Axelsson, 2006). It ranges from organisations that are completely autonomous,
through intermediate consolidations to the complete merging of organisations
(Axelsson and Axelsson, 2006). The WHO's Optimize1 project horizontally
integrated vaccine supply chains with other health commodity supply chains
(PATH and WHO, 2013). According to PATH and WHO (2013), this may re-
sult in eﬃciency and eﬀectiveness improvements as well as economies of scale
and improved supply chain performance. According to a framework developed
by Axelsson and Axelsson (2006), collaboration can be deﬁned as the combi-
nation of a high degree of horizontal integration and a low degree of vertical
integration. This type of integration is accomplished via voluntary agreements
and the willingness to work together (Axelsson and Axelsson, 2006). According
to John Snow Inc. (2016): creating synergies between the public and private
requires a deliberate policy and strategic framework, a mutual understand-
ing of the beneﬁts of private sector engagement, and the capability to tailor
solutions to local environments.
1.2 Problem Statement
Public-private supply chain integration, as well as a combination of horizontal
supply chain integration and collaboration, may assist with the improvement
of pharmaceutical supply chains by increasing the eﬃciency and eﬀectiveness,
thereby addressing current and impending supply chain challenges. However,
before public-private supply chain integration can be implemented, supply
chains need to be assessed in order to identify whether there are opportunities
for integration. Existing frameworks that aim to identify such opportunities
1For more information see: http://www.who.int/immunization/programmes_systems/
supply_chain/optimize/resources/en/
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for public-private engagement and integration in supply chains seem to lack
the following: (i) the provision of a step-by-step approach to identify oppor-
tunities for public-private engagement; (ii) the inclusion of various forms of
public-private engagement; (iii) an assessment of end-to-end in-country public
supply chains; and (iv) the aim to improve not only underperforming supply
chain areas but also well performing supply chain areas.
In summary:
(i) Pharmaceuticals is an essential component of the health system.
(ii) Public health supply chains face a great deal of challenges that aﬀect the
health of the population.
(iii) Numerous solutions have been implemented. However, according to some
authors (Matowe, 2015; Allain et al., 2010; Bornbusch et al., 2014; US-
AID, 2009), these solutions are not sustainable, suﬃcient nor proactive.
(iv) Public-private supply chain integration could improve the eﬀectiveness
and eﬃciency of pharmaceutical supply chains and address supply chain
problems.
(v) There is a lack of frameworks that provide supply chain managers the
guidance to identify opportunities for public-private integration and en-
gagement along the supply chain.
Therefore, this research proposes that the integration of public and private
pharmaceutical supply chains needs to be investigated in order to support
integration where it could address supply chain challenges and lead to im-
provements in eﬃciency and eﬀectiveness. In addition, this research proposes
the development of a conceptual framework which aims to assist developing
countries to evaluate pharmaceutical supply chains in order to: (i) determine
the supply chain's current level of integration; (ii) identify where there are op-
portunities to integrate with the private sector; (iii) determine the impact of
the potential engagement in terms of the risks and beneﬁts; and (iv) prioritise
areas where opportunities of integration have been identiﬁed.
1.3 Research Aim
The aim of this research is to develop a framework to analyse public phar-
maceutical supply chains in order to identify, evaluate and prioritise possible
opportunities for synergies between the public and private sectors that may
improve the eﬃciency and eﬀectiveness of public pharmaceutical supply chains.
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1.4 Research Objectives
The following objectives were identiﬁed as requirements for developing such a
framework, thus supporting the above stated research aim.
1. Review literature pertaining to public health supply chains, pharmaceu-
ticals and public-private integration in order to contextualise the problem
with which this research inquiry is concerned, as well as to provide di-
rection for the framework development. Literature that were analysed
include:
(i) Health supply chain challenges and solutions.
(ii) Pharmaceutical supply chains.
(iii) Public and private engagement in pharmaceutical supply chains.
(iv) Supply chain integration.
(v) Existing frameworks and methodologies that have been developed
to identify opportunities for public-private integration and engage-
ment.
2. Develop a conceptual framework to evaluate pharmaceutical supply chains
to identify opportunities for integration
3. Validate and improve the conceptual framework through engagement
with subject-matter experts (SMEs).
4. Perform an illustrative case study by applying the framework to the
South African context.
5. Discuss the impact of the research and opportunities for future research.
Section 1.6 outlines the document, along with an indication of the objec-
tives that will be met by each chapter.
1.5 Scope of Study
The following points delineate the scope of the study:
(i) The scope of this study focuses on three overlapping ﬁelds of research,
namely: public health supply chains, pharmaceuticals and public-private
integration.
(ii) The supply chain challenges and problems, as discussed in Chapters 1 and
3, that need to be addressed occur in developing countries. Therefore, the
framework is created to be able to assess pharmaceutical supply chains
from the perspective of developing countries.
(iii) In this study the private sector refers to the private for-proﬁt sector.
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1.6 Document Outline
Table 1.1 shows how the document is structured and what each section con-
tains. Table 1.2 gives an indication of where each objective is addressed in the
document.
Table 1.2: An indication of where objectives are met
Objective Chapter
1. Literature review of relevant topics 3
2. Develop a conceptual framework to
evaluate pharmaceutical supply chains
4 & 5
3. Validate the conceptual framework
by performing an exploratory case study
6
4. Perform an illustrative case study
by applying the framework to the South
African context
7
1.7 Chapter 1 Conclusion
This chapter introduces the study context by providing the background context
within which the study is formulated, and the problem statement. From the
context and problem statement, the research aim and objectives are established
and described. Lastly, the scope of the study is discussed and the layout of the
document is provided. In this chapter the study proposes the investigation of
public-private pharmaceutical supply chain integration. In addition, the study
proposes the development of a framework that will enable developing countries
to evaluate pharmaceutical supply chains in order to identify opportunities for
integration.
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Table 1.1: An outline of the document
Chapter Chapter Content
Chapter 2:
Methodology
i. Thesis strategy detailing the purpose of the research and the research ap-
proach.
ii. Proposed steps to develop the conceptual framework.
Chapter 3:
Literature Review
Health Supply Chains
i. Overview of the challenges that public health supply chains are facing.
ii. Overview of the methods used to improve public health supply chains and
the shortcomings of these methods.
Pharmaceutical Supply Chains
i. Overview of the importance of pharmaceutical supply chains.
ii. Overview of PSC structures.
iii. Overview of how PSCs function.
iv. Overview of how PSCs are managed.
Public-Private Engagements in PSCs
i. Overview of why the public and private sectors should work together.
ii. Overview of public-private engagement challenges.
iii. Overview of how engagement challenges can be overcome.
iv. Overview of the types of public-private engagements.
v. Examples of public-private engagements.
Supply Chain Integration
i. Overview of supply chain integration.
ii. Deﬁnition of supply chain integration.
iii. An introduction to public-private supply chain integration.
Chapter 4:
Existing
Frameworks and
Methodologies
i. Review of literature to determine what methods have been used to identify
opportunities of integration.
ii. Determine whether the research aim has been met by other authors.
iii. Identify research gaps.
iv. Adapt research gaps to framework criteria.
Chapter 5:
Preliminary
Framework
Development
i. Overview of the methodology used to develop the framework.
ii. The framework criteria are met by selecting the most appropriate solution.
iii. The individual steps of the framework are determined.
iv. The individual steps are integrated to form the preliminary framework.
Chapter 6:
Framework
Validation
i. Discussion on the internal validation that was carried out.
ii. Discussion on the external validation that was carried out.
Chapter 7:
Final Framework
i. The ﬁnal framework is presented.
ii. Each phase of the framework is discussed.
Chapter 8:
Illustrative
Case Study
i. Overview of the illustrative case study scope.
ii. Overview of the case study context.
iii. An illustration of how the framework can be applied to identify opportu-
nities for integration.
iv. A discussion on the opportunities to further improve the framework as
identiﬁed during the case study.
Chapter 9:
Conclusion &
Future Work
i. Summary of the research
ii. Discussion on how the research objectives are met.
iii. Limitations of the research study.
iv. Recommendations for future work.
Stellenbosch University  https://scholar.sun.ac.za
Chapter 2
Research Methodology
The objective of this chapter is to outline the approach that was followed to
develop a framework as stated in the research aim and objectives (Sections 1.3
and 1.4). This chapter is divided into two sections: the research design (Section
2.1) provides an overview of the research purpose (Section 2.1.1) and approach
(Section 2.1.2). Thereafter, Section 2.2 describes the research strategy, and
how the conceptual framework analysis methodology designed by Jabareen
(2009) was adapted for the purpose of this dissertation.
2.1 Research Design
The purpose of a research design is to ensure that the evidence obtained en-
ables us to answer the initial question as unambiguously as possible (De Vaus,
2001). A research design provides a framework for the collection and analysis
of data (Bryman and Bell, 2014). The research design is discussed in terms of
the research purpose (Section 2.1.1) and the research approach (Section 2.1.2).
2.1.1 Purpose of Research
The purpose of research can be classiﬁed into one of three categories (Saunders
et al., 2009):
(i) Exploratory Research: as the name suggests, exploratory research is con-
ducted to explore the identiﬁed problem (Singh, 2007). In exploratory
research, the researcher asks questions, seeks new insights and assess
phenomena from a new perspective (Saunders et al., 2009). Exploratory
research is useful when the researcher wants to clarify their understand-
ing of the identiﬁed problem (Saunders et al., 2009). There are three
dominant ways of conducting exploratory research: reviewing literature,
interviewing subject-matter experts and conducting focus group inter-
views (Saunders et al., 2009).
10
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(ii) Descriptive Research: descriptive research asks the question `what is
going on?' (De Vaus, 2001). The purpose of descriptive research is to
portray an accurate proﬁle of persons, events or situations (Robson,
2005). It does not attempt to establish causal relationships between
variables. Descriptive research encompasses descriptive statistics, such as
population censuses, time studies, employment statistics or the frequency
of occurrences (Singh, 2007; De Vaus, 2001). Competent descriptions
can challenge accepted assumptions about the way things are and can
provoke action (De Vaus, 2001).
(iii) Explanatory Research: The focus of explanatory research is asking `why'
questions (De Vaus, 2001). Explanatory research can be described as re-
search that aims to ﬁnd causal relationships between variables (Saunders
et al., 2009). Answering `why' questions requires developing causal an-
swers. Causal explanations maintain that phenomenon X is inﬂuenced
by factor Y (De Vaus, 2001).
The purpose of this research is exploratory for the following reasons:
1. During the literature review, limited research was found on the integra-
tion of pharmaceutical supply chains.
2. Not only has little research been done, but very few frameworks were
found that have been developed to facilitate the integration of pharma-
ceutical supply chains. A number of research gaps were found in Chapter
4 regarding the existing frameworks.
3. Engagement between the public and private sectors is a complex endeav-
our due to the risks of public-private engagement.
2.1.2 Research Approach
Research approaches can generally be divided into two groups, namely quan-
titative and qualitative research (Bryman and Bell, 2014).
The main diﬀerence between quantitative and qualitative approaches is that
quantitative research focuses on the collection and analysis of numerical data,
whereas qualitative research focuses on words rather than generating or using
numerical data (Saunders et al., 2009; Bryman and Bell, 2014). Another dis-
tinction between the two approaches is that quantitative research is generally
deductive, which means the emphasis is on testing theories. Qualitative re-
search, on the other hand, is inductive where the emphasis is on generating
theories rather than proving theories (Bryman and Bell, 2014).
The research approach of this dissertation is qualitative; the development
and validation of the framework involved the use of non-numeric methods,
which are generally inductive in nature.
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2.2 Research Strategy
The research strategy describes the logical sequence of steps that were followed
during the research process. An overview of grounded theory and Jabareen's
(2009) conceptual framework analysis (CFA) methodology is provided in Sec-
tion 2.2.1. In addition, Section 2.2.2 discusses how the CFA methodology was
adapted for the purpose of this dissertation.
2.2.1 Grounded Theory
Grounded theory (GT) is a methodology that was introduced by Glaser and
Strauss (1967). It was subsequently adapted in the literature for the pur-
poses of building theory from data (Corbin and Strauss, 1990; Strauss and
Corbin, 1994; Whitehead, 2013; Corbin and Strauss, 2012). GT can be de-
scribed as theory that was derived from data, systematically gathered and
analysed through the research process (Strauss and Corbin, 1998). Similar
to other qualitative research methods, GT involves the collection of data from
sources such as interviews, documents, books and observations (Corbin and
Strauss, 1990). The procedures of grounded theory are designed to develop
a well integrated set of concepts that provide a thorough theoretical explana-
tion of social phenomena under study (Corbin and Strauss, 1990). GT has
been modiﬁed over the years, with multiple versions now existing (Whitehead,
2013). The CFA method proposed by Jabareen (2009) was used as a guide for
this thesis' research strategy. The CFA method is used to build conceptual
frameworks based on the GT method (Jabareen, 2009). Reasons for choosing
GT and CFA include the following:
(i) GT enables researchers to capture complex contexts (Bryman and Bell,
2014).
(ii) It facilitates the linking of theory with practice (Bryman and Bell, 2014).
(iii) GT strategies allow researchers to identify gaps in their research during
early research stages (Charmaz, 2006).
(iv) Data is analysed systematically (Hussein et al., 2014).
(v) GT and CFA are based on an inductive approach (Jabareen, 2009; Glaser
and Strauss, 1967; Randall and Mello, 2012).
(vi) GT is an appropriate method to research supply chain management be-
cause it uses a holistic and process-oriented method to determine the
rules, processes, and strategies upon which supply chains operate (Ran-
dall and Mello, 2012).
(vii) The success of the GT approach has led to an increase in research where
GT is used to explain supply chain phenomena (Randall and Mello, 2012)
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The deﬁnition of the term `conceptual framework' is unclear and imprecise
(Jabareen, 2009). Jabareen (2009) deﬁnes a conceptual framework as a net-
work, or `a plane' of interlinked concepts that together provide a comprehensive
understanding of a phenomenon or phenomena. The conceptual framework
analysis steps suggested by Jabareen (2009) can be summarised as follows:
1. Map the selected data sources: an extensive review of multidisciplinary
literature should be done regarding the phenomena in question.
2. Read and categorise the data extensively: the literature identiﬁed in step
1 is read and categorised according to importance and discipline.
3. Identify and name concepts: the literature is reread to allow the re-
searcher to `discover' concepts.
4. Deconstruct and categorise the concepts: each concept is deconstructed
into its main attributes and characteristics.
5. Integrate the concepts: similar concepts are grouped together to form a
new concept.
6. Synthesise and re-synthesise: concepts are iteratively synthesised and
re-synthesised into a conceptual framework until the framework is well-
deﬁned.
7. Validate the conceptual framework: the conceptual framework is vali-
dated by `outsiders', i.e. other academics or practitioners.
8. Rethink the conceptual framework: the conceptual framework may be
revised according to new literature or comments.
The CFA methodology was used as a guide in developing the framework in
this research. As a result slight adjustments were made to the methodology
which are further discussed in Section 2.2.2.
2.2.2 Methodology
An adapted version of the CFA methodology was used for this dissertation.
Figure 2.1 provides an illustration of the research methodology which is adapted
from Jabareen (2009). Each phase of the research methodology is further dis-
cussed below.
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Figure 2.1: An overview of the research methodology
2.2.2.1 Phase 1: Problem Statement and Contextualisation
During Phase 1 of the methodology, information was gathered and read in
order to formulate a clear deﬁnition and understanding of the problem at
hand and to identify the research objectives. This includes both a preliminary
and comprehensive literature review of the identiﬁed ﬁelds of research which
are essential to ﬁnding a solution to the research problem.
Chapter 1: Background to the research problem is provided through a pre-
liminary literature review. In addition, the research aim, research objectives
and the scope of the study is discussed. The preliminary literature review and
research objectives help to determine what ﬁelds of research should be focused
on to obtain a good foundation of knowledge so that the research aim can be
achieved.
Chapter 3: Three ﬁelds of research were identiﬁed during the preliminary
literature review in Chapter 1, which are indicated by the blue shaded areas
of Figure 2.2. An extensive literature review was carried out on these ﬁelds
of research to provide further background information and form a deeper un-
derstanding of the problem at hand. Literature was gathered through Google
Scholar, Scopus, the Stellenbosch University library database and oﬃcial web-
sites of health and supply chain organisations such as the WHO, USAID, JSI
Inc. and MSH.
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Figure 2.2: Overlapping ﬁelds of research
2.2.2.2 Phase 2: Framework Development
In Phase 2 of the methodology, criteria are identiﬁed that the framework should
meet. These criteria form the main attributes of the framework. The solutions
to the criteria are then deconstructed into smaller steps. Various methods for
each step is investigated in order to determine which are the most appropriate
for the framework. Lastly, the selected methods and solutions to the criteria
are integrated to form the preliminary framework.
Chapter 4: A literature review is carried out on existing frameworks and
methodologies that aim to identify opportunities for public-private engagement
in health supply chains in order to:
1. Determine what methods have been used to identify opportunities for
public-private health supply chain integration or public-private engage-
ment.
2. Determine whether the aim of this dissertation has already been achieved
by another author.
3. Identify the research gaps of the frameworks.
4. Adapt the identiﬁed research gaps to framework criteria.
Four diﬀerent frameworks and methodologies, that aim to identify opportuni-
ties for public-private engagement, were identiﬁed for the review. From the
review, the following criteria were derived from research gaps:
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1. A clear step-by-step approach is needed to identify opportunities for
public-private pharmaceutical supply chain integration.
2. The framework should include various forms of public-private engage-
ments.
3. The framework should assess the end-to-end in-country public pharma-
ceutical supply chain for integration opportunities.
4. The framework should aim to improve any supply chain area, not just
underperforming areas.
Chapter 5: The preliminary framework is developed by ﬁrst meeting the
criteria from Chapter 4. The various possible solutions that may meet the
criteria are investigated, after which the best solution is chosen for each criteria.
The most important criteria is identifying an appropriate approach for the
framework. In Section 5.2.1 the DRIVE approach is identiﬁed as the most
appropriate approach to develop the framework. This section provides a review
of the methods that have been used for each step of the DRIVE approach as
well as a discussion of the relevance of the methods to the framework. Finally,
the most appropriate methods are chosen, which are then integrated to form
a preliminary framework.
2.2.2.3 Phase 3: Validation & Illustrative Case Study
The aim of Phase 3 of the methodology is to validate and improve the frame-
work by consulting individual subject-matter experts who have knowledge and
practical experience in the research ﬁeld addressed in this study.
Chapter 6: The preliminary framework is validated by four SMEs. The pre-
liminary framework is resynthesised according to the feedback, insights and
recommendations made by the SMEs.
Chapter 7: The ﬁnal framework is presented and discussed.
Chapter 8: An illustrative case study is conducted to illustrate how the
framework can be used to identify any opportunities for improvement that
it may still have. The identiﬁed opportunities can then be used as recommen-
dations for future work.
Chapter 9: The delimitations and limitations of the framework are discussed,
and the recommendations and future work are addressed.
2.3 Chapter 2 Conclusion
This chapter discusses the purpose of the research (Section 2.1.1), the research
approach (Section 2.1.2) as well as the reasons for using the GT approach
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(Section 2.2.1). A short introduction is given on the CFA method by Jabareen
(2009), which is adapted and used to execute the three phases of this thesis
(Section 2.2.2). The three phases include: Phase 1: Problem Statement and
Contextualisation; Phase 2: Framework Development; and Phase 3: Validation
& Illustrative Case Study.
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Chapter 3
Contextualisation: Public Health
Supply Chains, Pharmaceuticals
and Public-Private Integration
In this chapter a literature review is carried out on the following subjects: (i) an
overview of health supply chains, including the challenges health supply chains
face in developing countries as well as the methods used to improve health
supply chains; (ii) the importance of pharmaceutical supply chains, and the
structure, functioning and management of pharmaceutical supply chains; (iii)
an overview of public-private engagements in pharmaceutical supply chains;
and (iv) a review of supply chain integration, the deﬁnition of supply chain
integration and an introduction to public-private supply chain integration.
3.1 Health Supply Chains
This section explores the diﬃculties that health supply chains in developing
countries face. In addition, a short overview of the methods used to reduce
the eﬀects of these problems are provided along with the shortcomings of these
methods.
3.1.1 Current Health Supply Chain Challenges
Health supply chains are a crucial element of a health system and are vital
for the consistent and continuous delivery of high quality, aﬀordable health
products that are available and accessible to the countries' population (MIT-Z
ILP, 2008). However, the majority of developing countries have poorly func-
tioning health supply chains (Allain et al., 2010) which result in poor health
outcomes (MIT-Z ILP, 2008), increased costs, stockouts, wastage of products
and redundant eﬀorts (UN Commission, 2015). Health supply chains func-
tion poorly due to a lack of the required resources to ensure the accessibility,
18
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availability and aﬀordability of health commodities (UN Commission, 2015).
Developing countries often lack reliable information systems as well as ware-
housing and distribution resources (MIT-Z ILP, 2008). Health supply chains
need reliable and comprehensive data in order for managers to manage sup-
ply chain activities and functions, make decisions and improve the supply
chain's eﬃciency (Matowe, 2015). In addition, the data is used to determine
the quantity of products that the population needs and thereby ensuring that
each health facility has enough stock available (Matowe, 2015). Due to the lack
of adequate data and information systems for supply planning and forecast-
ing (MIT-Z ILP, 2008; Matowe, 2015; UN Commission, 2015), health supply
chains in developing countries are often unresponsive (UN Commission, 2015)
and ineﬃcient resulting in product stockouts (Matowe, 2015).
Another challenge is the absence of trained staﬀ (Allain et al., 2010). As
a result, untrained staﬀ and unqualiﬁed staﬀ are required to perform supply
chain tasks (Matowe, 2015; Allain et al., 2010) which leads to clinical staﬀ
spending more time on completing supply chain tasks rather than helping sick
or injured patients (Allain et al., 2010). Furthermore, public health supply
chains are under increasing pressure due to escalating volumes of products
ﬂowing through these supply chains as well as an escalating demand for health
products and services Donato et al. (2016); Allain et al. (2010); Bornbusch et al.
(2014). Allain et al. (2010) argue that an increase in the demand for health
products and services induces further complexity in health supply chains which
consequently increases costs. Increased donor funding also contributes to the
escalating volume of products in health supply chains (Bornbusch et al., 2014).
While public supply chains are trying to manage these increases, civil society
and partners demand better performance and cost eﬀectiveness (Bornbusch
et al., 2014). Meeting the increasing need for health services and products ne-
cessitates the implementation of robust regulatory oversight in order to ensure
high quality products are provided (Donato et al., 2016). These factors place
additional pressure on both the public and private sector health supply chains
(Donato et al., 2016).
The majority of public health systems comprise of numerous vertical sup-
ply chains which supply diﬀerent health programmes (Allain et al., 2010).
Each of the vertical supply chains receive diﬀerent amounts of donor funds
and attention (Allain et al., 2010). Some governments create separate supply
chains for health programmes so that the supply chain's activities, informa-
tion and investments are aligned with the health programme's objectives and
outcomes (Allain et al., 2010). In order to compensate for the public sec-
tor's poor performing supply chains and to implement health reforms, some
investors have developed alternative vertical supply chains (Bornbusch et al.,
2014). However, very few public sectors can accommodate numerous verti-
cal supply chains (Allain et al., 2010). The existence of numerous vertical
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supply chains in health systems have been labelled as ineﬃcient and counter-
productive methods to strengthening public health systems (Bornbusch and
Bates, 2013) and have been criticised for promoting fragmentation (O'Hanlon
et al., 2017). Moreover, the development of these vertical supply chains fur-
ther increase the health system's complexity (Allain et al., 2010) and result in
duplicated eﬀorts and resources (Village Reach, 2015). International organi-
sations such as USAID (USAID, 2009), PATH (WHO and PATH, 2013), the
World Health Organization and VillageReach (Village Reach, 2015) have been
involved in initiatives where vertical supply chains are merged with the antici-
pation that redundancies will decrease and that the eﬃciency and performance
of the supply chain will improve (Allain et al., 2010).
Other problems that contribute to poorly functioning health supply chains
include the inability to reach all populations, inadequate and insuﬃcient trans-
port, distribution and warehousing, stockouts and unreliable cold chains (MIT-
Z ILP, 2008; UN Commission, 2015; Allain et al., 2010). In essence, the public
health supply chains in developing countries often lack the required resources
and capacity to provide a continuous supply of health products, especially
when the volume and complexity of products keep increasing (MIT-Z ILP,
2008).
3.1.2 Methods Used to Solve Health Supply Chain
Challenges
Various international organisations have saved countless lives (International Fi-
nance Corporation, 2011) by contributing ﬁnancially (Allain et al., 2010) and
promoting the purchase and distribution of pharmaceuticals, including that
of malaria, tuberculosis and HIV (International Finance Corporation, 2011).
However, these funds ﬂuctuate, are often allocated to disease-speciﬁc pro-
grammes and the health programme resources may not be eﬀectively shared,
resulting in the underutilisation of resources (Allain et al., 2010). According to
International Finance Corporation (2011) donor funds may not be a suﬃcient
and sustainable method to address future health challenges.
A great deal of investment and eﬀort has been dedicated to addressing
health supply chain problems in the form of capacity building and supply
chain strengthening (Matowe, 2015; Bornbusch et al., 2014). Kaplan (2000)
deﬁne capacity building as the development of the ability of individuals and
organisations or organisational units to perform functions eﬀectively, eﬃciently
and sustainably. Capacity building and supply chain strengthening have been
successfully implemented in some cases where the eﬃciency (Matowe, 2015)
and the performance of the health supply chain improved, resulting in a greater
availability of health products (Bornbusch et al., 2014). Examples of successful
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cases include countries such as Rwanda and Zambia where it has been reported
that the pharmaceutical supply chains operate eﬃciently (Matowe, 2015). In
addition, the Medical Stores Department of Tanzania was improved to oper-
ate at a level that is better than expected (Matowe, 2015). However, Matowe
(2015) argues that capacity building has been remarkably unsuccessful at im-
proving the eﬃciency of health supply chains. Matowe (2015) cites cases such
as that of Malawi, where the Central Medical Store (CMS) received technical
assistance from the Global Fund for more than two years, yet the CMS con-
tinuously still encounters complications and problems. Similarly, Bornbusch
et al. (2014) argues that the results form capacity building and supply chain
strengthening initiatives are tenuous and that decision makers need to ques-
tion whether the solutions that are currently implemented work as well as they
should and whether they will be able to address future challenges. Due to the
ineﬀectiveness of capacity building projects, Matowe (2015) argues that this
approach needs to change. However, Matowe (2015) oﬀers no suggestion as
how capacity building approaches should change or how this approach can be
improved.
According to Bornbusch et al. (2014) too many governments lack the exper-
tise to operate supply chains and that the operation of supply chains is there-
fore not the government's core competency. Governments should rather be
responsible for the provision of oversight, guidance and vision such that health
supply chains can achieve the necessary results (Bornbusch et al., 2014). In
other words, the government's core competency should be a stewardship role
(Bornbusch et al., 2014). As a steward it is not the government's responsibility
to control facilities directly, but to facilitate the coordination and engagement
of various actors such that common goals can be collectively achieved (Born-
busch et al., 2014).
Currently, supply chain integration seems to be the favoured method of im-
proving health systems overall as well as improving health supply chain eﬃcien-
cies (Bornbusch and Bates, 2013). Within the health sector the term supply
chain integration usually refers to two types of integration, namely product
integration (USAID, 2011) (also known as horizontal integration (PATH and
WHO, 2013)) and vertical integration (Rai et al., 2006). Product integration
involves the consolidation of vertical health programme supply chains (US-
AID, 2011). On the other hand, vertical integration refers to the integration
of information ﬂows, physical ﬂows, and ﬁnancial ﬂows between a ﬁrm and
its supply chain partners (Rai et al., 2006). When referring to supply chain
integration in the health supply chain domain, it generally refers to vertical
integration. According to John Snow Inc. (2012) and USAID (2011) verti-
cally integrated health supply chains have six attributes, including: (i) agility;
(ii) clear role and responsibilities; (iii) aligned objectives; (iv) streamlined
processes; (v) collaboration and trust amongst supply chain actors; and (vi)
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visibility of information. Although product integration does improve supply
chain eﬃciency and reduces complexity and redundancy, it does not however
improve the availability of health products (USAID, 2009; John Snow Inc.,
2012). Integrating supply chains improves customer service and supply chain
performance, and reduces cost (USAID, 2009). In opposition to USAID (2009),
van Olmen et al. (2010) argue that merging vertical supply chains creates weak
links in the supply chain in areas such as distribution, stock management and
ordering systems. Ultimately, van Olmen et al. (2010) argue that the weak
links will weaken the entire supply chain.
Even though product and supply chain integration have improved numer-
ous health supply chains as discussed in case studies by John Snow Inc. (2012),
USAID (2011) and WHO and PATH (2013), several questions remain unan-
swered. For instance, will vertical supply chain integration be able to address
future health supply chain problems, taking into account that the volume and
number of health commodities is increasing (Donato et al., 2016; Allain et al.,
2010; Bornbusch et al., 2014), demographics, such as population growth, are
changing (WHO, 2011), the demand for health services are increasing (Allain
et al., 2010) and the burden of disease is increasing (WHO, 2011)? By exam-
ining the documents that are supplied by supply chain integration advocates,
such as WHO, PATH, USAID and JSI, it is unclear what resources developing
countries would require to implement supply chain integration. Naturally, the
resources required for supply chain integration will diﬀer from country to coun-
try (USAID, 2011), however by investigating the case studies by John Snow
Inc. (2012), USAID (2011) and WHO and PATH (2013) it seems as though
substantial physical and ﬁnancial resources are needed for the implementa-
tion of supply chain integration. This raises the question of how developing
countries can obtain the required resources to implement product or vertical
supply chain integration when there is a lack of resources; whether developing
countries should rely on NGOs and how health supply chains can be further
improved if integration has already been implemented.
Bornbusch and Bates (2013) argue that private sector research indicates
that multiplicity is currently the favoured method to improve supply chain
eﬃciencies. Bornbusch and Bates (2013) deﬁnes multiplicity as structuring
a supply system to take advantage of multiple supply chains or segments to
reduce risk and maintain supply. Multiplicity has, to an extent, been applied
to health supply chains through the use of public-private initiatives which
involves the public sector utilising the strengths of the private sector (MIT-
Z ILP, 2008; UN Commission, 2015). Looking at existing literature, it is
apparent that public-private initiatives do not aim to improve an entire health
supply chain as Bornbusch and Bates (2013) suggest. Currently, public-private
initiatives aim to resolve speciﬁc supply chain areas that are underperforming
or are problematic (USAID, 2010; UNICEF, 2016). Public-private initiatives
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are also predominantly carried out in vertical disease-speciﬁc supply chains due
to increased donor funding for disease-speciﬁc programmes (Kaboru, 2012).
In order to ensure the availability of products and address current and future
health supply challenges, more eﬃcient supply chain strategies need to be
implemented (WHO, 2011). In other words, reformists and decision makers
need to establish new and innovative supply systems (WHO, 2011) and adopt
new models and frameworks (Allain et al., 2010).
3.2 Pharmaceutical Supply Chains
In order to narrow the scope, this thesis will focus on pharmaceutical supply
chains for the reasons discussed in Section 3.2.1. After the reasons for focusing
on pharmaceutical supply chains have been discussed, an overview is provided
on the structure of pharmaceutical supply chains, followed by the functions of
pharmaceutical supply chains and the management of pharmaceutical supply
chains.
3.2.1 The Importance of Pharmaceutical Supply Chains
Tanzania is one of the countries that was seriously aﬀected by the HIV and
AIDS pandemic (Kamuzora, 2011). According to the United Nations Pro-
gramme on AIDS (UNAIDS) statistics, roughly 200 000 people were enrolled
to receive treatment from December 2009 (Kamuzora, 2011). Therefore, en-
suring that a continuous supply of ARVs is delivered to the right facilities,
in the right quantities is crucial to successfully treating patients and the suc-
cess of the programme (Kamuzora, 2011). Pharmaceuticals are a fundamental
component of the health system. The inaccessibility thereof could indicate
failure on the part of the health sector and the government (Barillas, 2005).
Medicines are essential for a well functioning health system for the follow-
ing reasons (MSH, 2012): (i) medicine improves population health and saves
lives; (ii) medicines advocate participation and trust in the health system; (iii)
medicines are expensive; (iv) medicines are unlike other products; and (v) def-
inite improvements can be made in the supply and use of medicines.
The ability of a health system to successfully respond to health problems
largely depends on the availability of pharmaceuticals (Barillas, 2005). Matowe
(2015) argues that the accessibility of medicines should be linked to pharma-
ceutical supply chain management systems because it facilitates eﬃcient distri-
bution, procurement and use of medicines. In addition to the wastage of scarce
resources, the occurrence of failures in pharmaceutical supply chains can result
in stockouts that could have life-threatening consequences (WHO, 2006). In
2004 it was estimated that approximately 2 billion people did not have access
to essential medicines on a regular basis, in addition it was argued that 10 mil-
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lion lives could be saved annually by addressing the lack of access to medicines
(WHO, 2004; Strengthening Pharmaceutical Systems (SPS), 2011). According
to Clark and Barraclough (2010) the improvement of supply management can
drastically improve the availability of pharmaceuticals. Tetteh (2009) argues
that the improvement of pharmaceutical supply chains should be considered
a top priority due to the eﬀect it has on the acceptability, aﬀordability and
availability of medicines.
3.2.2 Pharmaceutical Supply Chain Structure
The goal of any health supply chain is to improve a population's health out-
comes (John Snow Inc., 2017). In the case of pharmaceutical supply chains
this is achieved by ensuring that all activities are seamlessly linked to create
a network that delivers the right pharmaceuticals in the right quantities and
conditions, to the right facilities at the right time, for the lowest possible cost
(John Snow Inc., 2017; WHO, 2011). In the majority of LMICs, public and
private organisations exist side-by-side as distribution channels for pharmaceu-
ticals with a number of ﬂows between the two (WHO, 2011). Health supply
chains consist of levels, functions and partners (John Snow Inc., 2012). Ac-
tivities are carried out at multiple levels, including national, regional, central,
district and facility level (John Snow Inc., 2012). This is due to the fact that
health facilities and retail pharmacies do not have a lot of space to keep stock
(WHO, 2011). Therefore, supplies are periodically received from wholesalers
in the private sector and regional or district warehouses in the public sector
(WHO, 2011). This results in multiple levels of warehouses and distribution
between manufacturers and patients (WHO, 2011). Functions are the activ-
ities performed at individual links of an interconnected supply chain such as
procurement, storage, product selection and distribution. Although pharma-
ceutical supply chains are organised slightly diﬀerently in various countries,
Figure 3.1 illustrates the general structure of pharmaceutical supply chains
(WHO, 2011; MSH, 2012).
The number of entities at each supply chain level, the governance, owner-
ship and function of each entity varies signiﬁcantly from country to country
(WHO, 2011). The optimal number of levels is dependant on the size of the
population, geographical factors, demand variability and the availability of
human resources, transport and storage space (WHO, 2011).
3.2.2.1 Public Sector Supply Chains
In LMICs, the predominant supply chain structure in the public sector has a
central medical store (CMS) that is used as the primary storage and distribu-
tion facility (WHO, 2011). Regional stores (RS) and district stores (DS) act
as second and third level storage and distribution facilities, depending on the
country's geography and number of health facilities (WHO, 2011). In addition
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Figure 3.1: Pharmaceutical supply chains. Reprinted from World
Medicines Situation 2011, 3rd edition, Yadav,P., Tata,H., Babaley,M., Stor-
age and Supply Chain Management, page 4, Copyright (2011), URL:
http://apps.who.int/medicinedocs/documents/s20054en/s20054en.pdf, Date ac-
cessed: 04 May 2018.
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to the central, regional and district stores, some countries have other pri-
mary and secondary storage and distribution facilities as well that are used for
programme-speciﬁc vertical health supply chains (WHO, 2011). These extra
storage and distribution facilities increase the complexity of the supply system
making the coordination and management of pharmaceutical procurement and
distribution increasingly diﬃcult (WHO, 2011). Figure 3.2 illustrates the dif-
ferent structures public health supply chains can have, where CMS refers to
central medical store, RS to regional store and DS to district-level store.
There are two major approaches to distributing stock from higher supply
chain levels to lower supply chain levels, namely push systems and pull systems
(WHO, 2011).
Push system: Higher level stores, such as the CMS, determine the quantities
of stock will be distributed to lower level facilities (WHO, 2011; MSH, 2012).
At the beginning of a planning period a delivery plan is created and stock
is delivered according to the delivery plan. Lower level facility managers are
expected to provide stock and consumption data to higher level facilities so
that stock can be allocated to lower level facilities (MSH, 2012). Push systems
are also know as ration or allocation systems (MSH, 2012).
Pull system: In a pull system, lower level facilities determine the types and
quantities of stock that are required and ordered from higher level facilities
or stores (WHO, 2011; MSH, 2012). Higher level facilities could be public
warehouses or private sector suppliers (MSH, 2012). Managers are expected
to estimate the demand, determine the buﬀer stock and submit requisitions
to higher level facilities for their own facilities (MSH, 2012). Pull systems are
also known as independent demand or requisition systems (MSH, 2012).
Some countries use a combination of pull and push systems. In these
types of mixed systems primary health medicines are routinely supplied in
a kit, whereas regional and district hospitals determine their own stock re-
quirements (MSH, 2012). Push and pull systems are preferred under diﬀerent
circumstances (as described below), however the choice is largely determined
by the country's quantiﬁcation capacity at each level and the maturity of the
supply chain (MSH, 2012).
Circumstances under which push systems are preferred (MSH, 2012):
(i) Staﬀ at lower level facilities are not proﬁcient at inventory control.
(ii) Demand tremendously exceeds supply, making rationing imperative.
(iii) A limited number of products are being handled.
(iv) When disaster relief is required or when short term supply is required.
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Figure 3.2: Various examples of public health supply chain struc-
tures used to distribute essential medicines. Reprinted from World
Medicines Situation 2011, 3rd edition, Yadav,P., Tata,H., Babaley,M., Stor-
age and Supply Chain Management, page 8, Copyright (2011), URL:
http://apps.who.int/medicinedocs/documents/s20054en/s20054en.pdf, Date
accessed: 04 May 2018.
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Circumstances under which pull systems are preferred (MSH, 2012):
(i) Staﬀ at lower level facilities are proﬁcient at managing inventory and
determining requirements.
(ii) Suppliers or higher level facilities have suﬃcient supplies to meet the
needs of lower level facilities.
(iii) A large number of products are handled.
(iv) Staﬀ at lower level facilities are often supervised and their performance
is monitored.
(v) Good data is available to staﬀ who make decisions.
The structure of the supply chain also determines the resupply interval,
since the resupply interval is inﬂuenced by the storage capacity of facilities at
each level of the supply chain (MSH, 2012). The resupply interval in turn deter-
mines how often deliveries are made, for example annually, monthly, weekly,
etc (MSH, 2012). If stock is delivered weekly, stock levels will be low and
the probability of stockouts will decline, however transport costs will increase
drastically (MSH, 2012). If stock is delivered annually, stock levels and storage
costs will increase and transport costs will decrease (MSH, 2012).
3.2.2.2 Private Sector Supply Chains
In the private sector stock is distributed to lower level facilities via a network
of wholesalers, importers and pharmacies (WHO, 2011). Wholesalers serve
two functions, namely distribution and storage. This allows retail pharmacies
to be restocked frequently to meet the daily requirements and decreases the
overall stock levels that pharmacies need to carry (WHO, 2011). The number
of wholesalers in a country depends on government regulation, the market size
and political economics (WHO, 2011). Three methods of distribution are used
to get stock from wholesalers to pharmacies, namely: distribution by private
couriers, by wholesaler vehicles or customers pick-up stock at the wholesaler
(WHO, 2011). Sometimes wholesalers make use of public transport, such as
mini-buses, to deliver to customers who are further away. Pharmacists lo-
cated in rural areas travel to urban areas to fetch stock from wholesalers or
sub-wholesalers (WHO, 2011). Although the private sector has eﬀective dis-
tribution that ensures product availability, distribution costs can be extremely
high. NGOs also serve as important sources of supply, however this varies
substantially between countries (WHO, 2011).
3.2.2.3 Vertical Supply Chains
The public sector often has health programs that focus on speciﬁc health in-
terventions such as controlling TB, which may have their own vertical supply
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chain that operates separately from the country's pharmaceutical supply chain
(MSH, 2012). Vertical programs may seem appealing because of the quick re-
sults that are produced and the management of a vertical program is much
easier than managing horizontal programs with multiple interventions (MSH,
2012). However, various governments and policy makers believe that vertical
programs detract resources from constrained health systems. Sometimes ver-
tical supply chains duplicate or displace a country's existing supply chain. In
addition vertical and essential medicines supply chains often do not coordinate
with one another, resulting in an excess or deﬁcit of stock (MSH, 2012). Some
countries are attempting to integrate vertical and essential medicine programs.
Functions such as quality assurance, distribution, procurement and storage
can be integrated to save costs, increase distribution eﬃciency and achieve
long-term sustainability, however the outcome depends on the government's
commitment to the process (MSH, 2012; WHO, 2011).
3.2.2.4 Public-Private Supply Chain Roles
The structure of pharmaceutical supply chains is inﬂuenced by the roles the
public and private sectors play in the ﬁnancing, retail distribution and whole-
sale distribution of pharmaceuticals (MSH, 2012). There are six approaches
in which pharmaceuticals can be supplied, ranging from fully public to fully
private (MSH, 2012). Table 3.1 gives a summary of the various approaches
which are shortly described below.
Table 3.1: Supply of pharmaceuticals according to role of public and private sectors.
Source: MSH (2012)
Distribution
Financing Wholesale Retail
Public
Fully public Public Public
Private supply to government facilities Private
Social health insurance Private Private
Private
Private ﬁnancing and public supply Public Public
State wholesale monopoly Public Private
Fully private Private Private
Fully public: This supply system is usually characterised by the use of a
central medical store (CMS) where a government unit procures, ﬁnances and
distributes medicines. The state manages, owns and funds the entire supply
chain.
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Private supply to government facilities: The private sector provides pub-
licly funded pharmaceuticals to health facilities that are operated by the gov-
ernment.
Social health insurance: Public funding is used to reimburse patients or
pharmacies for medicines that are provided by the private sector.
Private ﬁnancing and public supply: Government health facilities dis-
pense medicines that are paid for, either in whole or in part, by patient fees.
State wholesale monopoly: A state monopoly imports, distributes and sup-
plies pharmaceuticals to private pharmacies as well as some government health
services.
Fully private: Medicines are bought from private pharmacies and are paid
for entirely by patients.
While there are a variety of ways in which the supply of pharmaceuticals
are organised, the following ﬁve basic approaches are used for public health:
central medical stores, autonomous supply agency, direct delivery system, pri-
mary distributor system and primarily private system (MSH, 2012). In prac-
tice, pharmaceutical supply chains consist of a mixture of these approaches
depending on the level of health facilities or the categories of products (MSH,
2012). Some of these approaches are also used in the private sector, however
the description by MSH (2012) focuses on the public sector perspective:
Central medical stores: Traditional public supply chain where pharmaceu-
ticals are procured and distributed by central governmental unit.
Autonomous supply agency: In this case the CMS is managed by a phar-
maceutical supply agency that is either fully or semi-autonomous.
Direct delivery system: In this system there is no CMS. Suppliers deliver
directly to districts and health facilities. The government is not responsible
for any storage or distribution of pharmaceuticals.
Primary distributor system: This system also has no CMS. In this case the
government contracts one or more distributors that receive pharmaceuticals
from the suppliers and then distributes them to health facilities.
Primarily private supply: In some countries, private pharmacies located
close to public health facilities are used to provide pharmaceuticals to public
sector patients.
According to UN Commission (2015) there are speciﬁc functions of the
supply chain that are more appropriate for the public sector or private sector,
however there are overlapping functions that could be carried out by either
sector. The functions can be divided as indicated in Figure 3.3.
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Figure 3.3: Supply chain functions that are most suited for each sector. Source:
UN Commission (2015).
3.2.3 Supply Chain Functions
Supply chain functions are the activities that, when combined, constitute the
supply chain (John Snow Inc., 2017). Health supply chain functions are de-
ﬁned diﬀerently by various authors in the health and pharmaceutical supply
chain literature. MSH (2012) and John Snow Inc. (2017) provide the most
comprehensive information on the supply chain functions, therefore the most
prominent supply chain functions are shortly discussed below in Section 3.2.3.1
through 3.2.3.5 using these two author's work.
3.2.3.1 Product selection
John Snow Inc. (2017) deﬁne product selection as ...the process by which
health programs, as a whole, select, evaluate and ultimately procure the prod-
ucts that will be used and consumed in service delivery. The list of medicines
produced during product selections is known as the essential medicines list
(EML) (MSH, 2012). The WHO deﬁnes essential medicines as those medicines
that satisfy the health needs of the majority of the population. Limiting the
number of medicines that can be used in the public sector leads to a more
manageable supply chain, improved medicines supply, increased rational pre-
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 3. CONTEXTUALISATION 32
scriptions and lower costs (John Snow Inc., 2017; MSH, 2012).
The EML is developed by ﬁrst creating a list of common diseases and
health problems that occur in the country (MSH, 2012). Based on the list of
health problems and disease patterns, the essential medicines, training, supply
and medicine us for each level of care can be determined and complied into
a national EML as shown in ﬁgure 3.4 (John Snow Inc., 2017; MSH, 2012).
The selection of essential medicines is limited to the public sector. The pre-
ferred method of selecting medicines for the public sector is through a selection
committee as this minimises the potential inﬂuence of private interests on the
selection process (MSH, 2012). Ideally, members of the selection committee
should not have any connections with pharmaceutical manufacturers or dis-
tributors (MSH, 2012). The selection of essential medicines should be based
on (i) the signiﬁcance of the medicine to disease patterns; (ii) the safety and
eﬃcacy of the medicine; (iii) the performance of medicines under various cir-
cumstances; (iv) quality; (v) appropriate cost-beneﬁt ratios; (vi) favourable
pharmacokinetic properties; (vii) likelihood that medicines can be manufac-
tured locally and (viii) the availability of medicines as single compounds (MSH,
2012).
3.2.3.2 Quantiﬁcation
John Snow Inc. (2017) deﬁnes quantiﬁcation as the process of estimating the
quantities and costs of the products required for a speciﬁc health program (or
service), and determining when the products should be delivered to ensure an
uninterrupted supply for the program. However this deﬁnition not only ap-
plies to program quantiﬁcation but also to the quantiﬁcation used in national
pharmaceutical supply chains (MSH, 2012). Figure 3.5 gives an illustration of
the quantiﬁcation process. Contextual factors are used in order to estimate
the required quantities. Examples of contextual factors include the capacity
of human resources, available funds, storage capacity and service delivery ca-
pacity (MSH, 2012). Quantiﬁcation is an iterative process (usually bianually)
where quantiﬁcation data needs to be reviewed, updated and recalculated to
reﬂect current actual consumption, service delivery and changes in policies
(John Snow Inc., 2017). The quantiﬁcation of pharmaceutical needs can be
done using one method or a combination of four methods (MSH, 2012). The
four main methods include (MSH, 2012):
Consumption method: The consumption method uses data from pharma-
ceutical consumption records to forecast future needs of pharmaceuticals. Data
are sourced from facility stock and consumptions surveys, LMIS reports and
reports of pharmaceutical products dispensed to patients (John Snow Inc.,
2017). The consumption method is the most accurate method, however the
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Figure 3.4: Essential medicines selection process. Reprinted from
World Medicines Situation 2011, 3rd edition, van den Ham,R., Bero,L.,
Laing,R., Selection of Essential Medicines, page 3, Copyright (2011), URL:
http://apps.who.int/medicinedocs/documents/s20054en/s20054en.pdf, Date ac-
cessed: 04 May 2018.
reliability of the method depends on the quality of data and the stability of
the supply system (MSH, 2012).
Morbidity method: The morbidity method calculates the theoretical amount
of pharmaceuticals needed to treat speciﬁc illnesses. Standard treatment
guidelines and reliable data on morbidity, patient attendance and epidemi-
ology is required to forecast pharmaceutical needs (MSH, 2012; John Snow
Inc., 2017). This method is considered the most complex method and takes a
considerable amount of time to execute. Even so, the method is beneﬁcial for
new programs as well as for justifying a budget request (MSH, 2012).
Proxy consumption method: The proxy consumption method is used when
no reliable data on consumption or morbidity is available. In such cases data,
such as disease incidence, pharmaceutical expenditures, demand or medicine
use, is used to extrapolate consumption rates and determine supply system
needs.
Service-level projection of budget requirements: This method is only
used when budgetary requirements are needed; it is not used to forecast the
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required pharmaceutical quantities. The cost of the average medicine per
patient attendance is used to forecast medicine costs in various types of health
facilities.
3.2.3.3 Procurement
MSH (2012) deﬁne procurement as the process of purchasing supplies directly
from national or multinational private or public suppliers; purchasing through
global agencies and procurement mechanisms or regional procurement systems;
or purchasing from international procurement agents. The procurement cycle,
as illustrated in ﬁgure 3.6, shows the activities and decisions that determine
the quantities of pharmaceuticals received, the quality of the pharmaceuticals
and the price paid (MSH, 2012).
Figure 3.6: The procurement cycle. Source: MSH (2012)
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Figure 3.5: An illustration of the process of quantifying health commodities.
Adapted from John Snow Inc. (2017)
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Various procurement models are used in developing countries to procure
pharmaceuticals and other health commodities (WHO, 2011). The following
models are the most commonly used procurement models (WHO, 2011):
Centralised procurement: On a national level, this procurement model is
traditionally used in the public sector. In this model the ministry of health
has a government procurement unit or a government procurement agency (for
example a central medical store) that is responsible for procuring pharmaceu-
ticals locally and internationally.
Parastatal organisation: In this model procurement is also centralised,
however a parastatal organisation (also known as an autonomous supply agency)
is responsible for the procurement. The organisation is partially or wholly
owned or governed by the government. As the name suggests, the organisa-
tion is granted autonomy to establish its own regulations regarding ﬁnancing
and procurement.
Decentralised procurement: Decentralised procurement involves the dele-
gation of procurement responsibilities from the national level to a lower level
(for example the regional, district or municipal level). Governments in a num-
ber of countries have decided to decentralise national procurement in an at-
tempt to better meet local requirements.
Procurement agents: Procurement agents are used when governments have
limited procurement capacity or funders have speciﬁc requirements. Examples
of procurement agents include the United Nations agencies and the Interna-
tional Dispensary Association (IDA)
Procurement models can use several procurement methods, depending on
the type and amount of products that need to be procured (John Snow Inc.,
2017; WHO, 2011). Procurement methods include:
Open tender: A formal process where suppliers, either local or international,
are invited to submit quotes based on the terms and conditions, scope and
speciﬁcations of the tender invite (MSH, 2012; John Snow Inc., 2017).
Restricted tender: Restricted tenders are similar to open tenders, however
suppliers must ﬁrst be approved by going through a pre-qualiﬁcation process.
During this process supplier's performance, manufacturing practices and ﬁnan-
cial viability are assessed. Any suppliers can apply for the pre-qualiﬁcation
process (MSH, 2012).
Competitive negotiation: In this method buyers approach a number of sup-
pliers for price quotes and may sometimes negotiate with suppliers to procure
at a speciﬁc price. The public sector is typically prohibited from negotiat-
ing with suppliers, therefore competitive negotiations are mainly used in the
private sector (MSH, 2012).
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International or local shopping: This method of procurement works the
same as competitive negotiation, with the exception that negotiation is pro-
hibited (MSH, 2012).
Direct procurement: Direct procurement, or sole-source procurement (John
Snow Inc., 2017), involves product procurement from a single supplier. Direct
procurement usually occurs when a speciﬁc product can only supplied by one
source (John Snow Inc., 2017), which can make this method the most expen-
sive. However, lower prices can be negotiated (MSH, 2012).
Limited-competitive bidding: In this method only a few pre-selected sup-
pliers are given a tender invitation. This occurs when rules and regulations
are in place that limit the procurement of speciﬁc products to a few suppliers
(John Snow Inc., 2017).
In some countries e-procurement and reverse auction have been introduced as
new procurement methods, however these methods are not generally used to
procure pharmaceuticals (MSH, 2012). According to MSH (2012) the procure-
ment process needs to:
(i) Manage supplier-buyer relationships ethically and transparently.
(ii) Acquire the correct products in the required quantities.
(iii) Secure the lowest cost price.
(iv) Ensure pharmaceutical quality assurance.
(v) Ensure deliveries are made on-time to prevent stock-outs.
(vi) Ensure that suppliers are reliable
(vii) Choose the purchasing schedule, safety stock levels and order quantities
in such way as to minimise the purchasing cost at each level of the health
system.
(viii) Accomplish these objectives as eﬃciently as possible.
3.2.3.4 Warehousing and Inventory Management
Products are stored at every facility along the supply chain (John Snow Inc.,
2017). Ensuring product integrity and safety throughout the supply chain
extending to the dispensary, requires good warehousing practices at every fa-
cility (John Snow Inc., 2017). Warehousing activities should be coordinated
so that products can be managed in an eﬃcient manner and so that order ful-
ﬁllment and distribution can be carried out promptly (John Snow Inc., 2017).
Warehousing activities include:
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1. Inspection of incoming deliveries
2. Putting away delivered products
3. Visual inspection of product quality
4. Order fulﬁllment
5. Picking and packing of products
6. Shipping
The aim of inventory management is to provide a continuous supply of
pharmaceuticals while minimising inventory holding costs and managing pro-
curement (MSH, 2012). The inventory strategy determines how the inventory
will be maintained to achieve the aim (John Snow Inc., 2017). However, be-
fore the inventory strategy can be deﬁned the following characteristics of the
supply chain need to be known (John Snow Inc., 2017):
1. The network structure and each supply chain level's role.
2. The characteristics and volume of products that ﬂow through the supply
chain.
3. The costs, budget and available resources.
4. The variability of demand and desired service levels.
5. Available tools and technology.
6. The company's relationship with suppliers, as well as suppliers' perfor-
mance and capacity.
Since the aim is to provide an uninterrupted supply of pharmaceuticals,
some stock will have to be held in inventory (MSH, 2012). Deciding which
products to hold in inventory should be based on the consumption of the
products as well as the value of the products to the public's health (MSH,
2012). Two methods can be used to determine which products should be kept
in stock, namely: VEN classiﬁcation or the ABC classiﬁcation (MSH, 2012;
John Snow Inc., 2017). VEN classiﬁes products into three groups according to
how critical the products are and the possible risk of a stock-out (John Snow
Inc., 2017).The roups are: vital, essential and non-essential (MSH, 2012) or
vital, essential and necessary (John Snow Inc., 2017). The VEN method is
useful when there is a shortage of funds to purchase all the required prod-
ucts (John Snow Inc., 2017). The ABC method on the other hand, classiﬁes
products according to the pharmaceuticals' value and volume of consump-
tion (MSH, 2012). Category A products are high-volume products, usually
represent about 10-20 percent of products and 75-80 percent of expenditure.
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Category B products represent 10-20 percent of products and 10-15percent of
expenditures. Lastly category C products are low-volume products that rep-
resent 60-80 percent of products and 5-10 percent of the expenditures (MSH,
2012). Decisions regarding when to order, what quantities to order and how to
maintain stock levels is determined by an inventory control system (John Snow
Inc., 2017). Inventory management may sound simple, however in many cases
poor inventory management can lead to ﬁnancial wastage, stock shortages or
excessive stock which can result in the decline of quality health care (MSH,
2012).
3.2.3.5 Distribution
Distribution involves the movement of products from the central warehouse to
the ﬁnal health facilities where the products are dispensed to patients (John
Snow Inc., 2017). Similarly to inventory management, the main objective of
distribution is to maintain a continuous supply of pharmaceuticals while mak-
ing sure that resources are used eﬀectively (MSH, 2012). In general, two main
distribution models are used: the direct distribution model and the distribution
network model (John Snow Inc., 2017). In the direct model, products are deliv-
ered directly from central distribution centres to service delivery points (John
Snow Inc., 2017). In distribution network model products are distributed to
health facilities as well as provincial and regional distribution centres (John
Snow Inc., 2017). Distribution systems have four basic characteristics, namely:
the degree of centralisation, population and geographic coverage, and the num-
ber of levels in the health system (MSH, 2012). The degree of centralisation
can be divided into central distribution and decentralised distribution (MSH,
2012). Central distribution is coordinated at national central medical stores
(CMS) and products are distributed to regional and provincial warehousing
where they are further distributed to health facilities (MSH, 2012). In de-
centralised distribution, lower-level facilities, such as district or regional facili-
ties, are responsible for distributing products according to their speciﬁc needs
(MSH, 2012). The activities performed during distribution form a cycle, as
shown in Figure 3.7, which starts when suppliers or manufacturers dispatch
the products and ends when consumption data is sent back to the procurement
unit (MSH, 2012).
3.2.4 Pharmaceutical Supply Chain Management
In order to function properly, a health system requires a supply chain man-
agement system that is maintained, designed and operated eﬀectively (John
Snow Inc., 2017). The Council of Supply Chain Management Professionals
deﬁne supply chain management as follows: Supply chain management en-
compasses the planning and management of all activities involved in sourcing
and procurement, conversion, and all logistics management activities. Impor-
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Figure 3.7: The distribution cycle. Source: MSH (2012)
tantly, it also includes coordination and collaboration with channel partners,
which can be suppliers, intermediaries, third party service providers, and cus-
tomers. In essence, supply chain management integrates supply and demand
management within and across companies (CSCMP, 2013). According to
the logistics cycle framework by John Snow Inc. (2017), health supply chains
consist of operational components that are supported by management func-
tions such as logistics management information systems (LMS), supply chain
workforces, ﬁnancing, performance management and risk management. Simi-
larly, the pharmaceutical supply management framework consists of four ba-
sic functions which are supported by management support systems, including
planning and administration, organisation and management, information man-
agement and human resource management (MSH, 2012). These management
support systems hold the pharmaceutical management framework together
(MSH, 2012). John Snow Inc. (2017) and MSH (2012) are the main sources
that give a good overall and in-depth explanation of how health and pharma-
ceutical supply chains are managed. For this reason a short description of each
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 3. CONTEXTUALISATION 41
support management component is given from each author.
3.2.4.1 The Logistics Cycle
As illustrated in Figure 3.8 the management functions of the logistics cycle
include: LMIS, supply chain workforce, ﬁnancing, performance management
and risk management (John Snow Inc., 2017).
LMIS: Supply chain workers collect and analyse information about each sup-
ply chain activity to help make decisions and coordinate future activities. Lo-
gistics information management systems are used to collect data, about the
supply and consumption of health products, as well as ordering and restocking
supplies. Data collected in the supply chain is used to inform decision making
regarding the activities that occur in the supply chain.
Workforce: The workforce is the most essential resource of the supply chain.
In order for the supply chain to operate eﬀectively a competent workforce is
required that can carry out the necessary supply chain functions. Managers
should improve the performance of staﬀ by supervising activities and providing
opportunities for continuous learning and development.
Financing: Financial management and allocation aﬀects all aspects of the
supply chain, including procurement quantities, storage space as well the num-
ber of staﬀ and vehicles. Financial management is very important because it
inﬂuences the availability of products and the eﬃciency of the supply chain.
Supply chain managers need to have a plan in place to ensure there is enough
ﬁnances and funding to procure the required products, to maintain the oper-
ation of the supply chain and to monitor costs and funding to ascertain the
viability of current operations.
Performance management: Performance monitoring and management is
essential to determine the supply chain's eﬀectiveness and eﬃciency. Perfor-
mance data gives supply chain managers an indication whether policies or
procedures need to be adjusted.
Risk management: Risk management is the process of identifying and miti-
gating causes of disturbances and dysfunction in the supply chain. This allows
supply chain managers to plan and manage areas of the supply chain that
require their attention the most.
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Figure 3.8: The logistics cycle. Source: John Snow Inc. (2017)
3.2.4.2 Pharmaceutical Supply Management Framework
The management support systems of the pharmaceutical supply management
framework (shown in Figure 3.9)include planning and administration, organi-
sation and management, information management and human resource man-
agement.
Planning and administration: Planning and administration includes the
management of pharmaceutical programs; planning for pharmaceutical man-
agement where planning involves the analysis of the current situation and
needs, establishing goals setting objectives and determining strategies and re-
sources required to achieve expected results; determining whether pharmaceu-
ticals and services should be contracted; ﬁnancial planning and management
which includes analysing and controlling expenditures; and planning and build-
ing storage facilities.
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Organisation and management: Organisation and management involves
security management at health facilities as well as the management of medical
stores, hospital pharmacies, health facilities, laboratories and medical supplies
Information management: Information management includes the monitor-
ing and evaluation of the pharmaceutical system; management information sys-
tems which are used to collect, process, report and use collected data to make
informed decisions; and the management of computer hardware and software.
Human resources management: Human resources are essential for the
planning, management and delivery of health services. The aim of human re-
source management is to cultivate and maintain a suﬃcient number of skilled
workers who provide quality pharmaceutical care. This is achieved through the
management and capacity development of human resources as well as design-
ing and implementing training programs to maintain worker's competence, to
teach workers how to respond to changing circumstances and implement new
approaches and technologies.
Figure 3.9: Pharmaceutical supply management framework. Source: MSH (2012)
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3.3 Public-Private Engagements in
Pharmaceutical Supply Chains
Abushaikha (2014) describes `relationships' in supply chains as a term that
encompasses diﬀerent degrees of interaction across the supply chain. Ac-
cording to Maloni and Benton (1997) relationships are formed to improve the
ﬁnancial and operational performance of supply chain participants by reduc-
ing costs and inventories as well as increasing shared information. A variety
terms have been used to describe the interactions between supply chain partic-
ipants; examples include coordination, cooperation, collaboration, integration
and partnerships (Chen et al., 2009; Abushaikha, 2014). In the context of
public and private sector relationships, UN Commission (2015) deﬁne private
sector engagement as "the deliberate, systematic collaboration of the govern-
ment and the private sector to move national health priorities forward, beyond
individual interventions and programs".
In this section the aim is to gain an understanding of what type relation-
ships the public and private sectors can have; how relationships can be formed
between the two sectors; what impact these relationships have on pharmaceuti-
cal supply chains; what type of relationships currently exist in pharmaceutical
supply chains; and how the two sectors might be integrated.
3.3.1 Why Work with the Private Sector?
One of the reasons why the public and private sectors should engage is that
the private sector is too large to ignore (IFC World Bank Group, 2011). For
example, in Sub-Saharan Africa more than 50 percent of the total health ex-
penditure is from the private sector (See Figure 3.10).
In many countries the private sector manages or owns between 40 and 50
percent of the health infrastructure which means the public sector can ex-
pand the scope and scale of health services by engaging with the private sector
(Harding, 2009; MIT-Z ILP, 2008). Not only does the private sector play
a signiﬁcant role in the health sector, but patients also often prefer the pri-
vate sector due to its responsiveness, convenience and ease of access (Harding,
2009). Governments are responsible for improving their health systems, how-
ever due to the shortage of resources and the magnitude of the private health
sector, governments are not able to fulﬁll this responsibility (IFC World Bank
Group, 2011). In order to improve the health system, governments need a
minimal level of engagement (IFC World Bank Group, 2011). The private
sector ﬁlls health delivery gaps by providing health services to the poor when
the public sector is unable to meet their needs (Harding, 2009). Contrary to
popular belief, the private sector caters for a wide variety of income groups
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Figure 3.10: Total health expenditure according to sector. Source: World Bank
(2014)
and not only the rich (IFC World Bank Group, 2011). Roughly 50 percent of
low-income groups receive health care from the private sector in Sub-Saharan
Africa (IFC World Bank Group, 2011). UN Commission (2015) lists a number
of public-private engagement examples that provide the following health sec-
tor beneﬁts: (i) increase the availability of medicines; (ii) ensure the quality
of health commodities; (iii) improve the eﬀective use of commodities; and (iv)
increase funds and resources for medicines. According to IFC World Bank
Group (2011) the slightest level of public-private engagement can make an
improvement in the use of resources as well as the quality of health care. En-
gaging with the private sector can strengthen supply chains, improve supply
chain capabilities and performance (John Snow Inc., 2016), and can assist the
public sector with overcoming supply chain challenges and increasing the ef-
ﬁciency and eﬀectiveness (MIT-Z ILP, 2008). Other beneﬁts of engagement
include (UN Commission, 2015; MIT-Z ILP, 2008):
(i) Providing access to specialised skills and expertise
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(ii) Promoting operational eﬃciency
(iii) Allowing governments to focus on core competencies
(iv) Providing access to capital investment and innovation
(v) Sharing risk
(vi) Adopting private sector best practices
(vii) Expanding private sector channels
Public-private partnership speciﬁc beneﬁts include ﬁlling public sector re-
source gaps; access to health products and eﬃciencies can be increased across
both public and private sectors; partnerships can introduce innovative manage-
ment and technologies; human resources are increased; and the health sector's
capacity to deliver services can increase (O'Hanlon and Jeﬀers, 2013). How-
ever, public-private engagement is not only for the beneﬁt of the public sector.
In some developing countries, such as Tanzania and Ghana, the private
sector has saturated the high-income market (O'Hanlon and Jeﬀers, 2013).
Consequently, the private sector now aims to expand its products and ser-
vices to lower income populations (O'Hanlon and Jeﬀers, 2013). Engaging
with the public sector will allow the private sector to expand its channels to
reach these lower income groups (MIT-Z ILP, 2008). In addition, MIT-Z ILP
(2008) investigated a number of public-private initiatives and found that some
were generating a proﬁt, which signiﬁes that the private sector may gener-
ate proﬁt and improve health outcomes through engagement with the public
sector. Many authors such as Nishtar (2004), Tennyson (2011), IFC World
Bank Group (2011), Prybil et al. (2015) and Kula and Fryatt (2014) argue
that emerging and current health problems cannot be successfully addressed
by each sector individually, but that signiﬁcant improvements are only possible
when the two sectors work together. Although there are many advantages of
public-private engagement, it also introduces many challenges that each sector
needs to overcome.
3.3.2 Public-Private Engagement Challenges
Although public-private engagement may provide many beneﬁts, there are
also challenges that need to taken into account before considering such en-
gagements. According to Prybil et al. (2015) challenges include conceptual
and language barriers, establishing and maintaining engagements, constraints
such as ﬁnances and public policy and demonstrating that the engagement has
a positive impact. UN Commission (2015) made a list of challenges each sector
faces when taking part in public-private engagements. The challenges that the
public sector faces when engaging with the private sector include: (i) conﬂicts
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of interest; (ii) a limited capacity to engage with the private sector due in-
experience with contract management which could result in corruption; (iii)
regulatory issues; (iv) information sharing issues due to the diﬀerent sources
the public and private sectors receive information from; and (v) external con-
straints such as the economic and political climate, hidden complexities of
donor structures in projects and national agencies and the likelihood that the
development and management of public-private engagements will be more ex-
pensive than internal government processes.
On the other hand, the private sector faces the following challenges when
engaging with the public sector:(i) lack of control since the contractual re-
quirements may stipulate the timing of processes as well as how resources
should be allocated and used; (ii) drawn out decision making process by the
government due to its structure; (iii) contracting problems due to some gov-
ernment's lack of transparency and standardised tender processes; (iv) delayed
payments due to budgetary issues and governmental processes; and (v) infor-
mation sharing issues due to delayed information sharing and data compilation
is not centralised which means that each sector is unaware of what has been
contributed. According to Tennyson (2011) such engagement challenges could
generate original and unexpected ideas that may actually be beneﬁcial to the
engagement. However, strategies are still needed to overcome the challenges
of public-private engagement.
3.3.3 Overcoming Public-Private Engagement
Challenges
In an eﬀort to overcome engagement challenges, many authors suggest simi-
lar factors are necessary for successful public-private engagements. Kula and
Fryatt (2014) reviewed 18 public-private interactions in South Africa and iden-
tiﬁed the following success factors: stewardship, co-ordination, regulation, ca-
pacity to support partnership, monitoring and evaluation, high level support
and buy-in, harmonization and innovation. According to the review the most
important success factor was the government's ability to support partnerships
since the private sector could take advantage of the engagement (Kula and
Fryatt, 2014). According to Tennyson (2011), three principles are required in
order for the two sectors to work together, namely transparency, equity and
mutual beneﬁt. Discussing these three principles is a useful starting point be-
fore formalising an engagement (Tennyson, 2011).
Similarly, Prybil et al. (2015) argues that public-private engagements re-
quire trust, eﬀort and commitment from all parties. According to Prybil et al.
(2015) the following characteristics need to be implemented in order for an en-
gagement to be successful: (i) values, a mission and vision; (ii) a collaborative
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culture; (iii) clearly deﬁned goals and objectives; (iv) a durable organisational
structure; (v) good leadership; and (vi) regular performance evaluations and
continuous improvements (Prybil et al., 2015). One of the success factors of
public-private engagement is the quality of the relationship between the two
sectors, therefore according to Kula and Fryatt (2014) fostering a good rela-
tionship is crucial to developing trust. In addition, it is important for both
sectors to understand the other sector's motivations and to identify appro-
priate incentive mechanisms so that both sector's interest are met (Kula and
Fryatt, 2014). UN Commission (2015) oﬀer the following recommendations for
overcoming public-private engagement challenges:
(i) Start with a realistic vision of what can be achieved
(ii) Build partnerships based on mutual trust
(iii) Foster transparency from all partners
(iv) Demonstrate commitment to private sector engagement
(v) Learn from other sectors
(vi) Advocate for change
Although public-private engagement could beneﬁt the health supply chain
and health system, it does not mean that it is the solution to all supply chain
challenges (UN Commission, 2015). Public-private engagement requires time,
commitment, measurable goals and aligned objectives (UN Commission, 2015).
3.3.4 Types of Engagements
Public-private engagements can take many forms; each form of engagement
can have diﬀerent levels of collaboration, length of commitments and sharing
of ﬁnancial risk (UN Commission, 2015). Authors identify and classify public-
private engagements diﬀerently according to their interpretation of what dif-
ferentiates and characterises speciﬁc engagements (John Snow Inc., 2016; UN
Commission, 2015; USAID, 2010; Whyle and Olivier, 2016). Some engage-
ment forms are widely recognised and accepted throughout the literature such
as outsourcing, partnerships and the adoption of private sector practices (UN
Commission, 2015; John Snow Inc., 2016; USAID, 2010). Due to the lack of lit-
erature on public-private pharmaceutical supply chain engagements, authors'
diﬀerent forms of public-private health supply chain engagements are shortly
discussed. This will give a better understanding of engagements within health
supply chains.
John Snow Inc. (2016) reviewed public-private engagements from more than
30 LMIC and found that there are four main models of engagement, namely:
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adapting and learning; collaboration; stewardship; and contracting. As the
name suggests, adapting and learning involves the adaptation of private sec-
tor supply chain tools and practices which help to improve supply chain per-
formance (John Snow Inc., 2016). Examples include information technology
and warehouse conﬁguration solutions, supply chain modelling software that
streamline routes and supply chain designs, and the implementation of pri-
vate sector best practice standards (John Snow Inc., 2016). Collaboration
involves multiple sectors (private, public and NGO) sharing the responsibility
of protecting the public good. This type of engagement necessitates consid-
erable relationship building and trust (John Snow Inc., 2016). The public
sector is responsible for providing stewardship to ensure that health products
are available and accessible to all. This includes enforcing regulations, being
responsible for the eﬃcacy and safety of health products and ensuring that
the performance of stakeholders are satisfactory. Supply chain managers who
are stewards of supply chains are responsible for oﬀering oversight, vision and
guidance (John Snow Inc., 2016).
In many countries the public sector contract the private sector to provide
speciﬁc services, such as distribution, warehousing or management, within
the public supply chain (John Snow Inc., 2016). Some authors (John Snow
Inc., 2016) use the terms outsourcing and contracting interchangeably, how-
ever USAID (2010) distinguish between the two. According to USAID (2010)
contracting entails the customer specifying what the contractor should do and
how it must be done. Conversely, during outsourcing the customer speciﬁes
the outcome but the contractor uses its expertise to determine how the task
will be completed USAID (2010). Whyle and Olivier (2016) identiﬁed eight
diﬀerent public-private engagement models in South Africa, including: public-
private partnership; social marketing; sector-wide approach; public-private
mix; vouchers; contracting; dual practice regulation and ﬁnancial support. Ac-
cording to the review social marketing, contracting and global public-private
partnerships were the most prevalent models respectively (Whyle and Olivier,
2016). Although the review found many instances of public-private engage-
ment, the focus of the review was on health service delivery and ﬁnancing
engagement models and not health or pharmaceutical supply chain engage-
ment models (Whyle and Olivier, 2016).
UN Commission (2015) diﬀerentiates public-private health supply chain
engagements according to the formality and complexity of the engagements.
The ﬁrst level of engagement is known as public-private interaction which is
usually informal and focuses on communication between the sectors. The sec-
ond is called public-private dialogue which focuses on cooperation and can
include both formal and informal engagements. The last level of engagement
is public-private agreement which involves contractual engagements that focus
on the collaboration of the public and private sectors (UN Commission, 2015).
UN Commission (2015) identiﬁed eight diﬀerent forms of engagements that fall
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within the three levels of engagements (i.e. interaction, dialogue and agree-
ment), which consist of: outsourcing, technical assistance, corporate social
responsibility, advocacy and coordination, ﬁnancing, partnerships, local man-
ufacturing and innovations. Similar to the adapting and learning deﬁnition
provided by John Snow Inc. (2016), technical assistance refers to engagements
where the public sector learns from private sector examples and successful
improvement strategies (UN Commission, 2015). This can be applied in sup-
ply chain areas such as quantiﬁcation, procurement, inventory management,
warehousing, human resource training and management, and capacity build-
ing. Innovation and advocacy engagements are similar to technical assistance
in the sense that private sector approach are implemented in the public sector.
Private sector organisations are continually introducing new innovations,
such as new products, innovative improvements, redesign or reverse innova-
tion, in order to remain competitive. These innovations can be applied to the
public supply chain to improve the eﬃciency (UN Commission, 2015). Advoca-
tive engagements involve the adaptation of the private sector's approaches to
coordination, advocacy and information sharing. Examples of advocative en-
gagements could include market surveys, advocacy on collaboration or policy
support. Advocacy and coordination can increase transparency and the inclu-
sivity of stakeholders during policy debates and improve access to information
UN Commission (2015). Companies that take part in corporate social respon-
sibility provide the public sector an opportunity for engagement without the
possibility of a conﬂict of interest. Examples of this type of engagement in-
clude donations, access to human resources or the provision of contributions
during times of abnormal demand (UN Commission, 2015). The public sector
can engage in long term ﬁnancial planning with the private sector in order to
accomplish supply chain objectives. Engagements through ﬁnancing can re-
duce supplier risk and introduce the possibility of performance based ﬁnancing
(UN Commission, 2015). Introducing local manufacturing may be an alterna-
tive to importing and could reduce costs such as transportation costs. Local
manufacturers could increase the diversity of suppliers and therefore improve
supply chain security (UN Commission, 2015).
3.3.5 Examples of Public-Private Supply Chain
Engagements
The aim of this section is to investigate existing public-private supply chain
engagements and to determine what impact these engagements have had on
the supply chains. Some examples are not speciﬁc to pharmaceuticals and
include other health commodities, however the same principles can be applied
to pharmaceutical supply chains.
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3.3.5.1 Commodity Coordinating Committees
Every supply chain function depends on the coordination of key participants
to provide crucial assistance and support (SIAPS, 2014). The coordination
of key participants can be achieved by creating commodity coordinating com-
mittees (CCCs) (SIAPS, 2014). CCCs are committees or groups that work
together to improve the availability of health supply chain commodities as well
as promote eﬃcient, eﬀective and sustainable supply chain systems and ser-
vice delivery. The multidisciplinary committees include representatives from
the public sector, private sector, non-governmental organisations (NGOs) and
donor agencies. CCCs have varying attributes depending the scope of work, in
other words CCCs can be formal, informal, part of the government or seperate
from the government. CCCs have successfully been used to improve the avail-
ability and access of reproductive health commodities in health supply chains.
However, CCCs can be applied to any type of health commodity, including
pharmaceuticals. One of the supply chain areas where CCCs have been used
in supply chains is the quantiﬁcation of health commodities where members
work together on forecasting and supply planning activities. In addition, the
CCCs aim to increase cooperation and collaboration among the diverse stake-
holders who are part of the quantiﬁcation process (SIAPS, 2014).
3.3.5.2 Distribution Partnership
UTi (now known as DSV) is a service logistics and third party logistics (3PL)
provider based in South Africa(UN Commission, 2015) UTi has a comprehen-
sive warehousing and distribution network that distributes pharmaceuticals,
cold chain products and medical devices for the private sector (UN Commis-
sion, 2015). UTi partnered with the public sector to deliver health commodi-
ties throughout South Africa. UTi has a unique business model due to the
fact that suppliers pay for UTi's operations in exchange for low risk access to
South Africa's growing market and handing over distribution management to
UTi (UN Commission, 2015). This resulted in a synergistic relationship since
the government received the beneﬁts of having an eﬀective distribution network
without incurring additional costs and suppliers had a reduced barrier-to-entry
in the South African market (UN Commission, 2015).
3.3.5.3 Vendor Managed Inventory
In vendor-managed inventory (VMI) systems the vendor, or supplier, is respon-
sible for managing, maintaining and replenishing the stock for the customer
(SIAPS, 2014). This approach is often used in the private sector and very rarely
used in the public sector (SIAPS, 2014; John Snow Inc., 2012). The potential
beneﬁts of VMI include decreased stock-outs, cost savings, quicker turnaround
and a reduction in government's burden of managing orders and transportation
which enables the government to focus on managing vendor contracts (SIAPS,
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2014). This approach has been applied in Nigeria and Zimbabwe. In Nigeria
the National Agency for the Control of AIDS (NACA) sub-contracted pri-
vate suppliers to deliver health commodities directly to service delivery points
(SIAPS, 2014). Similarly, the VMI approach was implemented in Zimbabwean
health facilities which led to a streamlined reporting and ordering process and
an increased eﬃciency of commodity and information ﬂow (John Snow Inc.,
2012). Personnel were then able to spend more time helping patients instead
of counting stock. The implementation of a VMI system resulted in increased
stock availability and stock outs of some medicines decreased by 33 percent
(John Snow Inc., 2012).
3.3.5.4 Warehouse-in-a-Box
In 2010, the Tanzanian Medical Stores Department struggled to accommodate
the country's expanding health programme due to an increase in the number
of health products, limited storage space and poorly managed and constructed
storage space (SIAPS, 2014). A proposed solution was to use a kit developed
by Imperial Health Sciences, called Warehouse-in-a-Box(WiB). Each WiB
contains the required infrastructure that a warehouse needs, such as racking
and furniture as well as job descriptions, standard operating procedures and
training documents. WiBs can be assembled rapidly and used in a variety of
settings including urban and rural settings (Imperial Health Sciences, 2014).
During implementation personnel receive training in areas such as warehouse
management, medicine disposal, quality control and medicine recall (SIAPS,
2014). After implementation audits are carried out in order to improve man-
agement skills and warehouse operations (SIAPS, 2014). As a result of ac-
quiring and implementing ﬁve WiBs, Tanzania's storage capacity increased by
195% even though the storage surface area only increased by 60%; roughly
$1 million of annual rent is saved by using the WiBs and 55 Medical Stores
Department staﬀ were trained (SIAPS, 2014).
3.3.5.5 Medicine Shoppe
Medicine Shoppe is an Indian retail pharmacy chain that has developed a
new type of clinic, called Sehat (which means health) that caters for people
from low-income areas (MIT-Z ILP, 2008). At each clinic a qualiﬁed doctor
provides check ups at a nominal cost. If a patient goes for a check up and
buys medicine from the store, the patient gets a doctor fee as a refund on
the medicines, resulting in a free check up (MIT-Z ILP, 2008). The clinic's
doctor only prescribes generic versions of retail drugs which further decreases
the costs incurred by the patients. The clinic also employs health workers who
visit households in order to identify people who show symptoms of disease and
direct them to the nearest clinic (MIT-Z ILP, 2008). The use of these clinics
improves low-income communities' access to primary care by making doctor's
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consultations and medicines aﬀordable. Partnering with a retail pharmacy
allows the public sector to reach poor communities since high real estate costs
are a barrier to entry for the public sector (MIT-Z ILP, 2008).
3.3.5.6 SMS for Life
Kenya's public sector often had antimalarial medicine and diagnostic supply
stock-outs (SIAPS, 2014). In order to solve the problem the Kenyan govern-
ment partnered with Novartis Pharma AG and piloted the project SMS for
Life. SMS for Life is a mobile application which consists of an SMS manage-
ment tool as well as a web-based reporting tool which allows health workers
to submit and record current stock levels (SIAPS, 2014). During the pilot
test the stock of artemether/lumefanttrine (AL) and a rapid diagnostic test
was tracked. By the end of the pilot test, stock-outs of AL reduced by 38%
(SIAPS, 2014).
3.4 Supply Chain Integration
Provided the present context of pharmaceutical and health supply chains as
discussed in sections 3.1 and 3.2, it can be argued that more proactive ap-
proaches should be taken by decision makers to improve health outcomes and
address supply chain challenges. Public-private supply chain integration may
be an approach that can further support the improvement of pharmaceutical
supply chains. Public-private supply chain integration is an approach that
combines elements of both horizontal supply chain integration and horizontal
supply chain collaboration. In order to clarify what the term `public-private
supply chain integration' refers to, an overview of supply chain integration is
provided (Section 3.4.1), after which horizontal supply chain integration and
collaboration are investigated (Sections 3.4.1.1 and 3.4.1.2). Next, the deﬁni-
tion of supply chain integration is provided to prevent confusion with other
integration terms (Section 3.4.2). Lastly, public-private supply chain inte-
gration is introduced in Section 3.5 as a possible solution to further improve
pharmaceutical supply chains.
3.4.1 Review of Supply Chain Integration
Integration is deﬁned by the Merriam-Webster Dictionary as follows: to
form, coordinate, or blend into a functioning or uniﬁed whole (Merriam-
Webster Inc., 1966). Supply chain integration involves cross-functional or
cross-departmental interactions which are often associated with coordination,
cooperation or collaboration (Chen et al., 2009). There is a proliferation of
deﬁnitions for `integration' in both the supply chain and public health liter-
ature. In the public health domain the term integration can be used for a
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number of diﬀerent concepts that sometimes overlap (Contandriopoulos et al.,
2003). Examples of these concepts include integrated service delivery (PwC,
2007), integration of care (Contandriopoulos et al., 2003), clinical integration
(Miller, 1996; Contandriopoulos et al., 2003), physician integration (Miller,
1996), functional integration (Miller, 1996; Contandriopoulos et al., 2003)and
integrated national health system (Reddy et al., 2011; Arbulo et al., 2015).
In the supply chain literature, an integrated supply chain can be deﬁned
as follows: An association of customers and suppliers who work together to
optimize their collective performance in the creation, distribution, and support
of an end product (National Research Council et al., 2000). According to the
National Research Council et al. (2000), the objective of supply chain inte-
gration is to focus and coordinate the relevant resources of each participant
on the needs of the supply chain and to optimize the overall performance of
the chain. There are two main forms of supply chain integration: horizontal
and vertical integration (Axelsson and Axelsson, 2006). Vertical integration
takes place when an organisation assumes control of sequential steps in a sup-
ply chain (Axelsson and Axelsson, 2006; Roberts et al., 2010). For example,
an organisation could take control of its suppliers (backward vertical integra-
tion) or its distributors (forward vertical integration) (Roberts et al., 2010).
In these supply chains information and activities are visible up and down the
chain, the number of steps in the process are fewer and there is greater coor-
dination between the levels of the supply chain (USAID, 2009). On the other
hand, horizontal integration occurs when two or more organisations, that are
at the same point in the supply chain, merge (Roberts et al., 2010). An ex-
ample of horizontal integration is when producers of a product merge. Figure
3.11 gives an illustration of horizontal and vertical supply chain integration.
Supply chain integration has been used in various ways in public health
supply chains. The focus has predominantly been on integrating public dis-
ease or program speciﬁc supply chains such as immunisation or TB supply
chains (Bornbusch and Bates, 2013; PATH and WHO, 2013; Kaboru, 2012;
USAID, 2009); (ii) vertical integration (John Snow Inc., 2012); and (iii) prod-
uct integration which involves combining some logistical functions of diﬀerent
commodities (UNICEF, 2016; USAID, 2009). Researchers in India proposed
the creation of the `Integrated National Health System' (INHS) in order to
achieve the objective of providing universal health care. The aim of an INHS
is to strengthen the public health system, promote and improve the eﬀective-
ness, equity, eﬃciency, and accountability at all stages of the health system by
integrating the private sector with the national health system (Reddy et al.,
2011). In an INHS all providers, including the allopathic systems as well as the
public and private sectors, are integrated. The various forms of public health
integration are frequently pictured along a continuum of inter-organisational
relationships (Axelsson and Axelsson, 2006). It ranges from organisations that
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Figure 3.11: Horizontal and vertical supply chain integration
are completely autonomous, through intermediate consolidations to the com-
plete merging of organisations (Axelsson and Axelsson, 2006). The WHO's Op-
timize project horizontally integrated vaccine supply chains with other health
commodity supply chains (PATH and WHO, 2013). According to PATH and
WHO (2013) this may result in eﬃciency and eﬀectiveness improvements as
well as economies of scale and improved supply chain performance. According
to a framework developed by Axelsson and Axelsson (2006) collaboration can
be deﬁned as the combination of a high degree of horizontal integration and
a low degree of vertical integration. This type of integration is accomplished
via voluntary agreements and the willingness to work together (Axelsson and
Axelsson, 2006).
Chen et al. (2009) deﬁnes process integration as follows: Process integra-
tion refers to the management of various sets of activities that aims at seam-
lessly linking relevant business processes within and across ﬁrms and eliminat-
ing duplicate or unnecessary parts of the processes for he purpose of building
a better functioning supply chain. Integration involves cross-departmental
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or cross-functional interactions which have been described as links or working
together. These interactions are commonly attributed to collaboration, coop-
eration or coordination (Chen et al., 2009). Some authors have proposed their
own deﬁnitions for integration. According to Papazoglou et al. (2000) an inte-
grated value system is formed when multiple ﬁrms with a shared target market
collectively plan, implement and maintain the ﬂow of information, services and
goods, such that the eﬃciency and value of the value system increases (Pa-
pazoglou et al., 2000). Subramanian and Sun (2016) deﬁned integrated value
chains as "a responsive system that creates a product or solution for the cus-
tomer requirement using a system of process called value packet which is capa-
ble of quantifying, measuring and managing the value of each activity across
the value chain". In the context of supply chain integration Flynn et al. (2010)
used the Webster dictionary deﬁnition of integration which states that inte-
gration is the collective control of multiple consecutive economic or industrial
processes which were previously carried out independently (Merriam-Webster
Inc., 1966).
Another concept that was found in the literature was integration through
value-adding partnerships (VAP). Foreman and Roberts (1991) applied this
concept of VAPs to health care in order to form eﬀective integrated systems,
however the meaning of integration was not deﬁned in the article. A VAP con-
sists of a group of autonomous ﬁrms where each coordinates its processes and
activities with the other "partners" of the value chain (Foreman and Roberts,
1991). The key term in this deﬁnition is "autonomous" since there is no need
for the ﬁrms to sign an oﬃcial partnership agreement, each ﬁrm is in control
and responsible for the way in which its business operates. When the concept
of VAPs is applied to health care, partnership activities would involve joint
education, outsourcing, purchasing and planning which could ultimately result
in economies of scale (Foreman and Roberts, 1991).
3.4.1.1 Horizontal Supply Chain Integration
According to Aboutalebi (2015) there are two forms of horizontal supply chain
integration. The ﬁrst is known as backward horizontal integration where a
company integrates with other companies that are similar (Aboutalebi, 2015).
For instance, a retail company may own or work with another retail company.
The second form of horizontal integration is forward horizontal integration
where companies collaborate with one another to provide customers with sub-
stitute options (Aboutalebi, 2015). For example, two companies can work
together to provide customers road transport and rail transport as an addi-
tional option (Aboutalebi, 2015). However, when speaking about horizontal
integration it generally refers to the consolidation of two or more organisations
that exist in the same tier of the supply chain (i.e. the consolidation of two or
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more manufacturers) (Huemer and Furlan, 2011). This is achieved by either
merging with a competitor or the acquisition of a competitor (Huemer and
Furlan, 2011).
Before the implementation of horizontal integration, managers need to de-
cide what will be integrated and how it will be integrated (PATH and WHO,
2013). According to PATH and WHO (2013) there are two options, either
products or processes can be integrated when integrating health supply chains.
Supply chains have various functions, including forecasting, procurement, in-
formation systems, orders, transport and storage (PATH and WHO, 2013).
Product integration is associated with the storage and transport functions and
involves the integration of product ﬂows (PATH and WHO, 2013). Process
integration includes the other remaining functions that are composed of supply
management processes (PATH and WHO, 2013). With regards to how supply
chains should integrate; supply chains can be integrated through segmentation
where products are grouped and delivered according to product characteristics
(PATH and WHO, 2013). For example, all products that require refrigeration
may be grouped together. Supply chains can also be fully integrated which
means that multiple, vertical supply chains are merged to form one supply
chain (PATH and WHO, 2013). Horizontal integration provides the follow-
ing beneﬁts: improved performance and eﬃciency, increased adaptability and
ﬂexibility, and economies of scale (PATH and WHO, 2013). However, these
beneﬁts were achieved by integrating numerous vertical public health supply
chains PATH and WHO (2013).
3.4.1.2 Horizontal Supply Chain Collaboration
Horizontal supply chain collaboration is deﬁned, according to Soosay (2010),
as unrelated or competing organisations, producing similar products or dif-
ferent components of a product, that form a cooperative association to share
resources such as warehouse space and manufacturing capacity. Numerous
organisations improve their supply chains to such an extent that additional
improvements result in insigniﬁcant cost savings and eﬃciency gains (Vanover-
meire et al., 2014). However, when these organisations take part in horizontal
supply chain collaboration, the eﬃciency and sustainability of the supply chain
improves signiﬁcantly (Vanovermeire et al., 2014). Research on horizontal sup-
ply chain collaboration is still in its infancy since it is a relatively new ﬁeld
of research (Vanovermeire et al., 2014). Currently, research predominantly
focuses on horizontal supply chain collaboration in the ﬁeld of logistics and
transportation management (Soosay and Hyland, 2015). Vanovermeire et al.
(2014) did a case study with three companies in order to test the feasibility
of implementing horizontal collaboration in logistics. The three companies do
their own deliveries, however 57 percent of two or all three of the companies'
orders are delivered to a common customer. For the case study Vanovermeire
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et al. (2014) determined how much it costs each company to: (i) deliver their
own products; (ii) deliver the products after the company has been optimised
internally; and (iii) deliver the products while collaborating with one another.
The results showed that cost savings of 13.65 percent was achieved after the
companies were optimised internally, whereas the horizontal collaboration re-
sulted in cost savings of 25.83 percent and a 26.58 percent decrease in the
number of delivery trips (Vanovermeire et al., 2014). According to Vanover-
meire et al. (2014) the eﬃciency can improve between 10 and 30 percent when
horizontal supply chain collaboration is implemented in the logistics area of
the supply chain.
Horizontal supply chain collaboration may result in the following (Aboutalebi,
2015; Vanovermeire et al., 2014; Sanchez Rodrigues et al., 2015; Cruijssen
et al., 2007): (i) increased delivery frequency and throughput as a result of
increased service levels; (ii) sharing of investments; (iii) reduced logistics costs
and economies of scale; (iv) market share increase; (v) increased eﬃciency
which results in sustainable logistics; and (vi) sharing and exchanging inno-
vative and best practices. More and more companies are forming horizontal
logistics collaborations by consolidating orders and using a shared transporta-
tion channel (Vanovermeire et al., 2014). A few companies go a step further
when collaborating horizontally by sharing resources and assets, collectively
making decisions and bargaining collectively to receive economies of scale; es-
sentially creating a new supply chain (Vanovermeire et al., 2014).
Björnfot and Torjussen (2012) argue that in order for organisations to
manage an ever-increasing demand and overcome market uncertainty, supply
chains must be structurally ﬂexible. According to (Björnfot and Torjussen,
2012) sharing capabilities and resources through horizontal collaborations en-
ables the supply chain to be structurally ﬂexible and may also result in a
more stabilised market. However, horizontal supply chain collaboration has
its own set of challenges, such as determining how gains should be divided
amongst partners, the risk of sharing information, the lack of appropriate IT
support, cultivating relationships and the lack of case studies to facilitate the
implementation of horizontal collaboration (Vanovermeire et al., 2014). The
barriers to implementing this type of collaboration include coordinating and
negotiating with partners, choosing the right partners and adopting the right
communications and information technology (Cruijssen et al., 2007). Horizon-
tal collaboration requires trust and commitment, and is based on a long-term
relationship with partners (Vanovermeire et al., 2014).
3.4.2 Deﬁning Integration
The purpose of this section is to deﬁne integration in order to prevent con-
fusion with all the other deﬁnitions of integration. Deﬁnitions from Axelsson
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Figure 3.12: The levels of integration
and Axelsson (2006), Foreman and Roberts (1991), National Research Coun-
cil et al. (2000) and UN Commission (2015) were combined to deﬁne supply
chain integration. For the purpose of this dissertation supply chain integration
is deﬁned as two or more autonomous supply chains that work together to (i)
improve their collective eﬃciency and eﬀectiveness; (ii) ﬁnd synergistic com-
binations of resources; and (iii) ﬁnd solutions to problems that each supply
chain may not achieve on its own by constructively exploring their diﬀerences
and combining expertise from diﬀerent organisations within the supply chains.
Similar to the description by Axelsson and Axelsson (2006) this type of supply
chain integration can be visualised as a step-wise process that starts from com-
plete autonomy (i.e. no integration) and progresses to interaction, to dialogue
and ﬁnally to agreement (fully integrated).
3.4.2.1 Levels of Integration
The levels of integration are deﬁned using the private sector engagement model
(also known as the P3 Model) as deﬁned by UN Commission (2015). The P3
Model consists of three phases (called levels from here on forth) through which
public-private engagements can go. Each level builds on the preceding level,
in other words engagements move from level 1 to level 2, and then from level
2 to level 3 in a step-wise manner. However, it is not necessary for each
public-private engagement to reach all three levels. As a private engagement
progresses to level 3, so will the complexity and formality of the engagement
increase. The levels are deﬁned as illustrated in Figure 3.12. Each level is
shortly discussed below.
3.4.2.2 Level 1 - Interaction
In public-private interaction, information is exchanged between the two sec-
tors to align understanding and assist each other. For example, private sector
providers could share data, such as case detections, with the public sector.
An example of interaction from the public sector could be as simple as com-
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municating with the private sector to ensure that new regulations have been
received and understood. This type of engagement is usually short term with
a duration of roughly one to two weeks or ongoing on a periodic basis.
3.4.2.3 Level 2 - Dialogue
Dialogue involves cooperation and negotiation between the public and pri-
vate sectors around shared interests. Dialogue does not necessitate shared
investments or formal agreements, it does however require that the two sectors
cooperate and work together eﬀectively. An example of a public-private dia-
logue is corporate social responsibility initiatives. These engagements usually
last about two to four months or ongoing on a periodic basis.
3.4.2.4 Level 3 - Agreement
Public-private agreement is the most complex form of engagement that in-
volves a formal contract between the public and private sectors which stipu-
lates each sector's roles and responsibilities. The agreement should also specify
each sector's investments and the conditions under which each sector will take
over risks and receive beneﬁts. Speciﬁc activities should take place during the
agreement process, such as a request for proposal (RFP), contract negotiations
and contract award, implementation and contract management. Public-private
agreements are typically long-term engagements.
Table 3.2 summarises the characteristics of each integration level.
Table 3.2: Integration level characteristics
Integration
level
Timespan Formality Engagement
focus
Interaction Short term
(1 - 2 weeks)
Informal Communication
Dialogue Medium term
(2 - 4 months)
Can be informal
or formal; does
not require a
formal agree-
ment or shared
investment.
Cooperation
Agreement Long term
(unspeciﬁed
how long)
Formal Collaboration
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3.5 Public-Private Health Supply Chain
Integration as a Possible Solution
Public-private supply chain integration is the application of integration (as
deﬁned in Section 3.4.2) to public and private supply chains. Countries that
harness the strengths of both the public and private sector often have health
supply chains that are more capable of handling epidemics and disease out-
breaks, better able to adapt to changing circumstance and more eﬀective (Do-
nato et al., 2016). For instance, developed countries leverage the strengths of
the private sector and depend on the private sector to distribute and supply
products as well as provide other services that complement the public sector
(MIT-Z ILP, 2008). Conversely, in developing countries private sector engage-
ment considerably less, yet face more challenges (MIT-Z ILP, 2008). As a
result of greater private sector involvement, health supply chains in developed
countries are able to continuously and eﬀectively supply health products (MIT-
Z ILP, 2008). This contrast between health supply chains in developed and
developing countries made MIT-Z ILP (2008) question whether increased pri-
vate sector engagement would improve low- and middle-income country health
supply chains.
Numerous authors, including Nishtar (2004); Tennyson (2011); IFC World
Bank Group (2011); Prybil et al. (2015); Kula and Fryatt (2014), argue that
both sectors are unable to address current and future health system challenges
individually and that the public and private sectors need to work together.
According to Nishtar (2004) public-private collaboration is crucial and un-
avoidable. In order for health supply chains to be responsive and adaptable
to the continuously changing environment, the private sector need to be in-
volved and be part of the solution (John Snow Inc., 2016). Kaboru (2012)
argues that private sector engagement will result in more eﬀective health sup-
ply chains and subsequently the health system will improve. Public-private
engagements can increase the availability of health products, thus increasing
disadvantaged populations' access to medicines and addressing some public
health supply chain problems (MIT-Z ILP, 2008). In addition, the reliability,
eﬀectiveness and eﬃciency of health supply chains can be improved across all
sectors, private sector best practices can be adopted and the private sector's
reach can be expanded through the implementation of public-private initia-
tives (MIT-Z ILP, 2008).
Governments need to become aware of the fact that plenty of other supply
chains encompass public health supply chains, each consisting of numerous
diﬀerent actors from the private and public sectors as well as faith-based and
non-governmental organisations (Bornbusch et al., 2014). Bornbusch et al.
(2014) argues that although the health system is a complex conglomeration
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of supply chains and actors, if it is properly managed and understood, the
health supply chains may be woven into a rationally integrated system. Con-
sequently, according to Bornbusch et al. (2014), the option and ﬂexibility may
exist for governments to decrease the number of distributors, suppliers, quality
assurance, funders and procurement agencies on account of all actors collabo-
rating to improve health outcomes. As previously mentioned Bornbusch et al.
(2014) argues that the government should not be operating supply chains,
however a few of the supply chain functions will remain the responsibility of
the government, including creating a vision and system strategy, regulating
pharmaceuticals, supervising the health system, policy-making and manag-
ing expenditures. This concept of integration introduced by Bornbusch et al.
(2014) is similar to a concept by Bornbusch and Bates (2013) called multiplic-
ity (as mentioned in Section 3.1.2). Bornbusch and Bates (2013) call for the
need for further research to determine how multiplicity can be implemented
such that the performance, risk management and costs of health supply chains
can be optimised. Furthermore, Bornbusch and Bates (2013) argue that the
implementation of multiplicity is essential as it will enable health supply sys-
tems to handle the increasing number and volume of health products in the
future.
The public and private sectors have worked together on numerous initia-
tives, however most of the initiatives occur in disease-speciﬁc programs or
have been created for the purpose of solving a speciﬁc supply chain problem.
Research suggests (as discussed in this section) that supply chains from each
sector, in this case the public and private sectors, may be integrated to take
advantage of each sector's strengths and address both current and impending
supply chain challenges.
3.6 Chapter 3 Conclusion
In this chapter a review of the literature pertaining to three intersecting re-
search ﬁelds, as introduced in Chapter 2 are presented. Reviewing the litera-
ture provides a deeper understanding of the problem the study aims to address.
The review includes an investigation of health supply chains, pharmaceutical
supply chains, public-private engagement and supply chain integration.
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Existing Frameworks and
Methodologies
From the literature review in the previous chapter, it is evident that public-
private integration could potentially be a solution that can improve health
supply chains, both in public and private sectors. This can be achieved using
the strengths of each sector to improve the eﬃciency and eﬀectiveness, and to
enable supply chains to better deal with current and future challenges. This
approach may be ambitious and pose some challenges risks (as discussed in Sec-
tions 3.3.2, 3.4.1.1 and 3.4.1.2) when considering to integrate public and private
pharmaceutical supply chains. However, it may be beneﬁcial to investigate if
it results in improved aﬀordability, access and availability of pharmaceuticals
due to better functioning supply chains. Although fully integrated pharma-
ceutical supply chains may not be feasible from the outset, a good starting
point may be the identiﬁcation of points along the public supply chain where
the public and private sectors can integrate.
There are various documents and frameworks that aim to identify oppor-
tunities for public-private engagement and frameworks that assist with the
implementation of public-private partnerships. However, there are no frame-
works, of which the author is aware, that assess pharmaceutical supply chains
to identify where along the public supply chain the two sectors can engage and
ultimately integrate. Therefore, the aim of this study is to create a framework
to assess and identify opportunities for integration along the pharmaceutical
supply chain such that (i) it can pave the way for further research on public-
private supply chain integration; (ii) it can be used in case studies that aim to
investigate the impact and implementation of public-private supply chain in-
tegration; (iii) it can assist decision-makers in developing countries to identify
opportunities for integration; (iv) it may provide a starting point and facilitate
the implementation of public-private supply chain integration.
The aim of some frameworks are similar in the sense that these frame-
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works identify opportunities for public-private engagements. However, if the
frameworks were to be used to identify opportunities for integration along
pharmaceutical supply chains, some research gaps would become apparent.
Such research gaps are discussed later in this section.
The aim of this chapter is thus to review existing frameworks and method-
ologies that identify opportunities for integration or private sector engagements
in pharmaceutical supply chains in order to:
(i) Determine what methods have been used to identify opportunities for
public-private health supply chain integration or public-private engage-
ment.
(ii) Determine whether the aim of this research enquiry has already been ad-
dressed by any of the frameworks included in the literature documented
in the preceding chapter.
(iii) Identify the research gaps of the frameworks.
(iv) Adapt the identiﬁed research gaps to framework criteria.
Three diﬀerent frameworks/methodologies were identiﬁed during the liter-
ature review,these frameworks include:
(i) Emerging trends in supply chain management: Outsourcing public health
logistics in developing countries
(ii) Integration of vaccine supply chains with other health commodity supply
chains: A framework for decision making
(iii) Private sector engagement: A guidance document for public health sup-
ply chains
Due to the limited research on the integration of public-private pharmaceu-
tical supply chain integration, frameworks and methodologies of general health
supply chains were included (i.e. framework i and iii). In the following sec-
tions, each method is brieﬂy described after which the research gaps, relative
to the aim of this dissertation, and thus the requirements from a framework to
support the attainment of the stated objectives, are identiﬁed (Sections 4.1 to
4.3). Lastly, in Section 4.4 this chapter's ﬁndings are summarised by means of
stating the criteria that will be used as guiding principles for the development
of the framework.
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4.1 Outsourcing Public Health Logistics
USAID (2010) developed a document that enables public health supply chain
managers to outsource public health logistics. The document describes the
basics of outsourcing, what supply chain functions can be outsourced, when
to consider outsourcing and how to outsource logistics functions. According
to the document, one section includes guidance on how to identify potential
opportunities for outsourcing within an organization... (USAID, 2010). The
process of identifying opportunities for outsourcing consists of three steps:
Step 1: Idenitfy core competency An organisation's core competency is
its main purpose that allows the organisation to make a proﬁt and compete
with other organisations. For example, Dell's core competency is manufactur-
ing customisable, high-quality computers. According to the USAID (2010),
the ministry of health should identify and consider outsourcing activities that
are not part of its core competencies or operational expertise. For example,
the staﬀ at central medical stores are proﬁcient at procuring and managing
stock, but have limited knowledge regarding ﬂeet management and scheduling.
Transportation is therefore a good candidate for outsourcing.
Step 2: Review the operational process The next step is for supply chain
managers to assess the performance of functional areas in order to identify
under-performing functional areas. After the core competency and the process
review are complete, the areas to be outsourced should be clear (USAID,
2010).
Step 3: Feasibility analysis After identifying areas that can be outsourced,
stakeholders need to assess the feasibility of outsourcing by making sure there
are no political and operational barriers. Additionally, they will need to discuss
how funding will be secured.
4.1.1 Research Gap: Outsourcing Public Health
Logistics
(i) This method only focuses on identifying opportunities for outsourcing
logistical functions, i.e. distribution, warehousing and inventory man-
agement, and not opportunities that may fall within other parts of the
end-to-end supply chain.
(ii) The method only considers one of the private engagement forms, i.e.
collaboration, adapting and learning, technical assistance or stewardship.
(iii) The method is speciﬁcally developed for outsourcing only since the aim
of the methodology is to shift the responsibility of certain supply chain
functions to the private sector so that the public sector can focus on core
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competencies. The shifting of responsibility to private sector excludes
collaborative engagements where both sectors need to work together. It
also misses opportunities for insourcing functions that could be done
more eﬃciently in-house.
(iv) In addition, the document suggests that private sector engagements
should only be considered when supply chain managers are experiencing
problems in the supply chain. Perhaps supply chain areas with average
performances can be improved to perform excellently or public sector
best practices can be upgraded to private sector best practices (in cases
where the private sector performs better than the public sector).
4.2 Integrating Vaccine Supply Chains with
Other Health Supply Chains
Yadav et al. (2014) and WHO and PATH (2013) developed a decision making
framework that determines where the integration of vaccine and other health
commodity supply chains will provide the most signiﬁcant beneﬁts. As part
of the framework, opportunities for integration (between vaccine and other
health supply chains) are identiﬁed. Opportunities for integration were iden-
tiﬁed by investigating the beneﬁts, disadvantages and ease of integration of
each supply chain function. The beneﬁts were determined by carrying out
a literature review, whereas disadvantages and ease of integration were iden-
tiﬁed by examining detailed case studies, experiences from integrating family
planning supply chains with essential medicine supply chains, and interviewing
key stakeholders. The resulting framework lists each supply chain function,
the beneﬁts and disadvantages of integrating each function and the ease of
integrating each function.
In an evidence brief, PATH and WHO (2013) explain how vaccine supply
chains were integrated with other health commodity supply chains. PATH
and WHO (2013) focused on the integration of physical products, which was
achieved by performing the following steps:
1. Deﬁne the goals of the supply chain and obtain stakeholder buy-in
2. Create supply chain segments (supply chain segmentation)
3. Identify standard operating procedures and service objectives of each
segment
4. Develop an implementation strategy
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4.2.1 Research Gap: Integrating Vaccine Supply Chains
with Other Health Supply Chains
(i) Both methods integrate two or more vertical public health supply chains,
instead of integrating a public and private supply chain.
(ii) Although the framework by Yadav et al. (2014) and WHO and PATH
(2013) may provide some insightful information regarding the beneﬁts,
challenges and ease of integration, there are no clear steps provided re-
garding how the framework should be used or how users should decide
which supply chain functions to integrate.
(iii) The method described by PATH and WHO (2013) is created to integrate
physical products which only occur in two supply chain functions, namely
storage and transport. This means that other supply chain functions
such as forecasting, procurement, orders and information systems are
excluded (PATH and WHO, 2013).
4.3 Private Sector Engagement Guidance
Document
The Private Sector Engagement Guidance Document was developed to assist
supply chain managers in identifying opportunities for public-private engage-
ment and provide guidance for executing the engagement process (UN Com-
mission, 2015). Opportunities are identiﬁed by describing the diﬀerent forms
of public-private engagements as well as the potential barriers each engage-
ment might have. A real world example is given for some of the engagement
forms. In the project selection section of the document, a table is provided
with methods to help decide whether a problem can be solved through pri-
vate engagement. In other words, supply chain managers should already know
where they want to implement private engagement.
4.3.1 Research Gap: Private Sector Engagement
Guidance Document
The document has a substantial list of engagement forms from which sup-
ply chain managers could pick to potentially solve a supply chain problem.
However, the document does not provide clear steps on how to identify oppor-
tunities for integration in a health supply chain.
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 4. EXISTING FRAMEWORKS AND METHODOLOGIES 68
4.4 Framework Development Criteria
From the above analysis of the three mentioned frameworks, it is evident that
the frameworks that are reviewed do not adequately align with the aim of
this research enquiry. The contextualisation of the problem (Chapter 3) along
with the exploration of the areas where existing frameworks lack to address
and support the speciﬁc research aim are used to infer the following framework
development criteria:
(i) A clear step-by-step approach is needed to identify opportunities for
public-private pharmaceutical supply chain integration.
(ii) The framework should include various forms of public-private engage-
ments.
(iii) The framework should assess the end-to-end in-country public pharma-
ceutical supply chain for integration opportunities.
(iv) The framework should aim to improve any supply chain area, and should
avoid exclusive focus on under-performing areas.
4.5 Chapter 4 Conclusion
In this chapter three existing frameworks and methodologies, that identify
opportunities for integration or private sector engagements, are reviewed. Re-
search gaps are identiﬁed during the review that are subsequently adapted to
framework development criteria.
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Chapter 5
Preliminary Framework
Development
In this chapter, the objective is to develop the preliminary framework. The
methodology of how the framework is developed is described after which the
steps, as outlined by the selected framework development methodology, are
conducted in order to conclude with a framework that evaluates pharmaceuti-
cal supply chains to identify opportunities for public-private integration. This
framework is subsequently subjected to subject matter expert validation in the
succeeding chapter.
5.1 Preliminary Framework Development
Methodology
This section explains how the framework is developed from the criteria that
were derived in Chapter 4. Figure 5.1 provides an illustration of the method-
ology which is discussed in further detail below.
5.1.1 Framework Foundation
The framework foundation consists of the elements of the framework that meet
the criteria identiﬁed in Chapter 4. These elements are collectively known as
the foundation because the framework must have these elements to fulﬁll the
criteria. In this step of the framework development, literature is reviewed to
identify possible solutions that may meet the criteria. The solutions are brieﬂy
discussed and the best option is then selected.
5.1.2 Individual Steps
Criteria 1 involved identifying an appropriate framework approach. In this
step of the framework development, the individual steps are determined using
69
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Figure 5.1: Preliminary framework methodology
the framework approach. For each step, a short literature review is carried
out to determine what methods other authors have used and why. Next, the
methods proposed in the literature are discussed in terms of their relevance to
the framework. Thereafter,the most relevant method, or selection of methods,
are chosen to be included in the framework.
5.1.3 Integrate
The last step of the framework's development involves integration of the frame-
work foundation and individual steps to form the preliminary framework.
5.2 Framework Foundation
For each of the criteria identiﬁed in Chapter 4, a short literature review is
carried out to identify suitable solutions. The most appropriate solution is
then chosen for the preliminary framework.
5.2.1 Criteria 1
Criteria 1 stated that a clear, step-by-step approach is required, therefore, the
aim of this section is to identify an approach which can be used to develop
the framework. Four well established process improvement approaches were
investigated since the the aim of the framework is to improve pharmaceutical
supply chains (i.e. the process) by identifying opportunities for integration.
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Each approach is shortly discussed, after which the one most suited to the
requirements of the current research is determined.
5.2.1.1 DMAIC
DMAIC is a process improvement acronym which stands for Deﬁne, Measure,
Analyse, Improve and Control (De Mast and Lokkerbol, 2012). DMAIC is
an integral part of the Six Sigma methodology which aims to reduce variabil-
ity in business processes (Badiru and Osisanya, 2016; Sokovic et al., 2010).
However, DMAIC has been applied as a general problem solving and process
improvement technique (De Mast and Lokkerbol, 2012; McAdam and Laﬀerty,
2004). DMAIC is a systematic, fact-based approach that provides result-driven
project management (Sokovic et al., 2010). The ﬁve steps of DMAIC are as
follows (Sokovic et al., 2010):
D: Deﬁne by identifying, prioritising and selecting the right project
M: Measure key process characteristics, the scope of parameters and their
performances
A: Analyse by identifying key causes and process determinants
I: Improve by changing the process and optimising performance
C: Control by sustaining the improvement gains
5.2.1.2 DRIVE
DRIVE is an approach that can be used for analysis and problem solving dur-
ing the process improvement process (Badiru and Osisanya, 2016). One of the
beneﬁts of this approach is that it helps to identify speciﬁc areas where im-
provements can be made (Boutros and Cardella, 2016). According to Boutros
and Cardella (2016) the approach consists of the following steps:
D: Deﬁne the scope of the process, deliverables and success criteria.
R: Review the current process and collect data
I: Identify improvements and necessary changes
V: Verify the improvements will meet the deﬁned goals and prioritise changes
based on impact
E: Execute the plan by implementing the changes and measuring the results.
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5.2.1.3 IDEAL
The IDEAL approach is a cycle of activities similar to the Plan-Do-Check-
Act approach (Persse, 2006). Figure 5.2 gives an illustration of the IDEAL
approach.
Figure 5.2: The IDEAL cycle. Source: Börjesson and Mathiassen (2004). © [2004]
IEEE
These are the steps as described by Persse (2006):
Initiate: In this step the organisation realises it has operational problems that
need to be solved. After the realisation, the organisation makes the decision
to take action. The initiate step involves the process of acquiring sponsorship
and formulating the scope of the problem.
Diagnose: The organisation's current process position, quality, strengths,
weaknesses and improvement areas are determined.
Establish: In this step the organisation establishes the solution.
Act: The organisation implements the solution.
Learn: The organisation learn from the implemented solution.
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5.2.1.4 FOCUS-PDCA
The FOCUS-PDCA approach was developed by the Hospital Corporation of
America and is an expanded version of the Deming cycle (Plan-Do-Check-Act)
(Wagner, 2002). FOCUS-PDCA is often used in healthcare research (Wagner,
2002). The approach consists of the following nine steps (Wagner, 2002):
F: Find a process to improve
O: Organise a team that knows the process
C: Clarify the current knowledge of the process
U: Understand sources or causes of variation. Determine how the process
varies and what problems resulted.
S: Select the process to improve
P: Plan the improvement
D: Do the improvement
C: Check the results
A: Act to hold the improvement gain
5.2.1.5 Approach Selection
Four process improvement approaches were investigated. The aim of the frame-
work is to identify opportunities for integration, however the implementa-
tion/execution of integration is outside the scope of this thesis. Therefore,
an approach that focuses primarily on identifying solutions and less on the
implementation and learning from the solution would be the most appropri-
ate candidate. As a result, the DRIVE approach was chosen to serve as an
overarching structure for the framework developed in this project.
5.2.2 Criteria 2
Criteria 2 stated that various forms of public-private engagements should be
included in the framework. The diﬀerent types of public-private engagements
are discussed in Section 3.3.4. As discussed many authors identify and clas-
sify public-private engagements diﬀerently according to their interpretation of
what diﬀerentiates and characterises speciﬁc engagements (John Snow Inc.,
2016; UN Commission, 2015; USAID, 2010; Whyle and Olivier, 2016). Some
engagement forms are widely recognised and accepted throughout the liter-
ature such as outsourcing, partnerships and the adoption of private sector
practices (UN Commission, 2015; John Snow Inc., 2016; USAID, 2010). Not
only are there a number of diﬀerent deﬁnitions for engagements, each with its
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own nuance, but many engagement types can be further sub-divided according
to diﬀerent characteristics. For example, Roehrich et al. (2014) conducted a
systematic literature review on one type of public-private engagement, namely
public-private partnerships and identiﬁed 9 diﬀerent types of partnerships.
The diﬀerences in engagement deﬁnitions and the number of diﬀerent en-
gagement types poses a problem when developing a framework that aims to
include most engagement types. From a practical and implementation stand-
point it would not make sense to include all the diﬀerent deﬁnitions and nu-
ances. Therefore it may be more useful to use a broader deﬁnition of public-
private engagements. Using the deﬁnition of the P3 provided by UN Commis-
sion (2015) will enable the framework to include most public-private engage-
ments since most engagements fall under under one of the three categories.
See Section 3.4.2 for the full deﬁnition of the P3 model.
5.2.3 Criteria 3
Criteria 3 states that the end-to-end in-country public pharmaceutical supply
chain must be assessed. Supply chain functions are the activities that, when
combined, constitute the supply chain (John Snow Inc., 2017). Health supply
chain functions are deﬁned diﬀerently by various authors in the health and
pharmaceutical supply chain literature and may include a larger number of
functions, or fewer. Table 5.1 illustrates the diﬀerence between the diﬀerent
deﬁnitions of the functions that supply chains consist put forward by diﬀerent
authors.
Assessing the supply chain functions for integration opportunities would
prove to be diﬃcult because the supply chain functions consist of many ac-
tivities. Dividing the functions in Table 5.1 further into smaller activities it
will allow for a more precise identiﬁcation of integration opportunities. When
deciding on which author's deﬁnition of supply chain functions to use, the prac-
ticality of using it in a framework must be kept in mind. SIAPS Ukraine (2016)
and John Snow Inc. (2017) break the supply chain functions into too many
activities which will make the framework tedious and time consuming, whereas
SIAPS (2014) break down the functions into further activities. Therefore, the
breakdown provided by MSH (2012) will be used (as indicated in Table 5.2)
since there is a balance between the practicality of using the framework and
assessing the supply chain in further detail.
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Table 5.1: Supply chain functions according to various authors.
Supply Chain Functions S
IA
P
S
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1
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S
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S
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0
1
4
)
J
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n
S
n
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M
S
H
(2
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1
2
)
Product selection x x x
Quantiﬁcation x x x
Procurement x x x x
Warehousing x x x
Inventory management x x x
Distribution x x x
Waste management x
Transportation x
Service delivery x x
Utilisation x x
Management support x
Regulatory policies x
5.2.4 Criteria 4
Criteria 4 states that the improvement of the supply chain, through integra-
tion, should not be limited to underperforming areas of the supply chain. This
criteria is met by assessing the end-to-end supply chain for integration oppor-
tunities and not including performance assessment approaches.
5.3 Individual Steps
This section further describes the developed framework by considering each
of the DRIVE process steps in a stepwise manner. In particular, each section
describes for each part of the DRIVE framework: i) the reviewed literature
relevant to that step; ii) a discussion of the relevance of the methods proposed
in literature; and iii) a selection of a combination of methods that were deemed
to be most relevant and thus included in the preliminary framework.
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Table 5.2: The functions and activities of the pharmaceutical supply chain as
deﬁned by MSH (2012)
Supply Chain Functions
1. Selection
Review prevalent health problems
Identify treatments of choice
Choose individual medicines & dosage
Decide which medicines will be available at each level of the health care system
2. Procurement
Quantify medicine requirements
Select procurement methods
Manage tenders
Establish contract terms
Assure pharmaceutical quality
Ensure adherence to contract terms
3. Distribution
Clear customs
Stock control
Stores management
Deliver to drug depots & health facilities
4. Use
Diagnose
Prescribe
Dispense
Use by patient
5. Management support
Organization of system
Finance & sustainability
Information management
Human resource management
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5.3.1 Deﬁne the Scope of the Supply Chain (D in
DRIVE)
The ﬁrst step of the DRIVE approach involves, as the name suggests, deﬁning
the scope of the problem as well as the success criteria such as deliverables
and success criteria (Boutros and Cardella, 2016).
5.3.1.1 Literature Review
In many projects or assessments one of the ﬁrst steps is to decide the scope
of the project as seen in project reports by PATH and WHO (2013), UNICEF
(2016), USAID | DELIVER PROJECT Task Order 4 (2013), USAID (2013)
and USAID | DELIVER PROJECT Task Order 1 (2011a). According to the
assessment guide and tool by USAID | DELIVER PROJECT Task Order 4
(2013), the assessment scope informs which data will be collected and what will
be analysed. Although the assessment guide and tool by USAID | DELIVER
PROJECT Task Order 4 (2013) focuses on the human resources of health sup-
ply chains, the document may provide some insight that can be used for this
framework. In a public health supply chain strengthening framework devel-
oped by UNICEF (2016) the scope is deﬁned before the strengthening exercise
due to the complexity of public health supply chains and the many factors
that need to be taken into consideration. Factors include the large variety of
health programmes and products (such as HIV, TB, vaccines, etc.), the mul-
tiple levels health supply chains have, the diﬀerent functions of health supply
chains (such as procurement, quantiﬁcation, distribution, etc.) and the vari-
ous support systems and policies (UNICEF, 2016). All elements within each
of the factors cannot be feasibly managed during a single project, therefore
UNICEF (2016) argue that consensus should be reached among the stakehold-
ers regarding priority areas on which joint eﬀorts will focus. The assessment
scope should be collaboratively developed and agreed upon by taking opinions
of various stakeholders into account (USAID | DELIVER PROJECT Task Or-
der 4, 2013; UNICEF, 2016).
The scope of the assessment largely depends on the available time and
resources (Eichler et al., 2012; USAID | DELIVER PROJECT Task Order
1, 2011a). The scoping phase of the tool developed by USAID | DELIVER
PROJECT Task Order 4 (2013) consists of ﬁve sections, namely: developing
the scope of the assessment; building and recruiting the assessment team based
on the required skills and knowledge as deﬁned in the assessment scope; en-
gaging stakeholders since the assessment success depends on the involvement
of these stakeholders; compiling reference materials related to the country,
context and supply chain in question; and developing a health supply chain
proﬁle by asking stakeholders to complete a survey regarding the capacity and
performance of the supply chain. According to USAID | DELIVER PROJECT
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Task Order 4 (2013) the assessment scope should include the purpose of the
assessment, the human resources building blocks that will be included, the
levels of the supply chain that will be assessed, the time frame of the assess-
ment and the desired skills of the assessment team. As part of developing the
scope, a budget needs to be developed in order to balance the priorities of
the assessment with budget constraints (USAID | DELIVER PROJECT Task
Order 4, 2013). USAID | DELIVER PROJECT Task Order 1 (2011a) and
USAID (2013) also include the development of a budget in the scoping phases
of the supply chain assessments to ensure that the objectives of the assessment
are met.
UNICEF (2016) deﬁne the supply chain scope according to four dimen-
sions, namely: supply chain levels, supply chain products/programmes, supply
chain functions and policy and support systems. UNICEF (2016) provide a
checklist with the dimensions to assist with the deﬁnition of the scope. Accord-
ing to UNICEF (2016) deﬁning the scope according to these four dimensions
help manage the supply chain complexity. Similarly to USAID | DELIVER
PROJECT Task Order 4 (2013) and UNICEF (2016), USAID (2013) deter-
mine which commodities will be included in the scope, the timeframe of the
assessment, as well as the health facilities that will be assessed.
5.3.1.2 Discussion of Methods
The majority of sources deﬁne the scope according to the supply chain levels
and groups of products, others also include speciﬁc supply chain functions and
support systems. No speciﬁc reason is given as to why the scope of the supply
chains is deﬁned in this way, however it is assumed it is done for the same
reason that UNICEF (2016) provided, which is that it reduces the complexity
of the supply chain and thus the assessment as well. In many projects the iden-
tiﬁcation of and engagement with stakeholders is important since stakehold-
ers provide the required data, information and insight that enables execution
of projects and assessments. Some scoping exercises require that assessment
teams be recruited so that they can work with the client who requested the
assessment or whose supply chain is being assessed. The assessment team as-
sists with data collection, preparations and report writing.
This framework is developed for public supply chain managers who want to
assess their own supply chains. Since the assessment will not be used for clients
an assessment team may not be required. If the supply chain manager needs
some assistance with the assessment, he/she can identify competent employ-
ees to help with the assessment. Recruiting an assessment team is not crucial
for the success of the assessment outcome. Some projects and assessments
require that reference materials be collected and reviewed during the process
of deﬁning the scope in order to gain a better understanding of the supply
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chain environment. This is addressed in the second step of the DRIVE ap-
proach, which is to review the current situation, and is therefore not necessary
in the scope deﬁnition step. It is often recommended that the purpose of the
project or assessment be clearly deﬁned as part of the scope deﬁnition. While
some frameworks or assessments could serve multiple purposes, this framework
serves one purpose which is to identify opportunities for integration. Thus, it
will not be required to deﬁne the purpose of the assessment during the scope
deﬁnition.
Sometimes employees and stakeholders are required to travel to a desti-
nation (or multiple destinations) where the assessment will take place. This
means that money will be spent on travelling, transport, hiring venues and
in the case of workshops, money will be spent on refreshments, food and any
other materials that may be required (such as printed guides, questionnaires,
projectors, etc.) It is therefore important for the person who is carrying ot
the assessment to draw up a budget to ensure that there is enough funding for
the assessment and to prevent overspending. It is also important to develop
a timeframe to ensure that deliverables are met on time and preventing the
assessment from taking longer than it should.
5.3.1.3 Selection of Methods
The proposed approach to scope the supply chain assessment includes four
components as described in Table 5.3, along with the reason why each method
was selected.
5.3.2 Review the Current Situation (R in DRIVE)
According to the DRIVE approach this step requires that the current situation
is reviewed by understanding the background and collecting information such
as performance data, problem areas and improvement options (Boutros and
Cardella, 2016). Therefore this section will be divided into two subsections,
namely: review and data collection.
5.3.2.1 Literature Review
Considering that the R in DRIVE consists of two steps, namely a review and
the collections of data, the literature review will be divided into two sections.
First, literature related to the review of the current situation will be reviewed,
followed by a literature review of methods used to collect data.
Review
According to UNICEF (2016), a review of the current situation is required
to ensure that problems and performance gaps are agreed upon by all stake-
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Table 5.3: Proposed components for determining the scope of the assessment
Component Reason for inclusion Adapted from
List of supply
chain levels
and products
Assists with the scope deﬁnition
and reduces/manages the com-
plexity of the assessment
(UNICEF, 2016)
UNICEF (2016);
USAID | DELIVER
PROJECT Task Order
4 (2013);
USAID (2013)
Stakeholder
engagement
Stakeholders can review ap-
proaches and outputs.
Stakeholders can contribute to
the data collection and method-
ology.
Stakeholders can verify ﬁndings
and recommendations.
Stakeholders can give input on
the feasibility and impact of
recommendations.
(USAID | DELIVER PROJECT
Task Order 4, 2013)
USAID | DELIVER
PROJECT Task Order
4 (2013)
Timeframe Establishing a timeframe will
inform when specifc assessment
steps will take place and when de-
liverables are due
(USAID | DELIVER PROJECT
Task Order 4, 2013)
USAID | DELIVER
PROJECT Task Order
4 (2013);
USAID|DELIVER
PROJECT (2011);
USAID (2013)
Budget Developing a budget will
determine whether there is suﬃ-
cient funding available to carry
out the assessment, achieve as-
sessment objectives and prevent
unecessary spending
(USAID | DELIVER PROJECT
Task Order 4, 2013) and (US-
AID|DELIVER PROJECT,
2011)
USAID | DELIVER
PROJECT Task Order
4 (2013);
USAID|DELIVER
PROJECT (2011);
USAID (2013)
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holders. USAID | DELIVER PROJECT Task Order 4 (2013) suggest doing a
document review to develop a better understanding of the larger context of the
supply chain. Being familiar with the context of the country and the chosen
supply chain will help to identify and clarify the supply chain's constraints
(USAID | DELIVER PROJECT Task Order 1, 2011a). Many health supply
chain guides, frameworks and reports make use of literature reviews to (i)
identify information gaps (Pharasi, 2009); (ii) collect background information
before an assessment (USAID, 2017; Village Reach, 2015; Islam, 2007; Lusby
and Panlibuton, 2006; USAID | DELIVER PROJECT Task Order 4, 2013);
(iii) understand the context of various ﬁelds (Steele, 2015; USAID | DELIVER
PROJECT Task Order 4, 2013); (iv) review past assessments (Village Reach,
2015); and (v) to collect data (Islam, 2007).
Reviews can be carried out to determine what relevant information already
exists and to understand the issues that aﬀect the supply chain (USAID | DE-
LIVER PROJECT Task Order 1, 2011a). Reviews are carried out by collect-
ing background materials and documents and using questionnaires to gather
further background information about the supply chain (USAID | DELIVER
PROJECT Task Order 1, 2011a; USAID, 2013). These questionnaires contain
questions regarding the supply chain context, stakeholders and reports that
may be relevant to the assessment (USAID, 2013). Documents that should
be included in the review include national health strategic plans that have
been conducted on the speciﬁc supply chain (USAID | DELIVER PROJECT
Task Order 1, 2011a; USAID, 2013), previous assessments or reports (Village
Reach, 2015; UNICEF, 2016), documents related to programs, processes and
policies, as well as any other documents recommended by stakeholders (USAID
| DELIVER PROJECT Task Order 4, 2013; UNICEF, 2016; USAID, 2013).
The country's strategic plan will help with understanding the country's supply
chain before the assessment (USAID | DELIVER PROJECT Task Order 1,
2011a). Other documents include surveys that have been conducted by the
country (USAID | DELIVER PROJECT Task Order 1, 2011a). Health supply
chain reviews should include the supply chain structure and general operations
and processes UNICEF (2016).
The supply chain structure can be determined by developing a map of the
supply chain (Gardner and Cooper, 2003). Gardner and Cooper (2003) deﬁnes
a supply chain map as follows: A supply chain map is a representation of the
linkages and members of a supply chain along with some information about
the nature of the entire map. Examples of supply chain maps are illustrated
in Figures 3.1 and 3.2. When strengthening public health supply chains, the
review should include the current performance, how it compares with the de-
sired performance as well as the determinants of success and failure (UNICEF,
2016). According to USAID (2013) the focus of the review should be to iden-
tify weaknesses within the chosen supply chain. Documents collected during
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the review are collected and distributed amongst assessment team members
(Islam, 2007; USAID | DELIVER PROJECT Task Order 4, 2013). Review
documents should be gathered and reviewed before commencing with the data
collection (USAID | DELIVER PROJECT Task Order 4, 2013). Other meth-
ods of collecting relevant information for the review include having meetings
with stakeholders, government oﬃcials and service providers (USAID, 2017;
Pharasi, 2009), visiting health facilities, reviewing processes and mapping the
distribution, procurement and storage of health commodities (Pharasi, 2009).
Data collection
There are various methods of collecting data, such as focus groups, inter-
views, surveys (USAID | DELIVER PROJECT Task Order 4, 2013; Pharasi,
2009; Islam, 2007; USAID, 2013; USAID | DELIVER PROJECT Task Order
1, 2011a; SIAPS Ukraine, 2016). Some frameworks, such as the one developed
by USAID | DELIVER PROJECT Task Order 4 (2013) include data col-
lection plans where the geographic focus, key informants, organisations, data
collection methodologies and schedules are taken into consideration. There are
also various data collection tools such as Excel® based tools, paper based sur-
veys, questionnaires, software programs, capability maturity models, KPI tools
(USAID | DELIVER PROJECT Task Order 4, 2013; Pharasi, 2009; WHO;
SCMS/Rwanda Ministry of Health, 2013; Tien et al., 2013; SIAPS Ukraine,
2016). USAID | DELIVER PROJECT Task Order 4 (2013) use a data collec-
tion tool for the assessment of public health supply chains. The tool consists
of four components where each component is speciﬁcally designed to collect
speciﬁc data. The data collection tool consists of the following components:
reference document review, public health supply chain proﬁle, diagnostic dash-
board and a supplemental survey (USAID | DELIVER PROJECT Task Order
4, 2013). The data collection tool was designed to increase the reliability, va-
lidity and accuracy of the data while ensuring that data collection is carried
out in a consistent manner (USAID | DELIVER PROJECT Task Order 4,
2013).
5.3.2.2 Discussion of Methods
Similarly to Section 5.3.2.1, this section will be divided into two sections,
namely review and data collection.
Review
Reviewing documents is a major component of the majority of assessments
and projects for various reasons, as discussed in Section 5.3.2.1. These docu-
ments contain important information that is useful and relevant to assessments.
Questionnaires and interviews with stakeholders also provide important infor-
mation since stakeholders' experiences and insights can be gathered and may
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 5. PRELIMINARY FRAMEWORK DEVELOPMENT 83
include missing information that is not available in any documents. Stake-
holders can also provide documents that are relevant to the assessment and
can be included in the document review. Knowing the supply chain structure
gives additional background information on the functioning and context of the
supply chain. Developing a supply chain map allows stakeholders to reach an
agreement on its structure and how it functions, and ensures that all stake-
holders have the same level of understanding of the supply chain in question.
Health facilities are usually visited when they are part of an assessment or data
needs to be collected from the facilities. Due to the fact that this framework
is a high-level supply chain assessment, it may not be required to visit speciﬁc
health facilities.
Data Collection
All assessments and projects reviewed in Section 5.3.2.1 collect data by means
of focus groups, interviews and surveys with stakeholders. This is because
stakeholders have experience in the assessed ﬁeld and can provide in-depth
information and explanations. Their expertise and knowledge might not be
available from other sources of information. Various data collection tools have
been used to ensure that data is collected in a consistent manner, it also ensures
that data is properly and correctly recorded thus increasing the reliability and
accuracy.
5.3.2.3 Selection of Methods
The proposed components and the reason for selection for the review of the
current situation are described in Table 5.4.
It is proposed that data will be collected on the current level of integra-
tion in order to get a further understanding of the current situation. Deter-
mining the current level of integration will give an indication of the current
public-private engagements in each supply chain area as well as the degree
of integration. Knowing the current level of integration will help determine
where future public-private engagements might be needed/helpful to the phar-
maceutical supply chain and prevent the duplication of existing public-private
engagements. It may also enable the identiﬁcation of integration opportunities
that could contribute to the strategic goals of the public sector. Data will also
be collected on the level of integration that the pharmaceutical supply chain is
capable of achieving in order to identify improvement options as suggested by
Boutros and Cardella (2016). Identifying the level of integration that the sup-
ply chain is capable of (integration capability) gives an indication of potential
integration opportunities, the impact the integration could have on the supply
chain and identiﬁes the supply chain areas where improvements can be made.
The proposed components and the reason for selection of the data collection
phase is shown in Table 5.5.
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Table 5.4: The proposed components for reviewing the current situation
Component Reason for inclusion Adapted from
Desktop/ document
review of the supply
chain and cur-
rent public-private
engagements
To gain a better understanding
of the supply chain and
its context (USAID | DE-
LIVER PROJECT Task
Order 4, 2013); identify
problems (UNICEF, 2016),
constraints (USAID | DE-
LIVER PROJECT Task Order
1, 2011) and information gaps
(Pharasi, 2009)
USAID | DELIVER
PROJECT Task Order
1 (2011); USAID (2013);
USAID | DELIVER
PROJECT Task Order 4
(2013); UNICEF (2016);
Village Reach (2015)
Supply chain map
indicating the struc-
ture of the supply
chain
The process of developing and
disseminating a supply chain
map leads to a common under-
standing of the supply chain.
Mapping helps with the visual-
isation of the supply chain and
identiﬁcation of areas that need
to be further analysed (Gard-
ner and Cooper, 2003)
UNICEF (2016)
Questionnaire or
interview with stake-
holders
In cases where information is
missing, insuﬃcient or unclear,
stakeholders may provide the
required information or recom-
mend relevant reports an doc-
uments.
USAID (2013); USAID |
DELIVER PROJECT
Task Order 1 (2011)
5.3.3 Identify Improvements and Necessary Changes (I
in DRIVE)
In order to identify improvements and the necessary changes it is proposed
that the supply chain's current level of integration and its integration capabil-
ity be compared. Although the results from the data collection tool (in Section
5.3.2.3) can be compared side-by-side, it could be quite a time-consuming pro-
cess and due to the size of the matrices, mistakes can be made during the com-
parison. Therefore, visual representations of the data will be used to compare
the current level of integration with the supply chain integration capability.
Graphs are excellent for visual representations because large amounts of
data can be condensed into formats that are easy to understand and eﬀectively
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Table 5.5: Proposed components of the data collection phase
Component Reason for inclusion Adapted from
Data collection tool:
Excel
A data collection tool may
simplify the process of col-
lecting data and ensure
that data is collected in a
consistent manner regard-
less of who uses the frame-
work
USAID |
DELIVER
PROJECT Task
Order 4 (2013).
Data collection
matrix devel-
oped by
author. See
Appendix A.
Interview/ focus
group with stake-
holders
Stakeholders have a good
understanding of the pub-
lic pharmaceutical supply
chain and how it functions.
Stakeholders will also know
to what extent the sup-
ply chain can integrate and
whether the PPSC has the
capacity to engage with the
private sector.
USAID | DE-
LIVER
PROJECT Task
Order 4 (2013);
Pharasi (2009);
Islam (2007);
USAID (2013);
SIAPS Ukraine
(2016)
communicate key points. It was decided that a radar graph will be used for the
comparison since it allows for a quick comparison and it is easy to determine the
gap between the current level of integration and the supply chain integration
capability.
5.3.4 Verify and Prioritise (V in DRIVE)
In this step of the DRIVE approach it needs to be veriﬁed that the improve-
ments will meet the deﬁned goals and changes need to be prioritised based on
its impact (Boutros and Cardella, 2016).
5.3.4.1 Literature Review
The most common method of validating data and ﬁndings is by hosting a
workshop with stakeholders (Steele, 2015; McCord et al., 2013; Islam, 2007;
USAID | DELIVER PROJECT Task Order 4, 2013; UNICEF and MSH, 2012).
During the workshops McCord et al. (2013) validate data by eliminating errors
and speaking with stakeholders to correct and double check discrepancies. In
the assessment tool developed by USAID | DELIVER PROJECT Task Order
4 (2013) the collected data is reviewed and analysed. Findings are validated
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and supported by the secondary information collected during the document
review. In cases where the assessment team still have questions or ﬁndings can-
not be validated with secondary information, stakeholders are re-interviewed
to validate the ﬁndings (USAID | DELIVER PROJECT Task Order 4, 2013).
Once the data has been validated the assessment team develops recommenda-
tions which also validated during a validation workshop (USAID | DELIVER
PROJECT Task Order 4, 2013). According to USAID | DELIVER PROJECT
Task Order 4 (2013) ﬁndings and recommendations should be validated by two
groups of stakeholders, namely: key stakeholders who are decision makers (for
example managers or donors) and stakeholders who are responsible for funding
or implementing the identiﬁed recommendations.
In addition to validating recommendations, stakeholders are also asked
to prioritise recommendations. Other authors such as UNICEF and MSH
(2012) and Islam (2007), also require stakeholders to prioritise solutions and
results during the validation workshop. Other methods include validating
and clarifying collected information by conducting face-to-face interviews with
stakeholders (Tata and Babaley, 2012). In some assessments, such as SIAPS
Ukraine (2016), information gathered during interviews is veriﬁed by observ-
ing processes and assets in health facilities. USAID (2013) verify information
by observing, walking through and taking photos in health facilities. During
the assessment, developed by USAID | DELIVER PROJECT Task Order 4
(2013), stakeholders are asked to prioritise interventions. This ensures that
the interventions are prioritised by people who understand the context the
best (USAID | DELIVER PROJECT Task Order 4, 2013). Interventions are
prioritised according to criteria such as the feasibility, importance, aﬀordabil-
ity, cost, timeframe, risk and impact of the intervention (USAID | DELIVER
PROJECT Task Order 4, 2013; Eichler et al., 2012; Unicef, 2011).
WHO (2004) prioritise according to the urgency of need and the availabil-
ity of resources. USAID | DELIVER PROJECT Task Order 1 (2011b), Unicef
(2011) and Galer et al. (2008) score each criteria on a scale from one to three,
where one is low and three is high. Criteria included the priority, feasibility
and availability of resources (USAID | DELIVER PROJECT Task Order 1,
2011b). Priority refers to the size of the impact and the importance of the
intervention; the feasibility refers to the extent of political and cultural sup-
port, infrastructure and policies; lastly resources refer to the funds, skills and
materials (USAID | DELIVER PROJECT Task Order 1, 2011b). There many
prioritisation methods that can be used, however according to Eichler et al.
(2012) the method should be consistent and transparent. Galer et al. (2008)
make use of a prioritisation matrix where interventions are ranked based on
the timeframe, cost, availability of resources and importance to quality. A pri-
oritisation matrix (PM) is a simple technique that objectively sorts and ranks
items according to importance (Fernandes et al., 2006; Gosenheimer et al.,
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2012). Items are ranked based on a set of important criteria (Gosenheimer
et al., 2012).
5.3.4.2 Discussion of Methods
Of the reviewed documents that discuss how data is validated, all used work-
shops or interviews with stakeholders to validate outcomes, recommendations
and data. This is likely because of stakeholders' experience in the ﬁeld.
Projects are prioritised according to various diﬀerent criteria as mentioned in
Section 5.3.4.1. Although the criteria of the diﬀerent assessments and projects
are similar, criteria are usually deﬁned based on what is important for each
project.
5.3.4.3 Selection of Methods
Due to the high risks associated with public-private engagements (as discussed
in Section 3.3.2 it is proposed that the possible improvements identiﬁed in
Section 5.3.3 be prioritised by analysing the risks and beneﬁts of engaging
with the private sector. The proposed components of the verify and prioritise
phase are shown in Table 5.6.
5.3.5 Execution (E in DRIVE)
The framework only focuses on identifying opportunities for integration in the
pharmaceutical supply chain, therefore implementing public-private engage-
ments in the identiﬁed opportunities is outside of the scope of this thesis.
There are many useful guides and documents that assist with determining
the feasibility of public-private engagements as well as identifying potential
partners for engagement and implementing public-private engagements. Con-
sequently, the execution step of the DRIVE approach will be excluded from
the framework. A list of useful documents is provided in Table 5.7.
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Table 5.6: Components of the verify and prioritise phase
Component Reason for inclusion Adapted from
Validation
workshop/
interview
The majority of assessments
that were reviewed, validated
data and ﬁndings via work-
shops and interviews with
stakeholders. Stakeholders
are able to validate data and
ﬁndings because of their ex-
pertise.
USAID |
DELIVER
PROJECT Task
Order 4 (2013);
UNICEF and
MSH (2012);
Steele (2015);
McCord et al.
(2013); Islam
(2007)
Risk-beneﬁt
prioritisation
Public-private engagements
are inevitable and provide
many opportunities but also
considerable risks (Buse and
Waxman, 2001). Risks and
beneﬁts need to be weighed
when engaging with the pri-
vate sector (O'Hanlon and Jef-
fers, 2013; John Snow Inc.,
2016; Tennyson, 2011)
Developed by
author. See Ap-
pendix B.
Table 5.7: A list of documents that are useful for implementing public-private
engagements
Author(s) Title
South African National Treasury PPP Manual
Tennyson The partnering toolbook: An essential
guide to cross-sector partnering
United Nations Commission
on Life-Saving Commodities
Private Sector Engagement: A Guidance
Document for Public Health Supply Chains
O'Hanlon and Jeﬀers Reference Guide for Development of
Public Private Partnerships in the Health
Sector for Countries in the SADC Region
Herzberg and Wright Public-Private Dialogue: The PPD
Handbook - A Toolkit for Business Envi-
ronment Reformers
Smith et al. Working with Private Sector Providers for
Better Health Care: An Introductory
Guide
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5.4 Preliminary Framework
The preliminary framework is created by integrating the framework founda-
tion and individual steps. Figure 5.3 gives an illustration of the preliminary
framework.
Figure 5.3: The proposed preliminary framework
5.5 Chapter 5 Conclusion
In this chapter the development of the preliminary framework is discussed. The
chapter outlines the methodology that is employed to develop the framework.
Furthermore, the methodology is carried out on a step-by-step basis to ensure
that the criteria identiﬁed in Chapter 4 are met, and to determine the speciﬁc
steps required in the proposed framework. Finally, the chapter concluded by
integrating all the steps and presenting the preliminary framework.
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Framework Validation
The objective of this chapter is to validate the preliminary framework that
was developed in Chapter 5. Section 6.1 discusses how internal validation was
carried out on the framework and Section 6.2 discusses how the framework was
externally validated through SMEs. Improvements were made to the prelimi-
nary framework according to the feedback provided by the SMEs, resulting in
the ﬁnal framework which is presented in Chapter 7.
6.1 Internal Validation
As part of the framework, an Excel® ﬁle was created (See the USB which
accompanies this thesis)1 to assist with the data collection and supply chain
assessment of identifying integration opportunities in pharmaceutical supply
chains. In order to determine whether the Excel® ﬁle functions properly, inter-
nal validation was conducted by the researcher. Internal validation was carried
out by entering mock data and evaluating whether the framework provided the
corresponding expected outputs. This was done iteratively with various sce-
narios/diﬀerent input data, so that a variety of diﬀerent outcomes could be
tested. When errors occurred or incorrect outputs were given, corrective action
was taken to ensure that the Excel® ﬁle functions as intended.
6.2 External Validation
The framework was externally validated through the use of a questionnaire.
Four subject-matter experts with experience in the health supply chain ﬁeld
were part of the validation process. The framework was presented to the SMEs
who provided feedback based on their experience and insight. The framework
was amended and improved based on the feedback provided by the SMEs.
1Alternatively use the link provided in Appendix F
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Table 6.1 provides a description of each SME's current position, background
with regards to health supply chains and exposure to public-private engage-
ments. Some SME's have decided to remain anonymous, in which case a code
is used to replace their name and their occupational descriptions are written
in such a way as not to violate anonymity.
Section 6.2.1 provides a description of the process that was followed to
validate the framework. Section 6.2.2 discusses each questionnaire question
along with the feedback that was received for that question. Lastly, Section
6.2.3 concludes the external validation.
Table 6.1: Subject-matter experts' background and exposure to public-private en-
gagement
SME Position Role Public-private en-
gagement exposure
SME 1
General Man-
ager
Responsible for the
management of the
centralised dispensing
for chronic medication
project as well as the
projects and engineer-
ing division
Employed by a pri-
vate company that
provides services to
the public sector
SME 2
Contract
Manager/
Consultant
Responsible for con-
tract management
post contract award
and ensuring the
availability of es-
sential medicines to
public and sometimes
private patients
Has experience with
public-private engage-
ments with regards
to relationship man-
agement, contract
management, risk
management, ten-
dering and service
provider licensing
inter alia.
SME 3
Supply Chain
Manager
Manages a supply
chain, procurement
and exports of health
commodities into
Africa
Manages the supply
and customer relation-
ship between a busi-
ness and NDoH
SME4
Consultant
Pharmacist
Managing technical
assistance projects
Management of
technical assistance
projects across the
medicine supply chain
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6.2.1 Validation Process
The validation of the framework was carried out by sending each SME three
electronic ﬁles. The ﬁrst ﬁle is a guide that explains: (i) the reason for creat-
ing the framework; (ii) the objectives of the framework; and (iii) how to use
the framework. In addition, the document provides necessary deﬁnitions and
documentation (such as templates, forms and questionnaires) that are needed
to further understand and apply the framework (See Appendix E). The sec-
ond ﬁle is an Excel® ﬁle which is used for the practical component of the
framework (See the USB accompanying this thesis)2. This ﬁle is used to col-
lect data, identify opportunities for integration, assess the risks and beneﬁts of
the identiﬁed opportunities as well prioritise the identiﬁed opportunities. The
third ﬁle is the questionnaire that is used to record SME's responses.
Once the documentation has been received, each SME could work through
the guide and Excel® ﬁle in their own time. In cases where SMEs needed
further clarity regarding the framework, telephonic calls were organised so
that SMEs could have their questions addressed by the student. Face-to-
face interviews were not conducted with SMEs as most were either out-of-
country or in another province. SMEs electronically forwarded the completed
questionnaires to the researcher after which telephonic calls were organised in
the event where the researcher needed more clarity on some of the answers.
The questionnaire and feedback from SMEs are further discussed in Section
6.2.2.
6.2.2 Questionnaire and SME Feedback
The questionnaire consists of two sections. The ﬁrst section contains back-
ground questions regarding the SMEs. These questions were used to determine
what experience the SMEs have had with supply chains and whether they have
experience with public-private integration. The second section contains ques-
tions regarding the framework. A copy of the questionnaire is presented in
Appendix C. Each question of the questionnaire and the relevant feedback
provided are discussed below. The completed questionnaires are provided in
Appendix D. Some information was removed from the completed question-
naires to ensure the anonymity of some SMEs.
1. Is there a need to identify opportunities for integration be-
tween the public and private sectors in pharmaceutical supply chains?
All SMEs agreed that there is a need for integration between public and
private pharmaceutical supply chains.
2Alternatively use the link provided in Appendix F
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SME 1 further stated that it is especially needed in areas such as the
management of stock at facilities, data integration and basic supply chain pro-
cedures.
SME 2 stated that integration is needed to increase direct deliveries and
to improve demand and supply planning as well as the visibility of the sup-
ply capacity. Furthermore, integration opportunities may be useful during the
phased implementation of the NHI in South Africa as integrating with the pri-
vate sector may assist with supply chain visibility and logistics management.
Public-private integration may also assist with the establishment of an Early
Warning System which would be used to prevent stock-outs and/or medicine
shortages. SME 2 further added that identifying opportunities for integration
will not only be needed for pharmaceuticals, but also for consumables and
surgical products.
SME 3 elaborated that the public sector aims to buy the cheapest medicine
so that more patients can be treated. However, this leads to ﬁerce competi-
tion between suppliers as well as import replacements, further resulting in
job losses. The integration of the public and private sector could make local
supply more sustainable, retain more jobs, improve South Africa's Balance of
Payment and result in more South African tax levied.
SME 4 stated that integration opportunities need to be identiﬁed so that
more private sector institutions can provide public services to public sector
patients. This is important for the implementation of NHI. In addition, the
integration of the public and private sector can help the public sector to meet
the health needs of the public sector. Public-private integration will also im-
prove supply chain visibility which will provide decision makers with more
information on the public sector demand as well as the supply capacity of the
supply chain. This information can then be used to prevent stock-outs.
2. Do you believe this framework would be a useful assessment
tool to identify integration opportunities?
All SMEs agreed that the framework is a useful tool to identify opportu-
nities for public-private integration.
SME 1 agreed that the framework is a useful tool to identify opportuni-
ties for integration. He further stated that there are some Excel® issues that
need to be improved. It was clariﬁed that he wanted measures put in place to
ensure that framework users cannot enter invalid data during data collection.
For example, when collecting data on the current level of integration, users
are required to enter a capital `x' in the appropriate space and only enter one
`x' per supply chain activity. Therefore, SME 1 suggested putting measures
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in place that would prevent users from entering other letters or entering more
than one `x' per supply chain activity. Furthermore, SME 1 suggested remov-
ing the `customs clearance' supply chain activity as it is irrelevant.
Both SME 2 and SME 4 stated that the public sector has limited capacity
and that the private sector's best practices need to be adopted and their ca-
pacity needs to be leveraged. Improved collaboration between the public and
private sector can increase the robustness of the supply chain and result in a
strong supply chain. In addition, the public sector needs to overcome many
supply chain and engagement challenges in order for the successful implemen-
tation of NHI.
3. Are there other frameworks that have the same purpose and
results that you are aware of?
None of the SMEs are aware of a similar framework.
4. Are there any shortcomings or feedback on the methodology
employed by the proposed framework? (Or what are the strengths
and weaknesses?)
SME 1 believes the framework is well thought through. However, he fur-
ther states that the framework may be too long and suggests that there should
be two versions, a short version and a detailed version.
Both SME 2 and SME 4 commented that the employed methodology is
sound and that the framework is structured in a way that allows for easy data
capturing. SME 4 further stated that the framework will improve compliance
from stakeholders.
SME 3 commented that he thinks the framework will be very useful as
a checklist to determine supply chain readiness. In addition, he states that
the framework will facilitate objective debates between stakeholders from the
public and private sectors.
5. In your opinion, how can the framework be improved?
SME 1 provided the same answer as for Question 4.
SME 2 and SME 4 suggested that a formulary and Standard Treatment
Guideline (STG) component be added to the framework. As the public sector
moves closer to the implementation of NHI, the establishment of formularies
and STGs will need to be strengthened; more private sector stakeholders are
needed to participate with the establishment of formularies and STGs. In addi-
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tion, they suggested that contract management, demand planning and supply
planning components be added to the framework. SME 4 stated that contract
management is closely linked to supply chain performance and provides a good
opportunity for improving collaboration and planning. SME 4 also states that
improved collaboration in demand and supply planning could assist with the
prevention of medicine shortages. Lastly, SME 4 suggested that `clearing cus-
toms' should be removed, as it is not an issue for the public sector, and that
information management play a bigger role in the framework. Information
management is an important for the planning and execution of supply chain
activities. The ability to share information timeously is also important for
decision-making.
SME 3 stated that some terminologies may need to be improved, but that
it would not add value to the developed framework. SME 3 then suggested to
rather leave the framework as is.
6.2.3 Validation Conclusion
The feedback from the questionnaires indicated that the SMEs found that
there is a need to identify opportunities for integration in pharmaceutical sup-
ply chains and that the framework would be a useful tool to achieve that need.
Overall the SMEs were very positive and content with the framework. Some
recommendations were made as to how the framework could be further im-
proved. These recommendations do not aﬀect the fundamental steps of the
framework. However, the recommendations were used to add some compo-
nents, that were deemed important by some SMEs, to the Excel® ﬁle and
remove some supply chain activities that do not add value to the assessment.
6.3 Chapter 6 Conclusion
The validation of the developed framework is discussed in this chapter. The
validation process involved the completion of a questionnaire by four SMEs.
The feedback from the SMEs was positive and was used to reﬁne the frame-
work. The reﬁned framework formed the ﬁnal framework which is presented
in Chapter 7.
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Final Framework
This chapter presents the ﬁnal framework which was developed throughout
Chapters 4 to 6. Section 7.1 provides an overview of the framework, after
which Sections 7.2 to 7.6 discuss each phase of the framework. Lastly, Section
7.7 provides an explanation of the results that are displayed on the dashboard
which is included in the Excel® ﬁle (See the USB accompanying this thesis)1.
It is recommended that this chapter is considered along with the supple-
mentary documents provided: (i) Excel® on the USB drive, and (ii) the frame-
work guide presented in Appendix E.
7.1 Framework Overview
The framework consists of ﬁve phases, namely:
1. Deﬁne scope
2. Review
3. Data collection
4. Identify Improvements
5. Verify & prioritise
Figure 7.1 illustrates the ﬁve phases of the ﬁnal framework, as well as the
corresponding pages in the guide (Appendix E), and tabs in the Excel® ﬁle
(See the USB accompanying this thesis). Each phase is discussed in detail
below.
1Alternatively use the link provided in Appendix F
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Figure 7.1: Final framework
7.2 Phase 1: Deﬁne Scope
Before commencing with the assessment, it is important to deﬁne the scope of
the assessment as well as the supply chain that is being assessed. The scope will
inform assessors of: (i) the scope of the supply chain that is being assessed (i.e.
where it begins and ends, which supply chain functions are being assessed and
the type of supply chain, for example malaria or TB medicine supply chain);
(ii) which stakeholders to engage during the assessment; and (iii) the data that
needs to be collected. This phase consists of four parts, namely: supply chain
levels and products, stakeholder engagement, timeframe and a budget. Each
of these are addressed in Section 7.2.1 through 7.2.4, respectively.
7.2.1 Supply chain levels and products
During the scope deﬁnition, a decision needs to be made regarding the sup-
ply chain levels and pharmaceutical products that will be assessed. Public
health supply chains usually consist of multiple levels, for example: national,
regional, district and community level. Public health supply chains often also
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Figure 7.2: Illustrative list of supply chain levels and products.
serve speciﬁc health programmes, each of which require unique groups of phar-
maceuticals (for example TB, essential medicines or vaccines). These factors
need to be taken into consideration during the deﬁnition of the scope. Ap-
pendix 1 in the framework guide (Appendix E) provides a list of the various
supply chain levels and pharmaceutical products that assessors can use to nar-
row the scope of the assessment. An illustration of the list is provided in Figure
7.2.
7.2.2 Stakeholder Engagement
The success of the framework relies on the involvement of stakeholders. Stake-
holders are engaged and involved in the process from the ﬁrst phase to the last
as they are important for collecting data, identifying improvements, validat-
ing outcomes and prioritising identiﬁed opportunities. Therefore, appropriate
stakeholders need to be identiﬁed. The identiﬁed stakeholders should include,
but not be limited to, people who have expertise in the supply chain that is
being assessed. Examples of stakeholders that could be contacted to take part
in the assessment include:
(i) Government (e.g. Ministry of Health ministers or stakeholders from other
departments such as ﬁnance, treasury, etc.).
(ii) Private sector organisations and businesses involved in health supply
chains.
(iii) Donors (e.g. WHO, USAID)
(iv) Local government.
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(v) Public pharmaceutical supply chain stakeholders (e.g. medical stores
manager, procurement unit, logistics manager).
(vi) Committees and coordinating bodies (e.g. regional drug and therapeu-
tics committees, formulary and treatment guideline committees, national
drug committee).
(vii) Regulatory bodies.
7.2.3 Timeframe
Submission dates for each of the assessment activities should be decided upon
in order to inform stakeholders when speciﬁc assessment tasks will take place,
to ensure that the all deliverables are completed and to prevent the assessment
from being extended too long. Appendix 2 in the framework guide (Appendix
E) provides a template that can be used to determine the timeframe of the
assessment as well as the submission dates of speciﬁc steps of the assessment.
7.2.4 Budget
The last task of the scope deﬁnition is to set up a budget in order to ensure
that there is suﬃcient funding to carry out the assessment. The following
should be taken into consideration when setting up the budget:
(i) Available funds for the assessment.
(ii) Travel costs that may be incurred to get stakeholders and assessors to the
location where the assessment will be carried out (e.g. ﬂights, transport,
car hire).
(iii) Time and costs associated with the assessor(s) taking time oﬀ work to
carry out the assessment.
(iv) Venues that may need to be hired for meetings and/or workshops.
(v) Materials and equipment that may be used during the assessment (e.g.
projectors, printed materials, stationery).
(vi) Refreshments during the assessment.
7.3 Phase 2: Review
The second phase of the assessment is to collect and review information about
the selected supply chain in order to gain a better understanding of the supply
chain context, especially with regards to current public-private engagements.
Phase 2 consists of three parts, namely a document review, a supply chain
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 7. FINAL FRAMEWORK 100
map and a questionnaire or interview. These are further discussed in Sections
7.3.1 through 7.3.3.
7.3.1 Document Review
Background documents about the relevant supply chain should be collected
and reviewed. These documents may provide insight regarding current private
engagements, problems that aﬀect the supply chain, potential integration op-
portunities, gaps in information, supply chain constraints as well as the general
context of the supply chain. Reviewing background documents will also assist
stakeholders to understand the supply chain. The following documents should
be considered for the review:
(i) Previous assessment reports.
(ii) Documents that relate to public-private engagements in the relevant sup-
ply chain.
(iii) Documents related to the supply chain functions.
(iv) Supply chain stakeholder and process maps.
Identiﬁed documents should be collected and distributed to all stakeholders
and assessors. Documents can be reviewed individually in each person's own
time or in groups. It is important that a list of the documents be kept. If any
information from one of the documents is used, the relevant document must
be cited in case any questions are raised or information needs to be veriﬁed.
7.3.2 Questionnaire/Interview
In the case where information from the review is missing, insuﬃcient or unclear,
stakeholders may need to be to complete a questionnaire or be interviewed in
order to acquire the required information. It is subject to the assessor's discre-
tion whether enough information was acquired during the document review.
In the case where is has been decided that additional information is required,
the assessor can either collect information from the stakeholders who are cur-
rently involved in the assessment process or additional stakeholders may be
identiﬁed for this part of the assessment. Appendix 3 in the framework guide
(Appendix E) provides a template for the questionnaire or interview. The
template may be adapted as required and the questions can serve as a guide
when interviewing stakeholders.
7.3.3 Supply Chain Map
Once all the information has been collected, stakeholders are required to map
the supply chain based on the collected information. Mapping the supply
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chain leads to a common understanding of the supply chain and provides a
visual representation of the supply chain. Assessors should decide how much
detail should be included in the supply chain map. However, a more detailed
map may provide insight to current private sector engagements as well as
opportunities for new engagements.
7.4 Phase 3: Data Collection
As the name suggests, phase 3 consists of data collection. Two main data
collection methods are used during phase 3, namely focus groups and inter-
views with the stakeholders that were identiﬁed in Phase 1. Data is collected
using the Excel® ﬁle as well as paper-based collection forms which serve as
templates (Appendix 4 in the framework guide) for the focus groups and inter-
views. During the data collection phase, data is collected on each of the nine
supply chain functions in the Excel® ﬁle. The nine supply chain functions are:
(i) Selection
(ii) Forecasting
(iii) Supply planning
(iv) Procurement
(v) Contract management
(vi) Distribution
(vii) Use
(viii) Management support
(ix) Information management
Each supply chain function consists of a number of activities that need to be
carried out. Each of these supply chain function activities are assessed (using
the deﬁnition created in Section 3.4.2) to determine if there are opportunities
for integration. The Excel® ﬁle and templates are used to collect information
regarding: (i) current public-private engagements at each supply chain function
activity; (ii) the current level of integration of each supply chain function
activity; (iii) the level of integration supply chain function activities should
reach to support operational eﬃciency and eﬀectiveness; and (iv) the reasons
why speciﬁc levels were chosen in (iii). The collected data inform assessors of
supply chain function activities' current level of integration as well as the level
of integration that may be reached to support the supply chain's the most
optimal operational eﬃciency and eﬀectiveness (also known as the integration
aim). Figure 7.3 provides an example of the table that is used in the Excel®
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ﬁle to collect data on the integration level for a speciﬁc supply chain function,
in this case the `Selection' supply chain function. The framework elements
relevant to the other supply chain functions are available in the Excel® on the
USB drive2 attached to this document.
Figure 7.3: The selection supply chain function data collection table used in the
Excel® ﬁle
7.5 Phase 4: Identify Opportunities
During phase 3, data was collected to determine the current level of integra-
tion as well as the integration aim. In phase 4, the collected data is used
to identify opportunities for integration. This is achieved by comparing the
current level of integration and the integration aim. The levels of integration
can be compared by creating graphs of the integration levels and looking at
the diﬀerence between them. The graphs are automatically generated in the
Excel® ﬁle once the data for a supply chain function is collected. Figure 7.4
provides an example of the graph for the `Selection' supply chain function. In
the example it is clear that for each supply chain activity the integration aim
is higher than the current level of integration, therefore there is an opportunity
to further integrate with the private sector. Opportunities can be identiﬁed
on the same tabs as where data is collected in the Excel® ﬁle (See USB ac-
companying this thesis) and page 13 of the guide (Appendix E) provides an
explanation of how opportunities are identiﬁed.
7.6 Phase 5: Verify & Prioritise
The last phase of the framework involves the validation of the data and ﬁndings
of the previous phases, prioritising the identiﬁed integration opportunities ac-
cording to the risks and beneﬁts of engaging with the private sector, and lastly
validating the prioritisation of the supply chain function activities by means
of a validation workshop or interviews. Each of these aspects are discussed in
Sections 7.6.1 through 7.6.3, respectively.
2Alternatively use the link provided in Appendix F
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Figure 7.4: Identifying opportunities for integration
7.6.1 Data Validation/Interview
Before continuing with the prioritisation of the supply chain function activities,
it is important that the data collected thus far is validated and agreed upon.
The validation workshop is intended for stakeholders to:
(i) Review and resolve any questions, issues or disagreements that reoc-
curred during the assessment.
(ii) Discuss and validate the ﬁndings of the assessment.
(iii) Provide input on the ﬁndings.
In some cases, speciﬁc information or ﬁndings may need to be validated;
or remaining questions need to be answered. In these cases where the issue
cannot be solved in the workshop, stakeholders may need to be interviewed
again to resolve the issue. Two types of stakeholders should be included in the
workshop, namely: those make decisions (for example the MOH) and those
who will be responsible for taking the ﬁndings further.
7.6.2 Risk-Beneﬁt Prioritisation
In the last phase, supply chain activities with opportunities for integration
were identiﬁed. In this phase these activities are prioritised in order to de-
termine which supply chain activity shows the greatest potential and should
be focused on ﬁrst. This is achieved by examining the risks and beneﬁts of
private engagement in the particular supply chain activity.
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Figure 7.5: Partial illustration of the prioritisation table
On the Prioritisation tab of the Excel® ﬁle, the supply chain activities
that have opportunities for integration are automatically listed under their
respective supply chain functions. A list of beneﬁts and risks are provided at
the top of the page. Explanations of the risks and beneﬁts are provided in
Appendix 5 of the framework guide, which can be distributed to stakeholders
to ensure that everyone understands each risk and beneﬁt.
In order to prioritise the supply chain activities, stakeholders need to rate
the impact each beneﬁt and risk (in the Excel® ﬁle) will have on the engage-
ment on a scale from 0 - 5, where 0 = no impact and 5 = very high impact.
Once the risks and beneﬁts ratings of each supply chain activity have been
completed, the supply chain activities will be prioritised. Supply chain activ-
ities are prioritised by calculating the beneﬁt-risk ratio for each activity and
then ranking each activity from the highest beneﬁt-risk ratio to the lowest.
The ratios are automatically calculated and each activity is ranked in the last
column of the sheet. At the bottom of the Prioritisation sheet is a results sec-
tion where the total risk and beneﬁt of each supply chain activity is plotted on
a graph to allow for a visual comparison of the risks and beneﬁts. Figure 7.5
shows an empty prioritisation table that is used to prioritise the supply chain
function activities. This is discussed on page 14 of the guide and explanations
of the risks and beneﬁts are provided in Appendix 5 of the guide (Appendix
E).
7.6.3 Prioritisation Validation
After the supply chain function activities have been prioritised, the risks
and beneﬁts of private sector engagement, as selected in the previous step,
as well as the prioritisation results can be validated by taking part in an-
other validation workshop or interview with stakeholders. These validation
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workshops/interviews have the same format as the previous validation work-
shops/interviews.
7.7 Dashboard
The dashboard is the landing page of the Excel® ﬁle (See the USB accompany-
ing this thesis)3. It summarises the results of the steps that are carried out in
the Excel® ﬁle. It is divided into the following four sections which are shortly
described in Sections 7.7.1 through 7.7.3, respectively: level of integration,
percent integrated, prioritisation and risks and beneﬁts.
7.7.1 Percent Integrated
In this graph the current level of integration and the integration aim for each
supply chain function is compared. The levels of integration for each supply
chain function is averaged and converted to a score out of 100. This shows how
integrated each supply chain function is, where 100% indicates that all supply
chain activities, in the speciﬁc supply chain function, are at the agreement
level and that the supply chain function is fully integrated.
7.7.2 Risks and Beneﬁts
This section contains two graphs, one for the risks and one for the beneﬁts.
Each graph indicates how much a risk/beneﬁt impacts each supply chain func-
tion, where 100 indicates a very high impact.
7.7.3 Prioritisation & De-integration
Under the prioritisation section the supply chain activities with opportunities
for integration are listed according to their rank (i.e. from highest priority
to lowest priority). The de-integration section lists the supply chain activities
that should de-integrate, i.e. engagements should go from a higher integra-
tion level to a lower integration level. Although identifying supply chain de-
integration possibilities is not the aim of the framework, it is included as it
may be relevant to stakeholders and may prompt important discussions.
7.8 Chapter 7 Conclusion
This chapter presents the ﬁnal framework (contained in Appendix E and the
USB accompanying the thesis) by discussing each step of the framework and
presenting some examples from the framework guide and Excel® ﬁle. Lastly,
3Alternatively use the link provided in Appendix F
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the dashboard, which summarises the results of the assessment, is brieﬂy dis-
cussed.
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Illustrative Case Study
The purpose of this chapter is to apply the ﬁnal framework to illustrate how
it can be used, what the outcome is of using it in a real world scenario and to
identify further opportunities for improvement that it may have. The scope
of the case study is discussed in Section 8.1. Next, contract management in
South Africa is brieﬂy discussed in Section 8.2 to provide context. In Section
8.3 the framework is used to identify opportunities for integration as part of
the case study. Lastly, Section 8.4 discusses some opportunities for further
improvement.
8.1 Scope of Case Study
For the case study, the framework is only applied to the contract management
supply chain function. In addition, it is applied to the South African con-
text, at the national level and does not focus on a speciﬁc product's supply
chain but rather on pharmaceutical supply chains in general. Furthermore,
only the Excel® tool part of the framework was utilised for the case study.
Figure 8.1 gives an indication of the framework phases that were carried out.
However, because only the Excel® tool was used, the data collection forms
were not completed during the data collection phase and the validation inter-
views/workshops were not carried out. Reasons for the limited scope of the
case study include:
(i) Time constraints prevented the application of the entire framework.
Therefore, only a section of the framework is used for the case study.
(ii) The South African context and the contract management function is the
focus of the case study as this is the ﬁeld of knowledge of the subject-
matter expert (SME) that participated and assisted in the case study.
(iii) The Excel® part of the framework is chosen for the case study as this is
the part that is primarily used to identify opportunities for integration
and produces the results of the assessment.
107
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Figure 8.1: Phases that were carried out during the case study.
8.2 Contract Management in South Africa
The South African government provides all national and provincial depart-
ments with a generic Contract Management Framework (CMF) that outlines
the requirements with regards to accounting for and management of contracts
(Department of National Treasury - Republic of South Aﬁrca, 2010). In addi-
tion, a Contract Management Guide (CMG) is provided which, as the name
suggests, provides guidance on how the CMF should be applied (Department
of National Treasury - Republic of South Aﬁrca, 2010). Together, the CMF
and CMG enables each department to develop and approve its own procedures,
policies and competencies within the scope of the CMF. According to the CMF
and CMG, contract management comprises of accounting for all contracts and
the management of contracts during the Contract Life Cycle (Department of
National Treasury - Republic of South Aﬁrca, 2010). The Contract Life Cycle
starts with the planning of the contract and ends with the close-out or re-
newal. Furthermore, the CMF, as illustrated in Figure 8.2, guides government
institutions on how to (Department of National Treasury - Republic of South
Aﬁrca, 2010):
(i) ensure that suitable procedures and policies are established
(ii) utilise appropriate contract management processes
(iii) recognise contractual obligations in ﬁnancial statements
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Figure 8.2: The Contract Management Framework. Source: Department of Na-
tional Treasury - Republic of South Aﬁrca (2010)
In recent years, South Africa's National Department of Health (NDoH) has
been implementing and piloting a number of initiatives that aim to strengthen
the health system (Meyer et al., 2017). These initiatives aim to provide a
continued supply of products and services, reliable payments, improved gov-
ernance and eﬃciencies, accessibility and aﬀordability of medicines and assist
the government with the successful implementation of National Health Insur-
ance (NHI) (Meyer et al., 2017). These initiatives are centred around the core
functions of the medicine value chain, as illustrated in Figure 8.3.
Figure 8.3: The medicine value chain functions. Source: Meyer et al. (2017)
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Figure 8.4: Traditional procurement approach. Source: Department of National
Treasury - Republic of South Aﬁrca (2015) which adapted it from: New Zealand
Ministry of Economic Development (2011)
A number of initiatives are currently being implemented in the contract
management function due to fragmentation which is caused by a lack of stan-
dard procedures and systems (Meyer et al., 2017). Once such initiative is the
introduction of a National Contract Management Unit (CMU). The CMU will
be responsible for monitoring the aggregated information, such as performance
metrics, collected by Medicine Procurement Units (MPUs) (Meyer et al., 2017).
MPUs have numerous responsibilities, including the management of provincial
contracts and implementing strategic and consistent protocols regarding con-
tract management (Meyer et al., 2017). MPUs provide these services for health
facilities within its jurisdiction (Meyer et al., 2017). Although the MPUs and
the CMU's shared job has already been put in place, institutional processes
that are responsive to a dynamic market will need to be developed in order to
further improve contract management, especially when taking the implemen-
tation of NHI into account (Meyer et al., 2017).
Another initiative is the implementation of strategic sourcing as a means
of procurement in public supply chains (Department of National Treasury -
Republic of South Aﬁrca, 2015). During traditional procurement, very little
eﬀort is put into the initial planning phase, resulting in a need for greater eﬀort
during relationship management and contract management phases where little
added value can be achieved (Department of National Treasury - Republic of
South Aﬁrca, 2015). This phenomenon is depicted in Figure 8.4.
However, with the implementation of strategic sourcing (Figure 8.5) each
phase of procurement is methodically worked through (Department of National
Treasury - Republic of South Aﬁrca, 2015). This results in more eﬀort being
put into the initial planning and research which assists in identifying solutions
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that enable needs to be met (Department of National Treasury - Republic of
South Aﬁrca, 2015). Furthermore, in the contract and relationship manage-
ment phase, less eﬀort is required for resolving problems, allowing more eﬀort
to be put into assessing supplier's performance and identifying opportunities
to save costs and realise beneﬁts (Department of National Treasury - Republic
of South Aﬁrca, 2015).
Figure 8.5: Strategic sourcing approach. Source: Department of National Treasury
- Republic of South Aﬁrca (2015) which adapted it from New Zealand Ministry of
Economic Development (2011)
8.3 Application of Framework
The contract management supply chain function in framework consists of the
following activities which will be assessed as part of the case study (Elsey,
2007; John Snow Inc., 2017):
(i) Needs clariﬁcation
(ii) Tender preparation
(iii) Tender publication
(iv) Bids evaluation
(v) Contract award
(vi) Changes in contract
(vii) Service delivery management
(viii) Relationship management
(ix) Contract administration
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(x) Risk assessment
(xi) Purchasing organisation's performance and eﬀectiveness review
(xii) Contract closure
The case study followed a step-wise procedure as outlined in the framework.
The following steps were carried out, which are further discussed in Sections
8.3.1 to 8.3.5:
1. Identify the current level of integration
2. Identify the integration aim
3. Identify opportunities for integration
4. Prioritise the identiﬁed opportunities for integration according to risks
and beneﬁts
5. Interpret and discuss results
As mentioned in Section 8.1, data was collected by working with an SME
that has expert knowledge on contract management in the public sector of
South Africa.
8.3.1 Current Level of Integration
As discussed in the framework guide in Appendix E, for each activity of the
supply chain function that is being assessed the current level of integration
should be selected. Figure 8.6 below indicates which level of integration was
selected for each activity. In cases where integration levels `interaction', `dia-
logue' or `agreement' were selected, Table 8.1 provides short explanations for
why a speciﬁc level was selected.
8.3.2 Integration Aim
For the integration aim, the same procedure is followed as with the current level
of integration. However, the level of integration is selected based on the level
of integration that may be achieved in the medium term in order to support
optimal operational eﬃciency and eﬀectiveness in the speciﬁc activity. Figure
8.7 below indicates which level of integration was selected for each activity.
Table 8.2 discusses the activities for which the integration aim is diﬀerent to
the current level of integration as identiﬁed in Section 8.3.1.
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Table 8.1: Explanations for why speciﬁc levels oﬀ integration were chosen
Activity Integration
Level
Explanation
Contract award Dialogue
The public and private sector organisations may negotiate once the
contract is awarded. Both parties have shared interests as both
parties need the contract terms to be met. The public sector needs
assurance from suppliers that products will be delivered on time so
that a continuous supply can be provided to patients at an agreed
price. Conversely, the suppliers need assurance that payments will
be received on time so that business can continue as usual. There-
fore, the public sector and suppliers negotiate, cooperate and work
together to ensure contract terms will be met.
Changes in
contract
Dialogue
In cases where suppliers may not be able to fulﬁll contract obli-
gations, for example when suppliers will not be able to deliver x
amount of a product due to a shortage of a speciﬁc active ingre-
dient, suppliers will notify the public sector that there will be a
shortage and the reason therefor. The public sector and suppliers
will then negotiate, work together and discuss how the problem
may be overcome so that patients do not experience a shortage or
stock-out of the medicine. In addition, both parties need to negoti-
ate what happens to other contract terms, such as payments, when
contract obligations are not met. Other contract amendments such
as changes in objectives or scope, are dealt with in the same manner
and the contract is amended.
Service delivery
management
Agreement
The public sector makes use of a third party to assist with the
performance management and assessment of companies and organ-
isation with whom they have contracts with.
Relationship
management
Interaction
The public sector periodically interacts and exchanges information
with organisations with whom they have contracts to keep each
other informed about the current state of aﬀairs, to ensure contract
terms are met and to maintain trust and understanding.
Contract admin-
istration
Interaction
During contract administration, the public sector and organisations
with which it has contracts will communicate and may exchange in-
formation regarding tasks such as budget and payment procedures,
resource management, orders and the monitoring of costs.
Risk assessment Interaction
During risk assessments, the public and private sector exchange in-
formation and discuss how identiﬁed risks may be avoided or man-
aged.
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Table 8.2: Explanation for why a diﬀerent integration level was chosen
Activity Change in
Integration
Level
Explanation
Tender
preparation
From no engage-
ment to interac-
tion
The public sector would be interested in commu-
nicating and interacting with the private sector to
determine what the best practices are regarding
tender preparation. The implementation of pri-
vate sector best practices could lead to the im-
provement in the eﬃciency and eﬀectiveness of the
tender preparation process.
Purchasing
organisation's
performance
and eﬀective-
ness review
From no engage-
ment to dialogue
At national level, the department of health's down-
stream purchasing organisations are the provin-
cial health departments because they purchase
pharmaceuticals from the NDoH. In this case, the
provincial departments of health act as procure-
ment agents. The department of health would in-
tegrate with the private sector organisations (such
as distributors and suppliers) to assist with the
assessment of provincial health departments' per-
formance and eﬀectiveness regarding procurement
and purchasing. For example, the province's abil-
ity to follow standard procedures may be checked,
or their ability to procure medicines in-time (so
that medicines can be timeously delivered) may
be assessed. Private distributors and suppliers can
then inform the department of health where there
may be problems during procurement and negoti-
ate and assist with providing a solution. Ensuring
that patients receive the necessary medicines, on-
time, is the priority and a mutual interest of the
NDoH, private suppliers and private distributors.
Therefore the two sectors may work together to
improve procurement processes.
Contract clo-
sure
From no engage-
ment to interac-
tion
Contracts with government are usually in place for
2 to 3 years. Once the contract ends, suppliers
may be required to lay-oﬀ workers due to the loss
of an income stream (from the government) and
may incur more expenses since some labs/factories
may not be used again (as in the case where hor-
mones are an ingredient). This is likely to persist
unless they are able to procure another govern-
ment tender. This is a disadvantage for suppliers.
However, the public and private sector may assist
one another by negotiating longer contracts during
contract closure (eg. 10 years) so that suppliers do
not have to deal with these problems. In return,
suppliers need to improve their oﬀer (i.e. lower
prices, better eﬃciency).
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Figure 8.6: Current level of integration for contract management
Figure 8.7: Integration aim for contract management
8.3.3 Identify Opportunities for Integration
Once the current level of integration and the integration aim have been identi-
ﬁed, a graph will be created in the Excel® ﬁle. Opportunities for integration
can be identiﬁed by comparing the current level of integration and the inte-
gration aim. The graph in Figure 8.8 is generated from the data collected in
Sections 8.3.1 and 8.3.2. From the graph it can be seen that there are op-
portunities for integration at various stages, such as the tender preparation,
purchase organisation's performance and eﬀectiveness review, and contract
closure activities due to the diﬀerence between the current level of integration
and integration aim.
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Figure 8.8: Graph indicating the current integration level and integration aim of
the contract management activities
8.3.4 Prioritisation
Once the integration levels have been identiﬁed for the current situation and
the integration aim, the activities with opportunities for integration are auto-
matically populated on the prioritisation Excel® sheet. These activities are
then prioritised according to the risks and beneﬁts of implementing the new
public-private engagement. Each risk and beneﬁt is rated on a scale from 0
- 5, where 0 indicates that the risk/beneﬁt will have a low impact on the en-
gagement and 5 indicates that the risk/beneﬁt will have a very high impact on
the engagement. Figure 8.3.5 shows the results of the risk and beneﬁt ratings.
Once the risks and beneﬁts have been rated for each activity, the activities are
prioritised to determine which activity shows the most potential and should
be focused on ﬁrst. Activities are prioritised from lowest risk, highest beneﬁt
to highest risk, lowest beneﬁt. In the last column in Figure 8.3.5 it can be seen
that the activity `tender preparation' has ﬁrst priority and should therefore be
focused on ﬁrst.
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Figure 8.9: Rating of activities according to risks and beneﬁts
In addition, the total risk and beneﬁt of each activity is compared in a
graph. Figure 8.10 illustrates the graph that is generated once the risks and
beneﬁts of of each activity has been rated. Although the activity `purchasing
organisation's performance and eﬀectiveness review' has the highest beneﬁt, it
has a higher risk than tender preparation. Tender preparation may have the
lowest beneﬁt, but it also has the lowest risk. Tender preparation is therefore
considered the priority of the three opportunities as it is a `low hanging fruit'.
Contract closure has the highest risk which is why it should be considered for
implementation last.
Figure 8.10: A comparison of the total risk and beneﬁt of each contract manage-
ment activity
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8.3.5 Results
As part of the framework, the Excel® ﬁle also provides a dashboard that sum-
marises the results of the assessment. The results displayed on the dashboard
are brieﬂy discussed below.
The ﬁrst result is a graph of the percentage integrated, as shown in Figure
8.11. The graph indicates how integrated the contract management function
currently is, and how integrated it would be if all the opportunities for inte-
gration, that were identiﬁed during the assessment, were to be implemented.
From the ﬁgure it is clear that the contract management function would be 11%
more integrated if the three opportunities for integration were implemented.
Figure 8.11: The current and possible percentage of integration of contract man-
agement
The second result summarises the risks and beneﬁts of implementing the
identiﬁed integration opportunities of contract management. In Figure 8.12
it is clear that the biggest beneﬁt from implementing the integration oppor-
tunities would be that process eﬃciencies would improve and that more risk
would be shared with the private sector. In addition, the biggest risks are
regulatory issues, the sharing of information, lack of control on part of the
private sector, delayed decision making by the public sector and contracting
challenges. It is also clear that on average, the private sector (indicated by
the green bars in Figure 8.12) would bear more risks than the public sector
(indicated by the blue bars). However, the public sector bears the highest risk
of `regulatory issues'. These graphs allow assessors to identify how integrating
with the private sector will beneﬁt the supply chain and which risks need to
be mitigated and planned for.
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Figure 8.12: A summary of the risks and beneﬁts of implementing integration
opportunities in the contract management function.
The last result indicates the priority that each supply chain activity was
assigned after the risk and beneﬁt assessment. Figure 8.13 indicates that the
integration opportunity identiﬁed during the preparation of tenders is the ﬁrst
priority. As discussed in Section 8.3.4, integrating with the private sector
during tender preparation is seen as a `low hanging fruit' due to the low risk.
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Figure 8.13: The assigned priority of each supply chain activity
8.4 Case Study Discussion
In this section the opportunities for improvement that were identiﬁed dur-
ing case study are discussed. Three main improvement opportunities were
identiﬁed. These related to (i) the deﬁnition of integration (Section 8.4.1);
(ii) the identiﬁcation of integration opportunities (Section 8.4.2); and (iii) the
identiﬁcation of risks and beneﬁts (Section 8.4.3).
8.4.1 Deﬁnition
As mentioned in Section 3.4.2, integration is deﬁned as follows: Integration oc-
curs when two or more autonomous supply chains work together to (i) improve
their collective eﬃciency and eﬀectiveness; (ii) ﬁnd synergistic combinations
of resources; and (iii) ﬁnd solutions to problems that each supply chain may
not be able to achieve on its own. Integration is achieved by constructively
exploring each supply chain's diﬀerences and combining expertise from diﬀer-
ent organisations within the supply chains. This type of integration can be
visualised as a step-wise process that starts from complete autonomy (i.e. no
integration) and progresses to interaction, to dialogue and ﬁnally to agreement
(fully integrated).
However, during the case study it became apparent that it is sometimes dif-
ﬁcult to distinguish between contractual relationships with the private sector
and integrating with the private sector. For example, many private suppliers
are contracted to supply pharmaceutical products to the government. Just
because the private supplier and the NDoH are contractually bound does not
mean that, at this point, the supply chain is fully integrated. It is strictly a
customer-supplier relationship. However, when the supplier and NDoH work
together to improve eﬃciencies, share resources and solve problems, as stated
in the deﬁnition of integration, then there is a degree of integration. For
instance, if the NDoH and a private supplier continuously aim to improve
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processes and cooperate with one another, the level of integration would be
Dialogue and not Agreement, even though they are bound by a contract.
In order to determine whether it is integration or not, one should look at
the deﬁnition of integration and identify whether one or more of the conditions
of the deﬁnition is met. In other words, does the public-private relationship
aim to improve the eﬃciency and eﬀectiveness, ﬁnd synergistic combinations of
resources or ﬁnd solutions to problems that each supply chain may not achieve
on its own?
8.4.2 Integration Opportunities
The second opportunity for improvement is best explained in conjunction with
Figure 8.14 which illustrates opportunities for integration.
Some integration opportunities may be missed because the current level of
integration and the integration aim may be the same. For example, in Figure
8.14 the current level of integration for contract administration is `Interaction'.
If, for instance, the public sector wanted to integrate with the private sector
to improve the public sector's contract administration at an `Interaction' level
(see integration aim for contract management in Figure 8.14), the opportunity
would be missed because the integration levels are the same. The framework
only identiﬁes opportunities for integration when the integration levels are dif-
ferent (i.e. the integration aim is higher than the current level of integration).
In order for the framework not to miss such opportunities, each supply
chain activity would have to be further broken down into their constituent
steps or activities, such that each step can be assessed for integration. This
may become a very cumbersome process and is thus outside the scope of this
study. However, it may be useful for future work to develop a much more
detailed framework, where single supply chain functions may be assessed at a
time.
8.4.3 Risks and Beneﬁts
The last shortcoming is that the assessment of the risks and beneﬁts are sub-
jective. The risks and beneﬁts of integrating with the private sector are de-
termined based on the ratings of stakeholders. Not only is it subjective but
the results may also vary depending on the background of the stakeholders
that are part of the assessment. For instance, if the majority or all of the
stakeholders that are part of the assessment represent the public sector, the
beneﬁts of integrating may be perceived to be much higher and the risks that
the private sector bears may be perceived to be much lower. This may occur
because some public sector representatives may not be informed about how the
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Figure 8.14: A graph used to identify opportunities for integration
private sector functions or may have some biases about the private sector. For
example, the public sector may assume that delayed payments is a small risk
for the private sector because the private sector generates substantial proﬁt.
The same subjectivity may occur when the majority of the stakeholders
represent the private sector. It is therefore important that there are represen-
tatives from both the private and public sector during the assessment and, if
possible, half should be from the private sector. In addition, there should be
consensus amongst the stakeholders on the risk and beneﬁt ratings.
8.5 Chapter 8 Conclusion
In this chapter the illustrative case study that was conducted, in order to
demonstrate how the framework works, what results the framework produces
and to identify opportunities for further improvement, is presented. The scope
of the case study is discussed, followed by a brief literature review that provides
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context to the case study. Next, the case study is carried out and discussed in
a step-by-step manner. Finally, three opportunities for further improvement
are identiﬁed.
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Chapter 9
Conclusion & Future Work
This chapter concludes the study by providing a summary of each chapter's
research ﬁndings in Section 9.1 and follows on with a discussion in Section 9.2
on how each research objective was met. The limitations of the study are also
discussed (Section 9.3), followed by a set of recommendations for future work
(Section 9.4). Lastly, the implications that the framework may have on policy
is discussed in Section 9.5.
9.1 Research Summary
This section discusses the research ﬁndings of each chapter.
Chapter 1: The background, context and problem statement of the study is
provided, from which the research aim and objectives were established. The
chapter further provided a discussion on the scope of the study, an outline of
the document contents as well as an indication of where each research objective
is met.
Chapter 2: This chapter presents the research methodology of the study.
The research purpose is established as exploratory and reasons there for are
provided. The chapter also discusses the research approach and the reasons for
selecting the speciﬁc research methodology. The chapter further details how
each phase of the selected methodology will be carried out.
Chapter 3: This chapter serves as the literature review of the study. The
chapter starts with a discussion of the problems that occur in public health
supply chains and the current methods used to address these problems. Phar-
maceutical supply chains are then investigated with regard to their impor-
tance, structure, functions and how these supply chains are managed. Next,
the reasons for engaging with the private sector are investigated, along with
the challenges of public-private engagements and how these challenges can be
overcome. Furthermore, the types of public-private engagements are investi-
gated and examples of public-private engagements in health supply chains are
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provided. The chapter concluded with the investigation of supply chain inte-
gration and the introduction of public-private health supply chain integration.
Chapter 4: The purpose of this chapter was to review frameworks and method-
ologies that aim to identify opportunities for public-private engagement. Ad-
ditionally, the chapter aims to identify whether or not the research aim has
been achieved by another author, what the research gaps are and how they
can be adapted to the framework criteria. Four frameworks and methodologies
were identiﬁed for the review and four framework criteria were formulated.
Chapter 5: Chapter 5 provides a discussion of the methodology used to de-
velop the framework from the criteria formulated in Chapter 4. The chapter
then discusses how the framework criteria are met and the individual steps of
the framework are selected. The chapter concludes by integrating the criteria
solutions and individual steps, and presenting the preliminary framework.
Chapter 6: The purpose of this chapter is to validate the preliminary frame-
work developed in Chapter 5. The chapter ﬁrst discusses how internal valida-
tion was carried out to ensure that the Excel® part of the framework functions
properly. The framework is then externally validated by SMEs through the
use of a questionnaire. Subsequent improvements were made to the frame-
work, based on the feedback from SMEs, to establish the ﬁnal framework (See
Appendix E and the USB accompanying this thesis)1. The chapter concludes
with the presentation of the ﬁnal framework.
Chapter 7: This chapter presents the ﬁnal framework (contained in Appendix
E and the USB accompanying the thesis) by discussing each step of the frame-
work and presenting some examples from the framework guide and Excel®
ﬁle. Lastly, the dashboard, which summarises the results of the assessment, is
brieﬂy discussed.
Chapter 8: In this chapter an illustrative case study is carried out to illustrate
how the framework can be used and to illustrate the possible outcomes of
using the framework. In addition, the chapter identiﬁes further opportunities
for improvement and future work. The scope of the case study is discussed,
after which a small literature review is carried out to provide some context to
the case study. The framework is then applied to a real-world scenario with
the help of an SME. Each step and outcome of the case study is discussed.
Lastly, the chapter discusses the areas in which the framework can be further
improved, as identiﬁed during the case study.
Chapter 9: Chapter 9 presents the conclusion of the study by discussing the
research ﬁndings, how the objectives were met and elaborating on the research
limitations and recommendations of future work.
1Alternatively use the link provided in Appendix F
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9.2 Outcomes of Research Objectives
The research aim of this study is to develop a framework that can be used to
facilitate the evaluation of public and private pharmaceutical supply chains in
order to identify the said opportunities for synergies that will support improved
access to medicine. In order to achieve the research aim, ﬁve research objectives
were established in Section 1.4 to guide the development of the framework.
Table 9.1 discusses how the research objectives were addressed in the study.
9.3 Limitations
The development of the framework and the validation thereof has some limi-
tations which should be taken into account:
(i) Public-private supply chain integration is still an emerging ﬁeld. Hence,
the range and scope of beneﬁts that can be attained from such integration
is still largely unknown.
(ii) As the integration of public-private pharmaceutical supply chains is an
emerging ﬁeld of research, the framework developed is exploratory in
nature. Therefore, the framework is not all-encompassing, and will need
to be improved with further research.
(iii) SMEs have agreed that such a framework is needed and have given feed-
back on how it can be improved. Although the feedback was used to
improve the framework, more input is required from experts in both
public and private sectors, as well as various areas from health supply
chains to ensure it optimally achieves its stated aims. Therefore, a lim-
itation of this study is that a limited number of subject-matter experts
were part of the validation of the framework. As a result, the frame-
work improvements are limited to their perspectives, experience and in-
sights. Furthermore, the feedback from SMEs is mostly given with a
South African perspective, despite the intention of it being applicable in
any LMIC. Therefore, the improvements and amendments made to the
framework are solely based on a South African context/perspective.
(iv) The application of the framework was limited to an illustrative case study
due to time constraints. Therefore, the usability of the framework could
not be tested and the framework could not be further validated. In
addition, the case study was limited to the Excel® part of the framework
as well as the contract management function and was carried out with
the assistance of a single SME. Therefore, insight gained during the case
study might be limited.
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Table 9.1: Discussion of addressed objectives
Objective Outcome Chapter
Objective 1:
Review literature rele-
vant to the study
The scope of the study (Section 1.5) focused on
three research ﬁelds, as shown in Figure 2.2. Lit-
erature was reviewed within these three research
ﬁelds. As stated in the research objectives, the
following literature was reviewed: (i) health sup-
ply chain problems and proposals to address the
problems; (ii) pharmaceutical supply chains; (iii)
public-private engagements in pharmaceutical sup-
ply chains; (iv) supply chain integration; and (v)
framework and methodologies used to identify op-
portunities for public-private engagement. The re-
view of the literature enables a deeper understand-
ing of the research problem and how it may be
addressed.
Chapter 3
Chapter 4
Objective 2:
Develop a concep-
tual framework to
evaluate pharmaceu-
tical supply chains
for opportunities of
integration
This objective is met by developing a framework
using the insight obtained during the literature re-
view as well as new information gathered during
the development process.The framework was de-
veloped using the CFA methodology proposed by
Jabareen (2009).
Chapter 4
Chapter 5
Objective 3:
Validate and improve
the developed frame-
work
The framework was validated by engaging with
four SMEs who have practical experience in the
health and pharmaceutical supply chain ﬁeld. The
SMEs provided feedback on the framework via
a questionnaire. The feedback was subsequently
used to improve the framework.
Chapter 6
Objective 4:
Perform an illustrative
case study by applying
the framework to the
South African context
This objective was met by applying the framework
to the contract management supply chain function
in South Africa. The case study illustrated how
the framework can be used and the results that the
framework produces. The case study was also used
to identify further opportunities for improvements
that the framework may have.
Chapter 7
Objective 5:
Discuss the impact of
the research and op-
portunities for future
work
The research ﬁndings, limitations of the study and
recommendations for future work are discussed
Chapter 8
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(v) As discussed in Section 8.4.2, the framework may miss the identiﬁcation
of some integration opportunities because it only assess supply chains
at an aggregated level. Further research and a more detailed approach
would be required to identify opportunities for integration when the cur-
rent level of integration and the integration aim are the same for a supply
chain activity.
9.4 Future Work
The limitations discussed in Section 9.3 can be adapted to recommendations
for future work.
(i) The scope of the beneﬁts of integration may be currently unknown. How-
ever the possible improvements, not only to supply chains, but to health
outcomes and patients' lives that may be achieved through integration
makes it imperative that further research be carried out on public-private
integration. Through further research, the full extent of the beneﬁts,
risks and applications of the framework can be understood.
(ii) Although the framework is exploratory in nature, through further re-
search on public-private integration and assessing supply chains to iden-
tify opportunities for integration, the framework can be iteratively im-
proved such that the classiﬁcation of the framework can be transformed
from an `exploratory' framework to an `appliable' framework that can be
practically implemented to improve pharmaceutical supply chains.
(iii) The framework was validated through four SMEs, however it would be
beneﬁcial to further validate the framework with input from profession-
als from various countries, with various supply chain and pharmaceu-
tical backgrounds such as public and private representatives, national,
provincial, district and community representatives as well as personnel
who work in diﬀerent areas of the supply chain. Validation from the
various professionals will further improve the framework and may enable
the development of frameworks that are suited to speciﬁc country con-
texts. In addition, further validation may instill trust in the results of the
framework and lead to the formalisation and adoption of the framework
by governments.
(iv) The author proposes that the framework be applied to a number of case
studies as this will further validate the framework and can be used to
provide practical evidence of the beneﬁts that may be achieved through
the use of the framework. The application of the framework to case
studies will also enable the framework to be reﬁned.
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(v) Further research may be required in cases where more detailed analyses
of the supply chain functions are desired. The framework may serve as
a basis for the development of frameworks that assess each supply chain
function in an in-depth manner. Such a framework would be ideal for
decision makers who want to increased private sector integration in a
speciﬁc supply chain function.
9.5 Implications for Policy
The implementation of the points listed in Section 9.4 may assist policy mak-
ers and decision-makers in developing countries with the implementation of
universal health coverage as many countries will need the help of the private
sector to successfully implement universal health coverage (UHC). During the
validation of the framework, SMEs expressed their interest in the framework as
a possible tool to bridge the gap of national health insurance (the term used
in South Africa to describe UHC) in South Africa. In addition, the devel-
oped framework serves as a foundation from which policy makers and decision
makers can adapt or develop their own framework to achieve public-private in-
tegration as part of their own strategic endeavours. Although the framework
does not facilitate an in-depth assessment of any particular pharmaceutical
supply chain area, it can serve as a best-practice point of departure for discus-
sions around the role that integration can play to improve supply chains and
can lead to the further development and implementation of detailed frame-
works per area. Discussions with SMEs have indeed indicated that there is a
deﬁnite need for this tool to assist with the improvement of supply chains and
complex relationship of the public and private sector.
9.6 Chapter 9 Conclusion
This chapter summarises the research ﬁndings of each chapter and discusses
how each research objective is addressed in the study. Furthermore, the limita-
tions of the study are discussed and subsequently adapted to recommendations
for future work. Lastly, the implication that the framework may have on policy
is discussed.
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Appendix A
Data Collection Tool: Integration
Matrix
This Appendix brieﬂy describes how the data collection matrix, used during
data collection, is developed.
The supply chain functions, that were selected to meet Criteria 3 (Section
5.2), are integrated with the levels of integration (Section 3.4.2) to form a ma-
trix. This matrix will facilitate the assessment of pharmaceutical supply chains
and is included in the Excel® data collection tool (See the USB accompanying
this thesis). A condensed example of the matrix is shown in Table A.1.
Table A.1: Condensed data collection matrix
Supply Chain Function No Engagement Interaction Agreement
Selection
Procurement
Distribution
Use
Management Support
The current level of integration can therefore be determined by ﬁlling in the
matrix. This can be done using the information gathered during the review
or by interviewing stakeholders. The same matrix can be used to establish
what level of integration the supply chain is capable of, i.e. the integration
capability.
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Appendix B
Risk-Beneﬁt Prioritisation
Before the identiﬁed opportunities for integration can be prioritised according
to the risks and beneﬁts, a list of of risks and beneﬁts needs to be compiled.
In Section B.1 a list of the risks and beneﬁts of engagement are compiled,
whereas Section B.2 explains how integration opportunities are prioritised.
B.1 Risks and Beneﬁts of Public-Private
Engagement
This section is divided into beneﬁts (Section B.1.1) and risks (Section B.1.2).
B.1.1 Beneﬁts
The following beneﬁts may be realised when the public sector engages with
the private sector (UN Commission, 2015; O'Hanlon and Jeﬀers, 2013):
Close the resource gap: Partnerships attract private capital which can be
used to fund services and procure assets or to supplement the public sector's
resources or by freeing up resources that can be used elsewhere.
Improve access and eﬃciencies: Partnerships can improve access to health
services and products by providing health services and products at aﬀordable
costs. Partnerships can also improve eﬃciencies by rationalising the use of ex-
isting resources, such as staﬀ and infrastructure, across the public and private
sector. Private sector engagements can also improve supply chain operational
eﬃciencies, for example economies of scale can be leveraged to improve access
to pharmaceuticals.
Innovation: The private sector is more equipped to invest in innovative meth-
ods and technologies than the public sector, therefore engaging with the private
sector could lead to the adoption of innovative technology, management ap-
proaches and health operations. In addition, innovative approaches, solutions
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and ideas will be generated when staﬀ from diﬀerent sectors and disciplines
work together. The private sector also beneﬁts by introducing new markets,
having access to investment opportunities and generating goodwill.
Expand and retain human resource: One of the biggest challenges in Sub-
Saharan Africa is the incidence of brain drain. By encouraging the growth
of the private sector human resources can be retained since it boosts business
opportunities within the country. The private sector can also provide access
to new technologies which expands career opportunities in the health sector.
Build capacity: The private sector can increase the public sector's coverage
and increase capacity by engaging with private providers which will increase
the number of service delivery points as well as the number of skilled human
resources. The private sector has the skills and expertise to overcome supply
chain challenges. Their skills and expertise can help build the public sector's
capacity, thereby allowing the public sector to better manage its own supply
chain. For example, public organisations have used private sector training
programmes to train staﬀ; the public sector has also engaged with the private
sector to assist with the optimisation of supply chains. Private sector engage-
ment can not only increase the public sector's coverage, but also the coverage
of the private sector (MIT-Z ILP, 2008).
Shared risk: There is a lot of risks involved when the public and private
sectors engage, including ﬁnancial, security, political, human resources and
infrastructure risks. Eﬀective engagements share risks between the public and
private sector which means that each sector accepts a share of the engagement
risks for which they are best suited. By sharing risks both sectors are more
willing to engage.
B.1.2 Risks
According to Tennyson (2011) and UN Commission (2015) both sectors need to
understand the risks and rewards that the other sector faces in order to develop
a successful engagement. Therefore, the risks of public-private engagements
can be divided into two groups, namely the risks of the private sector engaging
with the public sector and the risks of the public sector engaging with the
private sector (UN Commission, 2015). The risks of public-private engagement
is discussed in Section 3.3.2 and is replicated below for convenience. The public
sector faces the following challenges when engaging with the private sector (UN
Commission, 2015):
Conﬂict of interest and misalignment of motivations: The private sec-
tor usually measures its performance with performance metrics such as return
on investment and proﬁt. Conversely, the public sector's main concern is not
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about how much proﬁt it makes but rather ensuring the availability, aﬀordabil-
ity, accessibility and acceptability of medicines (MSH, 2012). This diﬀerence
results in a misalignment of the two sector's motivations and raises concerns
regarding the sharing of information which could be exploited. The public
sector has to address a few concerns such as conﬂicts of interest, competition
and the fear that projects might not be completed within budget and time
constraints due to a lack of transparency during the bidding process.
Limited capacity to engage with the private sector: The public sector
usually has limited experience regarding contract management. Inexperience
in contract management could result in badly written contracts which could
place the public sector in a vulnerable position and limits the public sector's
capacity to manage, develop, enforce and monitor contracts. These factors
increase the possibility of corruption and conﬂict of interests.
Regulatory issues: Often regulatory bodies are responsible for deﬁning con-
tracts between the public and private sectors, which means the public sector
can be restricted by the contract structure. The private sector mostly only
invests in new engagements when the contract length is long enough to spread
their risks over time in addition to providing enough beneﬁt. If the public
sector sets unrealistic terms, KPIs or lengths for contracts, it could drive up
costs and cause the engagement to seem unattractive to the private sector.
Sharing information: The public and private sectors receive consumption
data from diﬀerent sources. In the pharmaceutical industry, the private sector
receives data from retail outlets, distributors and health providers, whereas
the public sector uses consumption data that is usually manually collected at
health facilities.
External constraints: Public-private engagement opportunities will be in-
ﬂuenced by external constraints such as: (i)the economic and political climate;
(ii) hidden complexities of donor structures in projects and national agencies;
and (iii) the likelihood that the development and management of public-private
engagements will be more expensive than internal government processes.
The private sector has the following challenges when engaging with the
public sector (UN Commission, 2015):
Lack of control: During a public-private engagement the contractual require-
ments may stipulate the timing of processes as well as how resources should be
allocated and used. Requirements can be inﬂuenced by the political climate
and may increase the time and costs of the project since the private sector
has to compensate for having limited control over the resources required to
complete expected activities.
Delayed decision making by public sector: In the public sector the deci-
sion making process is often drawn out as a result of the government's structure
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or the contractual processes that need to be followed. This increases the pri-
vate sector's costs which is often not taken into consideration by the public
sector during initial engagement cost evaluations.
Contracting challenges: Not all governments have transparent and stan-
dardised tendering processes, which could lead to corruption and extended
contract negotiations. In addition, governments often want to enter short-
term contracts which is too short for the private sector to make a return on
their investment. Furthermore, government contracts may request the private
sector to take responsibility for the risk rather than sharing the risk.
Payment terms: In order for the private sector to continue its support dur-
ing the engagement, payments must be made on-time. However, budgetary
challenges and governmental processes often delay payments to the private
sector. Therefore, payment terms should be addressed early on to prevent the
engagement from failing.
Sharing information: Often frameworks and standards are not timeously
shared with the private sector. In addition, the private sector may not fully
understand how the public sector operates or the responsibilities concerning
aﬀordability and universal health coverage. Also, data compilation is not cen-
tralised which means that each sector is unaware of what has been contributed.
B.2 Risk-Beneﬁt Prioritisation
The list of beneﬁts and risks as well as the supply chain functions can now
be integrated into a table where the risks and beneﬁts of engagement can be
rated on a scale from 1 to 5 (See Figures B.1 and B.2). The beneﬁt and risk
ratings of each supply chain function is summed which results in an overall
beneﬁt and risk score. However, due to the fact that the number of risks are
greater than than the number of beneﬁts, the overall ratings are converted to
percentages to allow for a more accurate comparison. For each function, the
beneﬁt-risk ratio is calculated by dividing the beneﬁt percentage by the risk
percentage. This means that if the risks outweigh the beneﬁts the ratio will be
smaller than 1, if the beneﬁts outweigh the risks the ratio will be greater than
1. The supply chain functions can then be arranged from highest to lowest
after the beneﬁt-risk ratios have been calculated. Figure B.3 gives an example
of how functions are prioritised, where the last column indicates the position
of each supply chain function in the prioritisation list.
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Figure B.1: The resulting table where the beneﬁts of engagement can be rated
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Figure B.2: The resulting table where the risks of engagement can be rated
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Figure B.3: An example of prioritising supply chain function according to risks ad beneﬁts
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Framework Questionnaire 
 
Name & Surname:  
Date:  
 
Please answer the following questions and forward the completed questionnaire to 
16496698@sun.ac.za or jessicab0712@gmail.com . If you have any questions, please feel free to 
contact me via one of these e-mail addresses or phone me on 072 785 1122.  
 
Background Questions 
 
1. What is your occupation? 
 
2. What is your role in the organisation you are currently working for? 
 
3. Please elaborate on your exposure to health supply chains. 
 
4. Please elaborate on your exposure to public-private engagements in the health sector. 
 
Framework Questions 
 
1. Is there a need to identify opportunities for integration between the public and private 
sectors in pharmaceutical supply chains? 
 
2. Do you believe this framework would be a useful assessment tool to identify integration 
opportunities? 
 
3. Are there other frameworks that have the same purpose and results that you are aware of? 
Please elaborate. 
 
4. Are there any shortcomings or feedback on the methodology employed by the proposed 
framework? (Or what are the strengths and weaknesses?) 
 
5. In your opinion, how can the framework be improved?  
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Framework Questionnaire 
 
Name & Surname: Florian Menold, DSV Healthcare  
Date: 04.07.2018 
 
Please answer the following questions and forward the completed questionnaire to 
16496698@sun.ac.za or jessicab0712@gmail.com . If you have any questions, please feel free to 
contact me via one of these e-mail addresses or phone me on 072 785 1122.  
 
Background Questions 
 
1. What is your occupation? 
 
2. What is your role in the organisation you are currently working for? 
General Manager – Projects & Engineering 
GM for BU Centralized Dipsensing for chronic medication – public sector 
 
3. Please elaborate on your exposure to health supply chains. 
We deliver medication to public healthcare facilities in SA. 
We do this on 2 fronts, first as a wholesale / bulkd delivery to replenish stock levels, either 
to medical depots or as DDV’s to clinics in the whole country 
Secondly we dispense medication for chronic patients in 5 provinces (WC, EC, NW, GP and 
FS) to service the needs of about 2 Million patients a month. 
 
4. Please elaborate on your exposure to public-private engagements in the health sector. 
As DSV is a private company – we do service the public sector. 
Framework Questions 
 
1. Is there a need to identify opportunities for integration between the public and private 
sectors in pharmaceutical supply chains? 
YES, there definitely is.. areas of concern are 
• Management of Stock in Facilities 
• Data Integration / Data Accuracy 
• Basic Supply chain procedures 
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2. Do you believe this framework would be a useful assessment tool to identify integration 
opportunities? 
YES ! There are some technical Excel issues still there.. think that needs rework 
Some questions – e.g. around customs clearance, I think are not relevant. 
 
 
3. Are there other frameworks that have the same purpose and results that you are aware of? 
Please elaborate. 
No, not sure – but maybe you want to check online ? Maybe see what the plans on NHI are 
and what is covered in that white paper ? 
 
4. Are there any shortcomings or feedback on the methodology employed by the proposed 
framework? (Or what are the strengths and weaknesses?) 
 
I think it is well thought through. Question for me would be, who is the audience ? 
Some people will not have the time to go through all your documents and guides in detail. I 
would think about employing 2 methods here. 
One detailed and one “short” version. IT has its pros and cons, but you might opnly get 5 
responses out of 100 participants / target people ? 
 
5. In your opinion, how can the framework be improved?  
See above 
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Framework Questionnaire 
 
Name & Surname: Jaco Stokes 
Date: 2 July 2018 
 
Please answer the following questions and forward the completed questionnaire to 
16496698@sun.ac.za or jessicab0712@gmail.com . If you have any questions, please feel free to 
contact me via one of these e-mail addresses or phone me on 072 785 1122.  
 
Background Questions 
 
1. What is your occupation? 
Consultant/Contract Manager 
2. What is your role in the organisation you are currently working for? 
Deputy Director: Contract Management & Availability Monitoring 
3. Please elaborate on your exposure to health supply chains. 
I focus mainly Supplier Contract Management post contract award and ensuring that 
Essential Medicines are available to Public and sometimes Private patients. I have exposure 
to all elements of the Medicine Supply Value Chain 
4. Please elaborate on your exposure to public-private engagements in the health sector. 
My exposure has been in the following areas: 
• Relationship Management 
• Contract Management 
• Risk Management 
• Local & International Sourcing 
• Business Process Re-engineering 
• System & Tool development 
• Tendering 
• Service Provider Licensing 
• Central Chronic Medicine & Distribution 
• Production Planning 
• Demand Planning & Forecasting 
• Financial Management 
• Personnel Administration 
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Framework Questions 
 
1. Is there a need to identify opportunities for integration between the public and private 
sectors in pharmaceutical supply chains? 
Definitely, thinking along the lines of: 
• Universal system integration 
• Supply Chain visibility & logistics management in our move towards NHI 
• Increase in Direct Deliveries 
• Contracting, broader than pharmaceuticals, Consumables & Surgicals, but also 
Private institutions providing services & systems to public patients and institutions 
• Improvement of Demand & Supply planning 
• Improving supply capacity visibility 
• Establishment of Early Warning Systems to avoid stock-outs or shortages 
2. Do you believe this framework would be a useful assessment tool to identify integration 
opportunities? 
I do. Challenges referred to are relevant. We need to overcome quite a lot of these for NHI 
to function optimally. Capacity remains a challenge and we need to leverage more on best 
practices in the private sector. We need to work together and share resources for 
optimisation of a country supply value chain. 
3. Are there other frameworks that have the same purpose and results that you are aware of? 
Please elaborate. 
Not that I’m aware of 
4. Are there any shortcomings or feedback on the methodology employed by the proposed 
framework? (Or what are the strengths and weaknesses?) 
It is structured in a way that make capturing easy. The methodology is sound and it will 
improve compliance. 
5. In your opinion, how can the framework be improved?  
Consider the following: 
• The public sector have very strong processes related to the development of STGs. As 
we need to move towards NHI, formularies will need to be strengthened. 
• I miss a few elements linked to Contract Management, Demand Planning as well as 
Supply Planning. Parallel importation of key medicines need to be investigated as 
the pressure on the bid process often put pressure on available medicines required 
on the STGs. 
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Framework Questionnaire 
 
Name & Surname: SME 3 
Date: 1 July 2018 
 
Please answer the following questions and forward the completed questionnaire to 
16496698@sun.ac.za or jessicab0712@gmail.com . If you have any questions, please feel free to 
contact me via one of these e-mail addresses or phone me on 072 785 1122.  
 
Background Questions 
 
1. What is your occupation? SUPPLY CHAIN MANAGER 
 
2. What is your role in the organisation you are currently working for? SUPPLY CHAIN 
MANAGER 
 
3. Please elaborate on your exposure to health supply chains.  
 
 
4. Please elaborate on your exposure to public-private engagements in the health sector.  
 
Framework Questions 
 
1. Is there a need to identify opportunities for integration between the public and private 
sectors in pharmaceutical supply chains? Yes. The public sector, as managed by the DOH 
endeavours to buy the cheapest medicines so they can treat the most patients. This often 
leads to murderous competition and import replacement, which in turn results in job losses. 
By providing integration between public (customer base) and private (supply) sectors, local 
supply will become more sustainable, more jobs retained, an improved balance of payment 
and more SA based taxed levied.  
 
2. Do you believe this framework would be a useful assessment tool to identify integration 
opportunities? Yes 
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3. Are there other frameworks that have the same purpose and results that you are aware of? 
Please elaborate. I am not aware of any. 
 
4. Are there any shortcomings or feedback on the methodology employed by the proposed 
framework? (Or what are the strengths and weaknesses?) I think the framework will be very 
useful to be used as a checklist to confirm supply chain readiness before orders are placed 
and business execution starts. Working through such a checklist will also help to facilitate 
debate in an objective way between parties who represent different constituencies with 
varying business objectives.  
 
5. In your opinion, how can the framework be improved? I think the framework is great. One 
could possible revisit some to the terminology but in essence, semantical changes would not 
add value to the already developed framework, so I suggest you leave the framework the 
way it is.  
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Framework Questionnaire 
 
Name & Surname:  SME 4 
Date:  2 July 2018 
 
Please answer the following questions and forward the completed questionnaire to 
16496698@sun.ac.za or jessicab0712@gmail.com . If you have any questions, please feel free to 
contact me via one of these e-mail addresses or phone me on 072 785 1122.  
 
Background Questions 
 
1. What is your occupation? 
Consultant/Pharmacist 
2. What is your role in the organisation you are currently working for? 
 
3. Please elaborate on your exposure to health supply chains. 
Our project focusses mainly on supply chain, but includes all elements of the medicine 
supply value chain. The main elements of the value chain are: 
• Selection 
• Contracting 
• Supply Chain 
• Contract Management 
• Use 
We do also consider the supporting or enabling functions within this value chain including: 
• Governance and policy creation 
• Technology and data management 
• Human resources and workforce planning 
• Financial management 
• Sustainability – change management, communications and training 
 
4. Please elaborate on your exposure to public-private engagements in the health sector. 
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 Framework Questions 
 
1. Is there a need to identify opportunities for integration between the public and private 
sectors in pharmaceutical supply chains? 
Absolutely. For the following reasons: 
• To increase direct delivery 
• As we move to NHI, the lines between public and private sector will become more 
blurred 
• To allow for the contracting of private sector institutions to provide public sector 
services and serve public sector patients 
• To improve planning processes – i.e., demand and supply planning. Improve visibility 
into supply capacity linked to public sector demand, allows for the establishment of 
early warning signals to avoid stock-outs or shortages. 
• For selection and contracting purposes – if the public sector needs a certain pack 
size or strength of a medicine, improve integration can assist to shape the market to 
meet the needs of the public sector. 
2. Do you believe this framework would be a useful assessment tool to identify integration 
opportunities? 
I do. The challenges related to public-private engagements mentioned in the Framework 
Guide are real, but these need to be overcome if we are to succeed with NHI. Capacity is 
limited in the public sector and if private sector capacity can be used and leveraged. Improve 
collaboration can result in a very strong and robust supply chain.  
 
3. Are there other frameworks that have the same purpose and results that you are aware of? 
Please elaborate. 
I am not aware of any.  
 
4. Are there any shortcomings or feedback on the methodology employed by the proposed 
framework? (Or what are the strengths and weaknesses?) 
I think the methodology is sounds and structure in such a way that will make for ease of 
capture and improve compliance from stakeholders. 
5. In your opinion, how can the framework be improved?  
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Just some points to consider:  
• Selection: there is a very strong process in place within the public sector related to 
the establishment of Standard Treatment Guidelines – some private sector 
stakeholders do participate, but as we move closer to NHI the use of the STGs and 
resulting formularies across the entire sector will need to be strengthened. Market 
shaping is becoming critical as we are noticing more and more suppliers are not 
bidding on certain products, resulting in the need to source medicines through a 
Section 21 mechanism. 
• Procurement: I would suggest including contract management. This is post-award of 
a tender and is closely linked to supply chain performance. It also provides a good 
opportunity for improving collaboration and planning. The idea of S&OP type 
meetings with key suppliers would be beneficial. 
• Distribution: Clearing customs is not a major issue for the public sector. I would 
suggest adding something about Demand Planning and Supply Planning once the 
contracts have been awarded. Improved collaboration in these areas assists to avoid 
shortages. 
• Information Management: this is crucial for both parties from a planning and 
execution perspective. Interoperability of systems is critical and the ability to share 
timely information to make decisions.  
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Section 1: Introduction 
 
Background 
Well-functioning supply chains are the foundation of health systems (DGDA & MIT-Z ILP, 2008). The 
goal of public health supply chains is not only to deliver the right product, at the right time, but also 
to improve the country’s health outcomes and achieve broad development goals (such as reducing 
poverty and increasing productivity) (Bornbusch, Dickens, Hart, & Wright, 2014; John Snow Inc., 2017). 
Supply chains are crucial to deliver effective health care across all sectors by enabling the availability 
and provision of affordable, quality products at locations that are accessible to the population. 
However, health systems across the globe are struggling to deliver satisfactory health care (WHO, 
2007). One of the key health sector challenges is the inequitable and discriminatory access to essential 
medicines (Matowe, 2015; World Health Organization, 2011). Health supply chains in low-medium 
income countries face a number of challenges such as staff shortages, geographically reaching all 
consumers, limited or no information for forecasting and supply planning, insufficient warehouse 
space and management, increased complexity and increased number of products (Allain, Goentzel, 
Bates, & Durgavich, 2010; DGDA & MIT-Z ILP, 2008; John Snow Inc., 2016; UN Commission, 2015). The 
improvement of pharmaceutical supply chains should be regarded as a top priority as a result of its 
effect on the affordability, availability and acceptability of medicines (Tetteh, 2009). 
Many authors argue that public-private engagement should be a key aspect of any strategy aiming to 
improve the health system. While it is the government’s responsibility to improve public health 
systems, the absence of public resources, the challenges faced by the public supply chains and the size 
of a growing private sector suggests that governments cannot optimally improve health systems 
without engaging with the private sector (IFC World Bank, 2011). Public-private engagement is not an 
easy task due to barriers such as conflicts of interest, different information systems and different 
governance structures to name a few (Axelsson & Axelsson, 2006; Nishtar, 2004; UN Commission, 
2015). However, many believe that private sector engagement is imperative and unavoidable, and 
could lead to improved health care access, increased efficiency, reliability and effectiveness of supply 
chains as well as improves health outcomes (Bornbusch et al., 2014; DGDA & MIT-Z ILP, 2008; IFC 
World Bank, 2011; Kaboru, 2012; Nishtar, 2004; UN Commission, 2015). 
Assessing Public Pharmaceutical Supply Chains to Identify Opportunities for Integration: Framework 
Guide was created in conjunction with a framework to identify opportunities, risks and challenges 
associated with public-private pharmaceutical supply chain integration. Governments and supply 
chain managers could utilize these opportunities to inform decisions regarding private sector 
engagements that may lead to the strengthening of pharmaceutical supply chains as well as the 
improvement of supply chain efficiency and effectiveness.  
Important Definitions 
In order for stakeholders and assessors to be able to use the framework, some definitions need to 
be clarified. 
Integration   
Before continuing with the guide, it is important to define the word integration due to the proliferation 
of meanings in both the public health and supply chain literature. 
Definitions from Axelsson and Axelsson (2006), Foreman and Roberts (1991), National Research 
Council et al. (2000) and United Nations Commission on Life-Saving Commodities & Technical Refrence 
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Team (2015) were combined to define integration. For the purpose of this framework integration is 
defined as follows: Integration occurs when two or more autonomous supply chains work together to 
(i) improve their collective efficiency and effectiveness; (ii) find synergistic combinations of resources; 
and (iii) find solutions to problems that each supply chain may not be able to achieve on its own. 
Integration is achieved by constructively exploring each supply chain’s differences and combining 
expertise from different organisations within the supply chains. This type of integration can be 
visualised as a step-wise process that starts from complete autonomy (i.e. no integration) and 
progresses to interaction, to dialogue and finally to agreement (fully integrated).  
Levels of Integration 
The levels of integration are defined using the private sector engagement model (also known as the 
P3 Model) as defined by United Nations Commission on Life-Saving Commodities Technical Reference 
Team (2015). 
The P3 Model consists of three phases (in this guide it will be called levels from here on forth) through 
which public-private engagements can go. Each level builds on the preceding level, in other words 
engagements move from level 1 to level 2, and then from level 2 to level 3 in a step-wise manner. 
However, it is not necessary for each public-private engagement to reach all three levels. As a private 
engagement progresses to level 3, so will the complexity and formality of the engagement increase. 
The levels are defined as illustrated in Figure 1. Each level is shortly discussed below. 
 
 
Figure 1: Integration levels 
Level 1 - Interaction  
In public-private interaction, information is exchanged between the two sectors to align 
understanding and assist each other. For example, private sector providers could share data, such as 
case detections, with the public sector. An example of interaction from the public sector could be as 
simple as communicating with the private sector to ensure that new regulations have been received 
and understood. This type of engagement is usually short term with a duration of roughly one to two 
weeks or ongoing on a periodic basis. 
Level 2 – Dialogue 
Dialogue involves cooperation and negotiation between the public and private sectors around shared 
interests. Dialogue does not necessitate shared investments or formal agreements, it does however 
require that the two sectors cooperate and work together effectively. An example of a public-private 
dialogue is corporate social responsibility initiatives. These engagements usually last about two to four 
months or ongoing on a periodic basis.  
Level 1
Public-private 
interaction
Level 2
Public-private 
dialogue
Level 3
Public-private 
agreement
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Level 3 – Agreement 
Public-private agreement is the most complex form of engagement that involves a formal contract 
between the public and private sectors which stipulates each sector's roles and responsibilities. The 
agreement should also specify each sector's investments and the conditions under which each sector 
will take over risks and receive benefits. Specific activities should take place during the agreement 
process, such as a request for proposal (RFP), contract negotiations and contract award, 
implementation and contract management. Public-private agreements are typically long-term 
engagements. 
Table 1 summarises the characteristics of each integration level.  
Table 1: Characteristics of each integration level 
Integration Level Timespan Formality Engagement Focus 
Interaction 
Short term 
(1 – 2 weeks) 
Informal Communication 
Dialogue 
Medium term  
(2 – 4 months) 
Can be formal or 
informal; does not 
require formal 
agreement or shared 
investment  
Cooperation 
Agreement 
Long term 
(unspecified how long) 
Formal  Collaboration 
 
Supply Chain Functions 
The supply chain functions that are assessed in this framework include: selection, forecasting, supply 
planning, procurement, contract management, distribution, use, management support and 
information management (Management Sciences for Health, 2012). Each function is shortly described 
below (Management Sciences for Health, 2012): 
Selection 
A limited number of medicines are selected to improve the supply and rational use of medicines as 
well as to lower the costs of medicines. Medicine selection is determined by creating a list of common 
diseases that occur at each level of the health system. A multidisciplinary committee then determines 
the treatment of first choice (medicines), the formulary system and the treatment guidelines based 
on the list of common diseases. The supply chain is then required to supply the medicines that have 
been selected. 
Forecasting 
Each year data, such as consumption data, morbidity data, services data, demographic data and 
current performance data, are collected and used to estimate the quantities of products that are 
needed to meet the population’s health needs. Forecasting uses historical data and assumptions of 
future demand to estimate product consumption for the next year.  
Supply Planning 
Supply planning involves estimating the total cost and product requirements by using the forecasts 
from the previous supply chain function to ensure supply chains will have sufficient stock and optimal 
delivery schedules. Factors such as stock levels, lead times, consumption data and desired delivery 
dates are taken into account.  
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Procurement 
Procurement involves the process of purchasing medicines from international and national private 
suppliers as well as public suppliers. Purchases are made through global agencies, regional 
procurement systems or international procurement agents. 
Contract Management  
Contract management is the process of effectively managing the development, execution and 
assessment of contracts so that financial and operational performance is maximised and risk is 
minimised.  
Distribution 
The main goal of the distribution system is to maintain a continuous supply of medicines to health 
facilities and to ensure that resources are used effectively. This is achieved through the inspection, 
control, storage, delivery and dispensing of stock. 
Use 
The rational use of medicines require that patients receive medications appropriate to their clinical 
needs, in doses that meet their individual requirements, for an adequate period of time, and at the 
lowest cost to them and their community. 
Management Support 
The management support systems hold the pharmaceutical management framework together. These 
systems consist of organisation, financing and sustainability, and human resource management.  
Information Management 
Information management involves monitoring and evaluating performance targets as well as the 
progress of achieving objectives. Monitoring systems focus on inputs and short-term outputs and 
should be an integral part of day-to-day management. Evaluation is commonly discussed along with 
monitoring as part of an overall strategy. It refers to the periodic analysis of a program’s progress 
toward meeting established objectives and goals. Information management requires the use of 
pharmaceutical management information systems which are organized systems for collecting, 
processing, reporting, and using information for decision making. 
 
Purpose of the Framework and Guide  
The framework is designed to assess public pharmaceutical supply chains in order to: 
• Determine the supply chain’s current level of integration 
• Identify where there are opportunities to integrate with the private sector 
• Determine the impact of the potential engagement in terms of the risks and benefits 
• Prioritise areas where opportunities of integration have been identified 
This framework will help supply chain managers determine where private engagements efforts should 
focus. This guide was written to help supply chain managers implement the framework. It gives an 
explanation of how to execute each step, how data is collected and includes templates that may be 
used by users.   
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Framework Introduction  
The framework consists of five phases, namely: define scope, review, data collection, identify 
improvements and verify and prioritise.  Figure 2 illustrates the framework process which is further 
discussed in Section 2. 
The success of the framework relies on the involvement of stakeholders. Stakeholders are engaged 
and involved in the process from the first phase to the last as they are important for collecting data, 
identifying improvements, validating outcomes and prioritising identified opportunities. Stakeholder 
engagement is further discussed in Section 2.  
Excel File 
The framework is accompanied by an Excel file called Integration Opportunties.xlsm, which is used to 
simplify the data collection and prioritisation process. The file also contains a dashboard that displays 
the results of the assessment; this is further discussed in Section 3. Please note that the file does 
contain macros, therefore the macros need to be enabled when opening the file. When a framework 
step needs to be completed in the excel file, the text will appear in a grey box and the following icon 
will appear on the left side of the page:  
 
Figure 3: Computer icon. Icon is designed by Prosymbols on www.flaticon.com 
Outline of the Guide 
The guide is organised as follows: 
Section 1: Introduction – Section 1 provides background information regarding why such a framework 
may be needed. The definition of integration is also provided, along with the purpose of the 
framework and a short introduction of the framework. 
Section 2: Framework – Section 2 provides the step by step process that describes how the supply 
chain assessment should be carried out.  
Section 3: Dashboard – Section 3 provides an explanation of the Dashboard that is used to display the 
results of the framework.  
Section 4: Conclusion – A conclusion of the framework is given.  
1. Define scope
•Supply chain levels & 
products
•Stakeholder 
engagement
•Timeframe
2. Review
•Desktop/ document 
review
•Supply chain map
•Questionnaire/ 
Interview
3. Data collection
•Data collection tool
•Interview/ Focus 
group
4. Identify 
Improvements
5. Verify & 
prioritise
•Validation workshop/ 
interview
•Risk-benefit 
prioritisation
Figure 2: Framework process. Icons designed by Freepik and Smashicons on www.flaticon.com 
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Guide Users 
This framework was designed for anyone who wishes to assess public pharmaceutical supply chains. 
Examples of people who may use the framework include supply chain managers, government 
officials/organisations, donors, etc.  
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Section 2: Framework  
This section gives a description of each phase of the framework. 
Phase 1: Define Scope 
Before starting with the assessment, it is important to determine the scope of the supply chain and 
assessment. By defining the scope assessors will be informed of the supply chain being assessed, which 
stakeholders to engage with as well as the required data that needs to be collected and analysed.  The 
scope definition constitutes four parts: supply chain levels and products, stakeholder engagement, 
timeframe and budget.  
Supply Chain Levels and Products/Programmes 
Public health supply chains typically consist of three or more levels, including national, regional, 
district and community levels. The number of levels are often determined by  the health system 
structure which depends on the administrative and political structures (UNICEF, 2016).  Not only do 
public health supply chains have different levels, they also serve various different health programmes, 
each of which require unique groups of pharmaceuticals (for example TB, essential medicines, 
vaccines, etc.). Each country defines health programmes differently, some may be integrated across 
products (i.e. one supply chain is used for many pharmaceuticals), whereas others tend to be more 
vertical (i.e. each product or group of products have their own supply chain).  
A decision must be made as to which supply chain levels and which pharmaceutical 
products/programmes will be included in the assessment. Supply chain levels and 
products/programmes that will be included in the assessment should also be considered based on 
who is carrying out the assessment (and their authority) as well as where the intended results are 
required. For example, if a regional supply chain manager wishes to identify opportunities for 
integration in the essential medicines supply chain, then the regional level and essential medicines 
should be included in the assessment. A list is provided in Appendix 1 that can be used to select the 
supply chain level and products that will be included in the assessment.  
Stakeholder Engagement 
As previously mentioned, the success of the framework depends on the involvement and support of 
stakeholders. Stakeholders should be identified and contacted during Phase 1 of the framework since 
they will be involved in the assessment process from Phase 2 and onwards. Stakeholders should 
include but not be limited to people who have expertise in various health supply chain areas and have 
an impact on the assessed supply chain. Examples of stakeholders include: 
• Government (e.g. Ministry of Health ministers or stakeholders from other departments such 
as finance, treasury, etc.)  
• Private sector organisations and businesses involved in health supply chains 
• Donors (e.g. WHO, USAID) 
• Local government 
• Public pharmaceutical supply chain stakeholders (e.g. medical stores manager, procurement 
unit, logistics manager) 
• Committees and coordinating bodies (e.g. regional drug and therapeutics committees, 
formulary and treatment guideline committees, national drug committee) 
• Regulatory bodies 
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Timeframe 
Submission dates for each of the assessment activities should be decided upon in order to inform 
stakeholders when specific assessment tasks will take place, to ensure that the all deliverables are 
completed and to prevent the assessment from being extended too long. A timeframe template is 
provided in Appendix 2 that may be used to determine the submission dates.  
Budget 
The last task of the scope definition is to set up a budget in order to ensure that there is sufficient 
funding to carry out the assessment. 
The following should be taken into consideration when setting up the budget: 
• Available funds for the assessment. 
• Travel costs that may be incurred to get stakeholders and assessors to the location where the 
assessment will be carried out (e.g. flights, transport, car hire). 
• Time and costs associated with the assessor(s) taking time off work to carry out the 
assessment. 
• Venues that may need to be hired for meetings and/or workshops. 
• Materials and equipment that may be used during the assessment (e.g. projectors, printed 
materials, stationery). 
• Refreshments during the assessment. 
Phase 2: Review  
The second phase of the assessment is to collect and review information about the chosen supply 
chain in order to gain a better understanding of the supply chain context, especially with regards to 
current public-private engagements. Phase 2 consists of three components, namely a document 
review, a supply chain map and a questionnaire or interview.   
Document Review 
Background documents about the relevant supply chain should be collected and reviewed. These 
documents may provide insight about current private engagements, problems that affect the supply 
chain, potential integration opportunities, gaps in information, supply chain constraints as well as the 
general context of the supply chain. Reviewing background documents will also help stakeholders 
understand the supply chain and ensure that everyone is on the same page.  
The following documents should be considered for the review: 
• Previous assessment reports 
• Documents that relate to public-private engagements in the relevant supply chain 
• Documents related to the supply chain functions 
• Supply chain stakeholder and process maps 
Identified documents should be collected and distributed to all stakeholders and assessors. 
Documents can be reviewed individually in each person’s own time or in groups. It is important that a 
list of the documents be kept. If any information from one of the documents is used, the relevant 
document must be cited in case any questions are raised or information needs to be verified.  
Questionnaire/Interview 
In cases where information from the review is missing, insufficient or unclear, stakeholders may need 
to complete a questionnaire or be interviewed in order to acquire the required information. It is 
subject to the assessor’s discretion whether enough information was acquired during the document 
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review. In the case where is has been decided that additional information is required, the assessor can 
either collect information from the stakeholders who are currently involved in the assessment process 
or additional stakeholders may be identified for this part of the assessment.  
The following table can be used when identifying potential stakeholders to complete the 
questionnaire or interview: 
Stakeholder Name Organisation Department  Information that may be 
provided by the stakeholder  
    
    
    
    
 
A template for the questionnaire is provided in Appendix 3. The questionnaire may be adapted as 
required and the questions can serve as a guide when interviewing stakeholders. 
Supply Chain Map 
Once all the information has been collected, stakeholders are required to map the supply chain based 
on the collected information. Mapping the supply chain leads to a common understanding of the 
supply chain and provides a visual representation of the supply chain. Assessors should decide how 
much detail should be included in the supply chain map. However, a more detailed map may provide 
insight to current private sector engagements as well as opportunities for new engagements.  
Phase 3: Data Collection 
A description of the data collection methodologies are given, after which the steps to collect the data 
are explained.  
Data Collection Methodology 
There are two main method that are used to collect the data, namely: interviews and focus groups. 
Either method can be used depending how detailed the information should be and the resources that 
are available.  
Focus Groups 
Focus groups are used to get information from as many as 12 people at a time. Focus groups allows 
the assessor to collect information from many people at once which is useful when data collection 
time is limited. Focus groups are also useful to collect data by consensus, however data may not be as 
detailed as that collected from interviews. Participants of focus groups usually have similar 
characteristics, for example they may all be from one organisation or have expertise on a specific 
supply chain function.  
Interviews 
Interviews are usually conducted with one person at a time. Interviews are useful when more detailed 
data is required for the assessment, however it may take longer to collect enough data.  
Data Collection Tool 
Data is collected using the excel file (Integration Opportunties.xlsm) as well as paper-based data 
collection forms which are provided in Appendix 4. Please note that for the excel file to work, the 
macros need to be enabled. Each supply chain function is assessed separately in different sheets in 
the excel workbook. When first opening the excel file, a number of tabs will be visible at the bottom 
of the file. For the data collection step of the framework the following tabs will be used: SC Function 
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1 – Selection, SC Function 2 – Forecasting, SC Function 3 – Supply Planning, SC Function 4 – 
Procurement, SC Function 5 – Contract Management, SC Function 6 – Distribution, SC Function 7 – Use, 
SC Function 8 – Management Support and SC Function 9 – Information Management. When collecting 
data via focus groups one form can be filled in per supply chain function. If collecting data via 
interviews, each interviewee needs to fill in a form for each supply chain function. Before starting the 
data collection, forms for each of the supply chain functions should be printed and handed out.  
The data collection steps are described below. Start with the first supply chain function tab, namely 
SC Function 1 – Selection. 
Step 1:  
Stakeholders should read the descriptions of the supply chain functions under Section A of the data 
collection forms in order to understand what each supply chain function entails.  
Step 2: 
Open the SC Function 1 – Selection tab if it is not already open. Stakeholders should read Section A of 
the sheet. Section A gives an explanation of the activities that are carried out in each supply chain 
function.   
Step 3: 
Stakeholders should fill in the tables in Section B of the data collection forms. 
Step 4: 
Under Section B of the excel sheet, stakeholders need to fill in the matrix based on the information 
collected in Section B of the data collection forms. Below is an example of the matrix: 
Section B: Current Level of Integration 
Supply Chain Function Activity No Engagement  Interaction Dialogue Agreement 
Review prevalent health problems         
Identify treatments of choice          
Develop STGs and formularies      
Choose individual medicines & dosages         
Decide which medicines will be available  
at each level of the health care system 
        
 
In the matrix the current level of integration must be chosen for each supply chain function activity. 
This is determined by looking at the engagement types in section B of the data collection form and 
selecting the one that occurs most. For example, if the supply chain activity Identify treatments of 
choice has three public-private engagements at the interaction level and one at the dialogue level then 
the overall level of that supply chain activity is at interaction. In the matrix insert an X in the 
appropriate column for each supply chain function activity. Please note that only one level can be 
chosen per supply chain activity (i.e. one X per row). An example of a completed matrix is provided 
below. 
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Section B: Current Level of Integration 
Supply Chain Function Activity No Engagement  Interaction Dialogue Agreement 
Review prevalent health problems X       
Identify treatments of choice  X       
Develop STGs and formularies      
Choose individual medicines & dosages     X   
Decide which medicines will be available  
at each level of the health care system 
  X     
 
Step 5: 
Under Section C of the excel sheet is a similar matrix to the one in Section B. For this matrix, 
stakeholders need to identify the level of integration that they think each activity should achieve in 
the medium term in order to support the most optimal operational efficiency and effectiveness by 
filling in an X in the appropriate space.   
Step 6:  
Stakeholders should fill in Section C of the data collection form.  
These steps are repeated for each supply chain function.  
Phase 4: Identify Opportunities 
Opportunities for integration are identified by comparing the current level of integration with the 
integration aim as determined in Sections B and C in the excel file. 
The levels of integration can be compared by creating graphs of the integration levels and looking at 
the difference between them. These graphs are automatically created in Section D of each supply 
chain function’s excel sheet. Below an example of the graph is shown for the selection supply chain 
function. In the example it is clear that the integration aim is higher than the current level of 
integration, therefore there is an opportunity to further integrate/engage with the private sector. 
 
 
R E V I E W  
P R E V A L E N T  
H E A L T H  
P R O B L E M S
D E V E L O P  S T G S  
A N D  
F O R M U L A R I E S
C H O O S E  
I N D I V I D U A L  
M E D I C I N E S  &  
D O S A G E S
D E C I D E  W H I C H  
M E D I C I N E S  
W I L L  B E  
A V A I L A B L E  A T  
E A C H  L E V E L  O F  
T H E  H E A L T H  
C A R E  S Y S T E M
I D E N T I F Y  
T R E A T M E N T S  
O F  C H O I C E  
Current level of integration Integration aim
Agreement
Dialogue
Interaction
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Phase 5: Verify and Prioritise 
The last phase of the framework involves the validation of the data and findings of the previous 
phases, prioritising the identified integration opportunities according to the risks and benefits of 
engaging with the private sector, and lastly validating the prioritisation of the supply chain function 
activities by means of a validation workshop or interviews.  
Data Validation Workshop/Interview 
Before continuing with the prioritisation of the supply chain function activities, it is important that the 
data collected thus far is validated and agreed upon. The validation workshop is intended for 
stakeholders to:  
• Review and resolve any questions, issues or disagreements that reoccurred during the 
assessment 
• Discuss and validate the findings of the assessment 
• Provide input on the findings 
In some cases, specific information or findings may need to be validated; or remaining questions need 
to be answered. In these cases where the issue cannot be solved in the workshop, stakeholders may 
need to be interviewed again to resolve the issue. 
Two types of stakeholders should be included in the workshop, namely: those make decisions (for 
example the MOH) and those who will be responsible for taking the findings further. 
Risk-Benefit Prioritisation 
In the last phase, supply chain activities with opportunities for integration were identified. In this 
phase these activities are prioritised in order to determine which supply chain activity shows the 
greatest potential and should be focused on first. This is achieved by examining the risks and benefits 
of private engagement in the particular supply chain activity.  
On the Prioritisation sheet of the excel file, the supply chain activities that have opportunities for 
integration are automatically listed under their respective supply chain functions (Column A). A list of 
benefits and risks are provided at the top of the page. Explanations of the risks and benefits are 
provided in Appendix 5 which can be distributed to stakeholders to ensure that everyone understands 
each risk and benefit (DGDA & MIT-Z ILP, 2008; O’Hanlon & Jeffers, 2013; UN Commission, 2015).  
In order to prioritise the supply chain activities, stakeholders need to rate the impact each benefit and 
risk will have on the engagement on a scale from 0 – 5, where 0 = no impact and 5 = very high impact. 
Once the risks and benefits ratings of each supply chain activity have been completed, the supply chain 
activities will be prioritised. Supply chain activities are prioritised by calculating the benefit-risk ratio 
for each activity and then ranking each activity from the highest benefit-risk ratio to the lowest. The 
ratios are automatically calculated and each activity is ranked in the last column of the sheet (called 
Priority of functions). Supply chain activities should be further investigated according to ascending 
rank. In other words, the supply chain activity with a rank of 1 has the most benefits and least risks 
and should therefore be pursued/focused on first. Next would be the activity with a rank of 2, and so 
on. At the bottom of the Prioritisation sheet is a results section where the total risk and benefit of 
each supply chain activity is plotted on a graph to allow for a visual comparison of the risks and 
benefits. 
Prioritisation Validation 
After the supply chain function activities have been prioritised, the risks and benefits of private sector 
engagement, as selected in the previous step, as well as the prioritisation results can be validated by 
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taking part in another validation workshop or interview with stakeholders. These validation 
workshops/interviews have the same format as the previous validation workshops/interviews.  
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Section 3: Dashboard 
The dashboard is the landing page of the excel file. It summarises the results of the steps that are 
carried out in the excel file. It is divided into the following four sections which are shortly described 
below: level of integration, percent integrated, prioritisation and risks and benefits. 
Percent Integrated 
In this graph the current level of integration and the integration aim for each supply chain function is 
compared. The levels of integration for each supply chain function is averaged and converted to a 
score out of 100. This shows how integrated each supply chain function is, where 100% indicates that 
all supply chain activities, in the specific supply chain function, are at the agreement level and that the 
supply chain function is fully integrated.  
Risks and Benefits 
This section contains two graphs, one for the risks and one for the benefits. Each graph indicates how 
much a risk/benefit impacts each supply chain function, where 100 indicates a very high impact.   
Prioritisation and De-integration 
Under the prioritisation section the supply chain activities with opportunities for integration are listed 
according to their rank (i.e. from highest priority to lowest priority). The de-integration section lists 
the supply chain activities that should de-integrate, i.e. engagements should go from a higher 
integration level to a lower integration level. Although identifying supply chain de-integration 
possibilities is not the aim of the framework, it is included as it may be interesting to stakeholders and 
may prompt important discussions. 
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Section 4: Conclusion 
The guide provided the step-by-step process that assessors need to follow in order to identify 
opportunities for integration with the private sector. The framework only focuses on identifying 
opportunities for integration in the pharmaceutical supply chain, therefore implementing public-
private engagements in the identified opportunities is outside of the scope of this guide. There are 
many useful guides and documents that assist with determining the feasibility of public-private 
engagements as well as identifying potential partners for engagement and implementing public-
private engagements. A list of useful documents is provided in the table below.  
 
Author(s) Title 
South African National 
Treasury 
PPP Manual 
Tennyson 
The partnering toolbook: An essential guide to cross-sector 
partnering 
United Nations on Life-
Saving Commodities 
Private Sector Engagement: A Guidance Document for Public 
Health Supply Chains 
O’Hanlon and Jeffers 
Reference Guide for Development of Public Private Partnerships 
in the Health Sector for Countries in the SADC Region 
Herzberg and Wright 
Public-Private Dialogue: The PPD Handbook – A Toolkit for 
Business Environment Reformers 
Smith, Brugha and Zwi 
Working with Private Sector Providers for Better Health Care: 
An Introductory Guide 
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Appendix 1: List of Supply Chain Levels and Products/Programmes 
The following table provides a list of supply chain levels and products that can be used during Phase 1 
of the framework in order to define the scope of the supply chain being assessed. 
Supply Chain Levels 
 National 
 Regional 
 District 
 Community 
Products/Programmes 
 HIV 
 Malaria 
 Immunisation 
 Maternal & child health 
 TB 
 Essential medicines 
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Appendix 2: Timeframe Template 
Below is a template that can be used to determine the start and submission dates of the assessment 
framework. The template can be adapted as required by the assessors. 
Assessment 
Phase 
Task Start Date Submission 
Date 
Phase 2 
Document Review   
Supply Chain Map   
Questionnaire/Interview   
Phase 3 
Supply Chain Function 1   
Supply Chain Function 2   
Supply Chain Function 3   
Supply Chain Function 4   
Supply Chain Function 5   
Supply Chain Function 6   
Supply Chain Function 7   
Supply Chain Function 8   
Supply Chain Function 9   
Phase 4 Identify Opportunities   
Phase 5 
Data Validation Workshop/Interview   
Prioritisation   
Prioritisation Validation    
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Appendix 3: Review Questionnaire 
The following questionnaire can be used to obtain background information from stakeholders on the 
supply chain that is being assessed. The questionnaire is used to collect information in cases where 
the information collected during the document review is missing, insufficient or unclear. 
Assessing Public Pharmaceutical Supply Chains to Identify Opportunities for 
Integration – Review Questionnaire 
Name:  
Organisation:  
Title/Position:  
 
Your assistance is required for a supply chain assessment that is currently being carried out. The public 
(assessor to fill in the specific supply chain that is being assessed)  supply chain is being assessed to identify opportunities for 
public-private engagement. 
In order to assess the supply chain, information is required regarding the background of the supply 
chain as well as current public-private engagements. Your response will be used during the assessment 
of the supply chain.  
 
1. Do you have any past supply chain assessment reports regarding the supply chain in question that 
you can share? 
 
2. If your answer to the above question is no, do you know of any persons who may be able to share 
past supply chain assessment reports? If so, please fill in the table below. 
Stakeholder Name Organisation Department  Information that may be 
provided by the stakeholder  
    
    
    
    
 
3. Are there any current public-private engagements in the supply chain that you are aware of? If so, 
please fill in the table below. 
Short description of 
the engagement 
Supply chain function 
where the engagement 
occurs 
Organisations that are 
involved in the engagement  
Relationship between 
the public and private 
organisations 
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4. Do you have any background documents relevant to the following supply chain functions that you 
may share? 
❑  Selection  
❑  Forecasting 
❑  Supply Planning 
❑  Procurement 
❑  Contract Management 
❑  Distribution 
❑  Use 
❑  Management Support 
❑  Information Management 
 
5. Do you have any stakeholder or process maps of the supply chain in question that you can share? 
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Appendix 4: Data Collection Forms 
The following data collection forms are used in conjunction with the excel file to collect data during 
the supply chain assessment. A data collection form is provided for each of the supply chain functions. 
Data Collection Form: Supply Chain Function 1 - Selection 
Names of participants: 
 
Section A: Short description of supply chain function 
A limited number of medicines are selected to improve the supply and rational use of medicines as 
well as to lower the costs of medicines. Medicine selection is determined by creating a list of common 
diseases that occur at each level of the health system. A multidisciplinary committee then determines 
the treatment of first choice (medicines), the formulary system and the treatment guidelines based 
on the list of common diseases. The supply chain is then required to supply the medicines that have 
been selected. 
Section B: Current supply chain integration 
Please identify any public-private engagements in the following supply chain function activities and fill 
in the tables below. 
Supply Chain Activity: Review prevalent health problems 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Identify treatments of choice 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Develop STGs and formularies 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Choose individual medicines & dosages 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Decide which medicines will be available at each level of the health care system 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Section C: Supply chain integration aim 
Please provide the required information regarding why specific engagement levels were chosen in 
Section C of the excel file in the tables below. 
Supply Chain Activity: Review prevalent health problems 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Develop STGs and formularies 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Choose individual medicines & dosages 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Decide which medicines will be available at each level of the health care system 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Identify treatments of choice 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Data Collection Form: Supply Chain Function 2 - Forecasting 
Names of participants: 
 
Section A: Short description of supply chain function 
Each year data, such as consumption data, morbidity data, services data, demographic data and 
current performance data, are collected and used to estimate the quantities of products that are 
needed to meet the population’s health needs. Forecasting uses historical data and assumptions of 
future demand to estimate product consumption for the next year.  
Section B: Current supply chain integration 
Please identify any public-private engagements in the following supply chain function activities and fill 
in the tables below. 
Supply Chain Activity: Organise, analyse and adjust data  
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Build forecasting assumptions 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Calculate forecasted consumption for each product 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Compare and reconcile results for different forecasts  
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Section C: Supply chain integration aim 
Please provide the required information regarding why specific engagement levels were chosen in 
Section C of the excel file in the tables below. 
Supply Chain Activity: Organise, analyse and adjust data 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Build forecasting assumptions 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Calculate forecasted consumption for each product 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Compare and reconcile results for different forecasts 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Data Collection Form: Supply Chain Function 3 – Supply Planning 
Names of participants: 
 
Section A: Short description of supply chain function 
Supply planning involves estimating the total cost and product requirements by using the forecasts 
from the previous supply chain function to ensure supply chains will have sufficient stock and optimal 
delivery schedules. Factors such as stock levels, lead times, consumption data and desired delivery 
dates are taken into account.  
Section B: Current supply chain integration 
Please identify any public-private engagements in the following supply chain function activities and fill 
in the tables below. 
Supply Chain Activity: Organise, analyse and adjust data  
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Build supply planning assumptions 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Estimate total commodity requirements  
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Develop supply plan 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Compare costs to available funding 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Section C: Supply chain integration aim 
Please provide the required information regarding why specific engagement levels were chosen in 
Section C of the excel file in the tables below. 
Supply Chain Activity: Organise, analyse and adjust data  
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Build supply planning assumptions 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Estimate total commodity requirements 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Develop supply plan 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Compare costs to available funding 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Data Collection Form: Supply Chain Function 4 - Procurement 
Names of participants: 
 
Section A: Short description of supply chain function 
Procurement involves the process of purchasing medicines from international and national private 
suppliers as well as public suppliers. Purchases are made through global agencies, regional 
procurement systems or international procurement agents. 
Section B: Current supply chain integration 
Please identify any public-private engagements in the following supply chain function activities and fill 
in the tables below. 
Supply Chain Activity: Select procurement methods 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Assure pharmaceutical quality 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Section C: Supply chain integration aim 
Please provide the required information regarding why specific engagement levels were chosen in 
Section C of the excel file in the tables below. 
Supply Chain Activity: Select procurement methods 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Assure pharmaceutical quality 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Data Collection Form: Supply Chain Function 5 – Contract Management  
Names of participants: 
 
Section A: Short description of supply chain function 
Contract management is the process of effectively managing the development, execution and 
assessment of contracts so that financial and operational performance is maximised and risk is 
minimised.  
Section B: Current supply chain integration 
Please identify any public-private engagements in the following supply chain function activities and fill 
in the tables below. 
Supply Chain Activity: Needs clarification 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Tender preparation 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Tender publication 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Bids evaluation 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Contract award 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Changes in contract 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Service delivery management 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Relationship management  
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Contract administration 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Risk assessment  
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Purchasing organisation’s performance & effectiveness review 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Contract closure 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Section C: Supply chain integration aim 
Please provide the required information regarding why specific engagement levels were chosen in 
Section C of the excel file in the tables below. 
Supply Chain Activity: Needs clarification 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Tender preparation 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Tender publication 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Bids evaluation 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Contract award 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Changes in contract 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Service delivery management  
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Relationship management  
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Contract administration 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Risk assessment  
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Purchasing organisation’s performance and effectiveness review 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Contract closure 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Data Collection Form: Supply Chain Function 6 - Distribution 
Names of participants: 
 
Section A: Short description of supply chain function 
The main goal of the distribution system is to maintain a continuous supply of medicines to health 
facilities and to ensure that resources are used effectively. This is achieved through the inspection, 
control, storage, delivery and dispensing of stock. 
Section B: Current supply chain integration 
Please identify any public-private engagements in the following supply chain function activities and fill 
in the tables below. 
Supply Chain Activity: Stock control 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Stores management 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Deliver to drug depots & health facilities 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Section C: Supply chain integration aim 
Please provide the required information regarding why specific engagement levels were chosen in 
Section C of the excel file in the tables below. 
Supply Chain Activity: Stock control 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Stores management 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Deliver to drug depots & health facilities 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Stellenbosch University  https://scholar.sun.ac.za
50 
 
Data Collection Form: Supply Chain Function 7 - Use 
Names of participants: 
 
Section A: Short description of supply chain function 
The rational use of medicines require that patients receive medications appropriate to their clinical 
needs, in doses that meet their individual requirements, for an adequate period of time, and at the 
lowest cost to them and their community (Management Sciences for Health, 2012). 
Section B: Current supply chain integration 
Please identify any public-private engagements in the following supply chain function activities and fill 
in the tables below. 
Supply Chain Activity: Diagnose 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Prescribe 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Dispense 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Use by patient 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Section C: Supply chain integration aim 
Please provide the required information regarding why specific engagement levels were chosen in 
Section C of the excel file in the tables below. 
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Supply Chain Activity: Diagnose 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Prescribe 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Dispense 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Use by patient 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Data Collection Form: Supply Chain Function 8 – Management Support 
Names of participants: 
 
Section A: Short description of supply chain function 
The management support systems hold the pharmaceutical management framework together. These 
systems consist of organisation, financing and sustainability, and human resource management.  
Section B: Current supply chain integration 
Please identify any public-private engagements in the following supply chain function activities and fill 
in the tables below. 
Supply Chain Activity: Organisation of system 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Finance & sustainability 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Human resource management 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Section C: Supply chain integration aim 
Please provide the required information regarding why specific engagement levels were chosen in 
Section C of the excel file in the tables below. 
Supply Chain Activity: Organisation of system 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Finance & sustainability 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Human resource management 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Data Collection Form: Supply Chain Function 9 – Information Management 
Names of participants: 
 
Section A: Short description of supply chain function 
Information management involves monitoring and evaluating performance targets as well as the 
progress of achieving objectives. Monitoring systems focus on inputs and short-term outputs and 
should be an integral part of day-to-day management. Evaluation is commonly discussed along with 
monitoring as part of an overall strategy. It refers to the periodic analysis of a program’s progress 
toward meeting established objectives and goals. Information management requires the use of 
pharmaceutical management information systems which are organized systems for collecting, 
processing, reporting, and using information for decision making (Management Sciences for Health, 
2012). 
 
Section B: Current supply chain integration 
Please identify any public-private engagements in the following supply chain function activities and fill 
in the tables below. 
Supply Chain Activity: Data selection 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Data collection 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Data visibility 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Digital LMIS 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Supply Chain Activity: Data use  
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
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Supply Chain Activity: Data quality 
Short description 
of engagement 
Organisations 
involved 
Describe relationship 
between organisations 
Citation (if 
applicable) 
Type of 
engagement 
     
     
     
     
     
 
Section C: Supply chain integration aim 
Please provide the required information regarding why specific engagement levels were chosen in 
Section C of the excel file in the tables below. 
Supply Chain Activity: Data selection  
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Data collection  
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Data visibility 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Digital LMIS 
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
   
 
Supply Chain Activity: Data use  
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Supply Chain Activity: Data quality  
What integration level have 
you chosen? 
Why have you chosen that 
level? 
How will this benefit the 
health system/supply 
chain/public sector? 
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Appendix 5: Explanations of Risks and Benefits 
Explanations of the risks and benefits of public-private engagements are provided below. 
Benefits of public-private engagements 
Close the resource gap: Partnerships attract private capital which can be used to fund services and 
procure assets or to supplement the public sector's resources or by freeing up resources that can be 
used elsewhere. 
Improve access and inefficiencies: Partnerships can improve access to health services and products 
by providing health services and products at affordable costs. Partnerships can also improve 
efficiencies by rationalising the use of existing resources, such as staff and infrastructure, across the 
public and private sector. Private sector engagements can also improve supply chain operational 
efficiencies, for example economies of scale can be leveraged to improve access to pharmaceuticals. 
Innovation: The private sector is more equipped to invest in innovative methods and technologies 
than the public sector, therefore engaging with the private sector could lead to the adoption of 
innovative technology, management approaches and health operations.  In addition, innovative 
approaches, solutions and ideas will be generated when staff from different sectors and disciplines 
work together. The private sector also benefits by introducing new markets, having access to 
investment opportunities and generating goodwill. 
Expand and retain human resource capacity: One of the biggest challenges in Sub-Saharan Africa is 
the incidence of “brain drain”. By encouraging the growth of the private sector human resources can 
be retained since it boosts business opportunities within the country. The private sector can also 
provide access to new technologies which expands career opportunities in the health sector. 
Build capacity: The private sector can increase the public sector's coverage and increase capacity by 
engaging with private providers which will increase the number of service delivery points as well as 
the number of skilled human resources. The private sector has the skills and expertise to overcome 
supply chain challenges. Their skills and expertise can help build the public sector's capacity, thereby 
allowing the public sector to better manage its own supply chain. For example, public organisations 
have used private sector training programmes to train staff; the public sector has also engaged with 
the private sector to assist with the optimisation of supply chains. Private sector engagement can not 
only increase the public sector's coverage, but also the coverage of the private sector. 
Shared risk: There is a lot of risks involved when the public and private sectors engage, including 
financial, security, political, human resources and infrastructure risks. Effective engagements share 
risks between the public and private sector which means that each sector accepts a share of the 
engagement risks for which they are best suited. By sharing risks both sectors are more willing to 
engage. 
Risks of public sector engaging with the private sector 
Conflict of interest: The private sector usually measures its performance with performance metrics 
such as return on investment and profit. Conversely, the public sector's main concern is not about 
how much profit it makes but rather ensuring the availability, affordability, accessibility and 
acceptability of medicines. This difference results in a misalignment of the two sector's motivations 
and raises concerns regarding the sharing of information which could be exploited. The public sector 
has to address a number of concerns such as conflicts of interest, competition and the fear that 
projects might not be completed within budget and time constraints due to a lack of transparency 
during the bidding process. 
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Limited capacity to engage with the private sector: The public sector usually has limited experience 
regarding contract management. Inexperience in contract management could result in badly written 
contracts which could place the public sector in a vulnerable position and limits the public sector's 
capacity to manage, develop, enforce and monitor contracts. These factors increase the possibility of 
corruption and conflict of interests. 
Regulatory issues: Often regulatory bodies are responsible for defining contracts between the public 
and private sectors, which means the public sector can be restricted by the contract structure. The 
private sector mostly only invests in new engagements when the contract length is long enough to 
spread their risks over time in addition to providing enough benefit. If the public sector sets unrealistic 
terms, KPIs or lengths for contracts, it could drive up costs and cause the engagement to seem 
unattractive to the private sector. 
Sharing information: The public and private sectors receive consumption data from different sources. 
In the pharmaceutical industry, the private sector receives data from retail outlets, distributors and 
health providers, whereas the public sector uses consumption data that is usually manually collected 
at health facilities. 
External constraints: Public-private engagement opportunities will be influenced by external 
constraints such as: (i)the economic and political climate; (ii) hidden complexities of donor structures 
in projects and national agencies; and (iii) the likelihood that the development and management of 
public-private engagements will be more expensive than internal government processes. 
Risks of private sector engaging with the public sector 
Lack of control: During a public-private engagement the contractual requirements may stipulate the 
timing of processes as well as how resources should be allocated and used. Requirements can be 
influenced by the political climate and may increase the time and costs of the project since the private 
sector has to compensate for having limited control over the resources required to complete expected 
activities. 
Delayed decision making by public sector: In the public sector the decision-making process is often 
drawn out as a result of the government's structure or the contractual processes that need to be 
followed. This increases the private sector's costs and is often not taken into consideration by the 
public sector during initial engagement cost evaluations. 
Contracting challenges: Not all governments have transparent and standardised tendering processes, 
which could lead to corruption and extended contract negotiations. In addition, governments often 
want to enter short-term contracts which is too short for the private sector to make a return on their 
investment. Furthermore, government contracts may request the private sector to take responsibility 
for the risk rather than sharing the risk. 
Payment terms: In order for the private sector to continue its support during the engagement, 
payments must be made on-time. However, budgetary challenges and governmental processes often 
delay payments to the private sector. Therefore, payment terms should be addressed early on to 
prevent the engagement from failing. 
Sharing information: Often frameworks and standards are not timeously shared with the private 
sector. In addition, the private sector may not fully understand how the public sector operates or the 
responsibilities concerning affordability and universal health coverage. Also, data compilation is not 
centralised which means that each sector is unaware of what has been contributed.   
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Appendix F
Excel File
The following link contains the Excel® ﬁle:
https://www.dropbox.com/sh/3c3qn9bpdzi2a45/AABW3vdoPDt8E0ZKOBKoa2Iea?dl=0
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